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A very popular error:  
having the courage of one's convictions;  
rather it is a matter of having the courage  
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As we age, the organs that make up our bodies progressively lose their functionality, 
resulting in age-related diseases and ultimately death. Various theories have been put 
forward to explain why the process of aging should occur (1). Initially it was proposed that 
aging is programmed to prevent populations from becoming too large, but in the wild mortality 
is much more likely to occur as a result of extrinsic mortality (predation, infection, starvation, 
environmental conditions). According to the ‘mutation accumulation theory’, germ-line 
mutations which act late in life are not selected for by evolution since in the wild, organisms 
will be removed from the population before the mutations have any effect. This selection 
shadow is also important in the theory of ‘antagonistic pleiotropy’, proposing that genes with 
beneficial effects early in life can be deleterious later in life. In our modern world we can live 
up to and into the selection shadow, allowing pleiotropic genes to affect our bodies. In the 
‘disposable soma theory’ the organism is thought to distribute a finite amount of energy 
between maintenance of the body and reproduction. The ‘disposable soma theory’ implicates 
that organisms are subject to damage. One of the first theories to explain this damage is the 
‘oxygen radical theory of aging’ (2). 
 
Sources and types of damage 
The sources of cellular damage can be both extrinsic and intrinsic and mostly consist of or 
result in free radical molecules. Examples of extrinsic sources are sunlight (UV-A and UV-B), 
ionizing radiation (radioactivity), polluted air (NO-radicals), food (fat, charred products) and 
environmental chemicals (pesticides) (3). Whereas common sense can protect us from many 
extrinsic stressors, this is more difficult for intrinsic sources of stress. The very process that 
keeps us alive, that of cellular energy production, also results in the production of damaging 
reactive oxygen species (ROS)(4). Additionally, the fuel used to produce energy in the 
mitochondria, glucose, acts as a damaging agent, either directly damaging proteins by 
binding to them (nonenzymatic glycation or NEG) or by inducing ROS (5). The damaging 
nature of ROS has even been harnessed by evolution: leukocytes produce ROS and use 
them to attack infectious pathogens and there is increasing evidence that ROS serve as 




lead to damage, for example in chronic inflammations. Indeed, with increasing age the 
immune system gets progressively deregulated (7). 
 
Cellular responses to stress-induced damage 
Multicellular organisms have become increasingly complex during evolution and many have 
renewable tissues. The skin and gut are examples of organs which are continuously renewed 
by proliferative progenitor cells, but damage to tissues is also repaired by cells which have 
become proliferative temporarily. In a healthy organism, the loss of cells is balanced by the 
new formation of cells, a situation also known as ‘proliferative homeostasis’. As described 
above, damage on the cellular level can deregulate vital cellular processes, resulting in cell 
death or the opposite: uncontrolled proliferation or cancer. Both will clearly disturb the 
proliferative homeostasis and affect organs and the body. Current thinking dictates that 
evolution has devised proteins to both protect cells (caretakers) and remove damaged cells 
from the pool of proliferative cells (gatekeepers) (8).   
When cells contract damage, various mechanisms come into action to first arrest the cell 
cycle, and then gauge the extent of the damage and to finally react accordingly. If the 
damage is repairable, the cell will do so and continue proliferating afterwards. Autophagy, the 
process in which the cell degrades its own organelles in the lysosomes, is an important 
process for repair and the turnover of damaged cellular constituents and affects longevity (9). 
If the damage is irreversible, cells can die in an orchestrated and controlled manner, a 
process called apoptosis, or stay alive in a permanent state of arrest termed cellular 
senescence. In case of extensive damage the regulation of apoptosis and senescence might 




Apoptosis is currently relatively well-understood. Though apoptosis is an important anti-
cancer mechanism, it is not only essential for the removal of damaged cells but also plays an 
important role in the development and maintenance of the healthy organism (10). 
Morphological hallmarks of apoptosis are condensed chromatin, nuclear fragmentation, 




intracellularly, in case of cellular damage, or by external signal molecules (e.g. TNF-family 
proteins). When stress has led to DNA damage, the tumor suppressor proteins p53 and Rb 
are activated and will activate a pathway leading to mitochondrial membrane 
permeabilization and release of cytochrome c which activates a number of proteases from 
the caspase-family. Despite being fragmented, the degradation of all cellular constituents 




Already in 1956, Hayflick observed that human fibroblasts, though growing very well in vitro, 
had a limited lifespan of about 50±10 population doublings (PDs), the so-called Hayflick limit 
(11), after which fibroblasts stopped proliferating but could be kept alive for months and 
displayed an abnormal morphology when compared with proliferating fibroblasts. This state 
was called replicative senescence (RS). Later studies described more morphological and 
biochemical properties that are different in senescent cells: they contain higher levels of ROS 
and of ROS-induced damage products like lipofuscin and changed mass and functionality of 
mitochondria and lysosomes. Indeed, one of the most widely used markers, Senescence 
Associated-β-galactosidase (SA-β-gal) activity (12) is of lysosomal origin.  
It was suggested that the aging of an organism was the result of proliferative cells having a 
maximum replicative capacity (13), implying the existence of a ‘cellular clock’. When 
proliferating, cells are not capable to replicate their DNA all the way to the end of linear 
chromosomes. Non-coding G-rich repeats, called telomeres, function as buffer zones and 
shorten after every division. This led to the ‘telomere-length mitotic clock hypothesis’, but it 
soon became obvious that the maximum replicative capacity of cells was not only a matter of 
shortening telomeres. Some cells can actively elongate their telomeres with the enzyme 
telomerase. Indeed, artificial expression of telomerase dramatically extends replicative 
capacity of cells in vitro, even if the telomeres are shorter than those of control cells which do 
not express telomerase, suggesting that there is no simple relation between telomere length 
and maximum replicative capacity (14;15).  
Replicative exhaustion is not the only cause of cellular senescence. It can also be induced 




oncogenes (stress induced premature senescence or SIPS) (16;17). In most cases, 
senescent cells display upregulated activity of the tumor suppressor proteins p53 and Rb, 
which also play an important role in the DNA damage response (DDR) which has been 
shown to be an important initiator of cellular senescence. Telomeres are bound to a complex 
of proteins forming a protective ‘cap’. Shortening of telomeres or damage-inducing factors 
like ROS can lead to ‘uncapping’ after which the exposed telomeres are considered as DNA 
damage by cells.  
The cyclin-inhibitor p16 plays an important role in senescence. It is thought to activate Rb in 
a p53-independent manner, thus creating an extra level of protection against cancer. Indeed, 
in many human tumors p16 is inactivated. Not all senescent fibroblasts express p16 and 
those that do, generally do not express p21 or display the typical DNA damage foci at the 
telomeres. These findings suggest that there is a DNA damage induced route to senescence 
and a route activated by other stressors, leading to senescence via p16. 
 
The involvement of p53 and Rb in both apoptosis and senescence indicates an interaction 
between the two pathways, but it is not well understood which factors determine if a cell goes 
into apoptosis or into senescence (8;10).  
 
Models for studying aging 
Animal models 
Our knowledge of the mechanisms of aging is to a large extent the result of studying short-
lived species (18). Much has been learned from knocking out or overexpressing single genes 
in these model organisms, but most age-related processes and diseases involve many genes 
in multiple signaling pathways and complex interactions on the systemic, tissue, cellular and 
genetic level. Although species ranging from worms to mammals seem to share many 
mechanisms, translation of results from experiments with these animal model systems to the 
human situation is very precarious (19). In Drosophila and C. Elegans, the p53 and Rb 
homologues also regulate apoptosis and senescence but not as an anti-cancer mechanism 
(8). Between mammals significant differences in signaling can be found. In mouse cells, 
either p53 or Rb inactivation prevents senescence, whereas in human cells inactivation of 




delay the onset of senescence, whereas it does in human cells (17). There are also many 
differences in signaling between the different tissues within an organism. Thus, cellular 
responses to stress and damage will be dependent on species, cell type and the type and 
extent of stress or damage (16). 
 
In vivo versus in vitro 
As already alluded to, manipulation of single genes in model organisms has given much 
insight in to the pathways governing the mechanisms of aging. Evidently, this genetic 
manipulation is not possible in humans for ethical reasons. It is, however, possible to 
experiment with cells isolated from humans. Analogous to the translation of results from 
animal models to humans, the translation of in vitro results to the in vivo situation is difficult 
for two main reasons. First, in vitro characteristics of cells depend on culture conditions like 
the type of medium, batch and concentration of added serum, oxygen concentration and the 
number of PDs undergone in vitro, making it difficult to compare studies (20). Second, cells in 
vitro have been removed from their natural environment, being deprived of many factors in 
the blood (e.g. cytokines and growth factors) and cell-cell and cell-matrix interactions (19). 
Despite these caveats, cells cultured in vitro reflect differences between the organisms they 
were derived from. Skin fibroblasts derived from longer living species are more resistant to 
toxic stress when compared with shorter living species (21). Even within species, skin 
fibroblasts from longer living mutant mice were more resistant to stress (22).  
 
Aim of this thesis 
Earlier we showed that nonagenarian siblings from families with the propensity for longevity 
displayed a 41% lower risk of mortality compared with sporadic nonagenarians (23) and that 
the offspring of these nonagenarian siblings displayed a significantly lower prevalence of 
myocardial infarction, hypertension and diabetes mellitus when compared with their partners 
(23). The general objective of this thesis is to study cellular processes responsible for the 
increased longevity in the offspring, using human dermal fibroblast strains. We aimed to first 
show differences in in vitro cellular phenotypes, comparing fibroblast strains from offspring 
and partners under non-stressed conditions and after oxidative stress. As a proof-of-principle 




focussed on apoptosis and senescence since they are thought to play a major role in stress 
responses. Second, we were interested in the signaling pathways driving the differences in 
cellular phenotypes.  
 
Study populations 
The Leiden Longevity Study 
This study was set up to investigate the contribution of genetic factors to healthy longevity by 
establishing a cohort enriched for familial longevity (24). From July 2002 to May 2006, 420 
families were recruited consisting of 991 long-lived Caucasian siblings together with 1705 of 
their offspring and 760 of the partners thereof. There were no selection criteria on health or 
demographic characteristics. Compared with their partners, the offspring were shown to have 
a 30% lower mortality rate and a lower prevalence of cardio-metabolic diseases (23;24). A 
biobank was established from fibroblasts cultivated from skin biopsies from a subset of 
offspring-partner pairs. 
 
The Leiden 85-plus Study 
This study is a prospective population-based follow up study in which 599 inhabitants of 
Leiden, the Netherlands, aged 85 years took part (25). The study was set up to assess 
common chronic diseases and general impairments in the general oldest-old population. 
Information on common chronic diseases was obtained from records of subjects’ general 
practitioners and pharmacies while general impairments were assessed with functional tests 
and standardized questions during face-to-face interviews. A biobank was established from 
fibroblasts cultivated from skin biopsies of surviving 90-year-old participants and from 
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Senescence Associated-β-galactosidase (SA-β-gal) activity is a widely used marker for 
cellular senenescence. SA-β-gal activity is routinely detected cytochemically, manually 
discriminating negative from positive cells. This method is time-consuming, subjective and 
therefore prone to operator-error. We aimed to optimize a flow cytometric method described 
by other workers using endothelial cells to better differentiate between populations of 
fibroblasts in degrees of SA-β-gal activity. Skin fibroblasts were isolated from young 
(mean±SD age: 25.5±1.8) and very old (age 90.2±0.3)  subjects. Different pH modulators 
were tested for toxicity. To induce stress-induced senescence, fibroblasts were exposed to 
rotenone. Senescence was assessed measuring SA-β-gal activity by cytochemistry (X-gal) 
and by flow cytometry (C12FDG). The pH modulator Bafilomycin A1 (Baf A1) was found to be 
least toxic for fibroblasts and to differentiate best between non-stressed and stressed 
fibroblast populations. Under non-stressed conditions, fibroblasts from very old subjects 
showed higher SA-β-gal activity than fibroblasts from young subjects. This difference was 
found for both the flow cytometric and cytochemical methods (p=0.013 and p=0.056 
respectively). Under stress-induced conditions the flow cytometric method but not the 
cytochemical method revealed significant higher SA-β-gal activity in fibroblasts from very old 
compared with young subjects (p=0.004 and p=0.635 respectively). We found the modified 
flow cytometric method measuring SA-β-gal activity superior in discriminating between 
degrees of senescence in different populations of fibroblasts. 
 
 





Cellular senescence can be induced by exhaustion of replicative capacity (1) or exposure to 
cellular stress (2). A variety of cellular markers of senescence have thus far been identified, 
amongst which there are cellular morphology (3), telomere length (4) and Senescence 
Associated-β-galactosidase (SA-β-gal) activity (5-8). β-Galactosidase is a collective name for 
enzymes which cleave non-reducing β-D-galactose residues from glycoproteins, 
sphingolipids and keratan sulfate in β-D-galactosides (9). These enzymes function optimally 
at pH 4. In senescent cells, β-galactosidase activity can also be detected at pH 6, although 
the function of SA-β-gal at this pH remains unknown (6). 
SA-β-Gal activity can be cytochemically detected using 5-bromo-4-chloro-3-indolyl-β-D-
galactoside (X-gal) as a substrate. Fibroblasts are stained, digitally recorded and SA-β-gal 
positive fibroblasts are manually counted and expressed as a percentage of total fibroblasts 
(6-8). Subjectivity, i.e. a low inter-rater reproducibility, is the main disadvantage of the 
method, and the procedure is highly time consuming. Kurz et al. (10) used a method based 
on flow cytometry to quantify SA-β-gal activity in endothelial cells (HUVEC). The flow 
cytometric method is not subjective and has a high throughput when compared with the 
cytochemical method. Kurz et al. (10) found the flow cytometric method to correlate well with 
the cytochemical method when using HUVECs. 
Although the use of human fibroblasts was also exemplified in the paper by Kurz et al. (10), 
here we further extend the applications of the flow cytometric method in fibroblasts by 
performing the experiments under conditions of lysosomal alkalinisation and measuring 
stress induced premature senescence (SIPS). In this manuscript, we describe the 
optimization of the flow cytometric procedure, for use in human diploid fibroblasts and its 
comparison to the conventional cytochemical method. To investigate if the two methods are 
equally able to discriminate SA-β-gal activity between subpopulations of fibroblasts, we have 
compared fibroblast strains derived from young and very old subjects, both under non-






Materials & methods 
 
Fibroblast Cultures 
Fibroblast strains were obtained from participants of the Leiden 85-plus Study, a population-
based follow up study in which 599 inhabitants of Leiden, the Netherlands, aged 85 years 
took part (11). Skin biopsies were taken as described earlier (12) at the age of 89 or 90 
years. In order to have a contrast in chronological age, skin biopsies were also obtained from 
young subjects (mean±SD age: 25.5±1.8 years).  
Biopsies were taken from the sun unexposed medial side of the upper arm and cultured 
under standardized conditions (12) at 37°C, 5%CO 2 and 100% humidity in D-MEM:F-12 
supplemented with 10% fetal calf serum (FCS, Gibco, batch no. 40G4932F), 1 mM MEM 
sodium pyruvate, 10 mM HEPES, 2 mM Glutamax and antibiotics (100 Units/ml penicillin, 
100 µg/ml streptomycin, 2.5 µg/ml amphotericin B). This medium will be referred to as growth 
medium. All reagents were obtained from GIBCO, Breda, the Netherlands. When cultures 
reached 80% to 90% confluence, fibroblasts were subcultured using a 1:4 split ratio.  
Experiments for optimization of the sample preparation were performed with two fibroblast 
strains from young subjects. Immunohistochemical double staining for p16 and SA-β-gal was 
performed using three randomly chosen strains under non-stressed and stressed conditions 
as well as one high passage strain that had undergone 79 population doublings. After 
optimization, fibroblast strains from ten young and ten very old subjects, which were 
randomly selected from the Leiden 85-plus Study, were compared. 
 
Induction of cellular stress 
Fibroblasts were seeded at a density of 2.6x104 fibroblasts per 25-cm2 flask and in Permanox 
2-chamber slides (Nunc, VWR, Amsterdam, the Netherlands) at 1.0x104 fibroblasts per 
chamber (4.2 cm2/chamber). In pilot experiments, fibroblasts were stressed with 0.2 µM - 1 
µM rotenone for three days (data not shown). Exposure to 0.6 µM rotenone induced 
considerable senescence after three days and this concentration was subsequently used to 
stress fibroblast strains from young and very old subjects.  
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Four hours after seeding, medium was replaced by growth medium supplemented with 0.6 
µM rotenone. Fibroblasts were incubated for 72 hours in rotenone-supplemented medium, 
after which they were analyzed. All experiments were repeated. 
 
Lysosomal pH adjustment 
Lysosomal pH was increased to pH 6 by adding bafilomycin A1 (baf A1) or chloroquine 
(10;13) to the growth medium. Nigericin in a buffered solution was used to change the pH of 
all intracellular compartments (10;14;15). 
Baf A1: Fibroblasts were  incubated for one hour in growth medium supplemented with 100 
nM baf A1 at 37°C, 5% CO 2, and one hour in growth medium with 100 nM baf A1 and 33 µM 
5-Dodecanoylaminofluorescein-di-β-D-galactopyranoside (C12FDG) prior to analysis.  
Chloroquine: Fibroblast were incubated for two hours in growth medium containing 100 or 
300 µM chloroquine at 37°C, 5% CO 2, and one hour in growth medium with 100 or 300 µM 
chloroquine and 33 µM C12FDG. 
Nigericin (10 µM) was added to the culture in the presence of a potassium-rich 2-(N-
morpholino) ethanesulfonic acid (MES) buffer (150 mM KCl, 10 mM NaCl, 1 mM MgCl2, 0.1 
mM CaCl2, 10 mM Glucose, 10 mM MES buffer), pH 6, and incubated for 15 minutes at 37°C, 
not CO2 enriched, after which C12FDG was added (33 µM) followed by one hour incubation at 
37°C, not CO 2-enriched.  
 
Measurement of toxicity pH-modulators 
Toxicity of pH modulators was determined by measuring apoptosis and necrosis using the 
TACS Annexin V-FITC kit (R&D Systems, Abingdon, United Kingdom) and a FACSCalibur 
flow cytometer (BD, Oxford, United Kingdom). Events were gated into quadrants and Annexin 
V positive/propidium iodide (PI) negative (Annexin V+/PI-) and Annexin V positive/propidium 






Immunohistochemical double staining for p16 and sen escence-associated β-
galactosidase  
To show that rotenone induces senescence, double staining for p16 and SA-β-gal was 
performed as previously described by Itahana et al. (16). Fibroblasts were seeded in 
Permanox 4-chamber slides at 4000 cells/chamber and allowed to attach for four hours. After 
treatment with 600 nM rotenone for three days, fibroblasts were fixed with 4% 
paraformaldehyde in PBS for 4 minutes and stained for SA-β-gal activity as described in the 
subsequent paragraph. After permeabilization for 20 minutes in 0.2% Triton (Sigma, St Louis, 
MO, USA) in PBS, samples were blocked with blocking buffer (3% BSA in PBS) for one hour 
at room temperature and incubated for two hours with anti-p16 (JC8) antibody (Santa Cruz 
Biotechnology Inc., Santa Cruz, USA), diluted 1/100 in blocking buffer. After three washes 
with PBS, coverslips were incubated with Alexa Fluor® 488 labeled anti-mouse antibody 
(Invitrogen, Breda, The Netherlands) diluted 1:1000 in blocking buffer for one hour. Slides 
were mounted with Vectashield Fluorescent Mounting Medium (Vector laboraties, 
Burlingame, CA, USA) and photographed with a Leica fluorescence microscope (Leica 
Microsystems, Rijswijk, the Netherlands). Per sample, 100 randomly chosen cells were 
assessed for SA-β-gal positivity and for p16 positivity. 
 
Flow cytometric measurement of SA- β-gal activity 
C12FDG is a substrate which, when hydrolyzed by SA-β-gal, becomes fluorescent and 
membrane impermeable (10,17). C12FDG was added to the pH modulation medium/buffer. 
Fibroblasts were incubated with this solution for one hour at 37°C, 5% CO 2 (nigericin-buffer 
incubation not CO2 enriched). After incubation, fibroblasts were trypsinized with trypsin EDTA 
(Sigma, St Louis, MO, USA), washed with PBS, resuspended in 200 µl PBS, and analyzed 
immediately using a FACSCalibur flow cytometer. Data were analyzed using FACSDiva 
software (BD, Oxford, United Kingdom). Cell debris was excluded on basis of light scatter 
parameters. C12FDG was measured on the FL1 detector (500-510 nm wavelength). SA-β-gal 
activity was expressed as the FL1 median fluorescence intensity (MdFI, in arbitrary units) of 
the fibroblast population.  
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Cytochemical staining for SA- β-gal activity 
The cytochemical method was conducted as described by Dimri et al. (6). A Senescence 
Cells Histochemical Staining Kit was used (Sigma, St Louis, MO, USA) and fibroblasts were 
processed according to the manufacturer’s guidelines. Slides were washed twice with PBS, 
counterstained with Mayers-Hematoxylin staining solution (Sigma, St Louis, MO, USA) for 5 
minutes at room temperature and washed twice again with PBS. Fibroblasts were then 
viewed by phase contrast on a Leica microscope (Leica Microsystems, Rijswijk, the 
Netherlands) and recorded at a 100x magnification by a digital color camera. Per sample, 
500 randomly selected fibroblasts were photographed and counted. The number of positive, 
blue fibroblasts was divided by the total number of counted fibroblasts, resulting in the 
percentage of SA-β-gal positive fibroblasts.  
 
Statistical analysis 
All analyses were performed with the software package SPSS 14.0 (SPSS Inc., Chicago, IL). 
Differences between pH modulators were analyzed by one-tailed Student’s t test. Differences 
between non-stressed and stressed fibroblasts as well as differences between fibroblast 
strains from young and very old subjects were analyzed by two-tailed Student’s t test. Results 
of cytochemical SA-β-gal measurements were divided into tertiles and related to the flow 
cytometric results. Differences between tertiles were analyzed by ANOVA. Co-localization of 
p16 and SA-β-gal was described by calculating the specificity (p16-negative fibroblasts as 
percentage of SA-β-gal-negative fibroblasts) and sensitivity (p16-positive fibroblasts as 
percentage of SA-β-gal-positive fibroblasts). To determine the correlation between the flow 






Unlike the cytochemical assay, in which cells are fixed with formalin, the flow cytometric 
method measures SA-β-gal activity in living cells. Therefore, the toxicity of the pH modulating 




annexin V+/PI- fibroblasts, reflecting early apoptotic cells, was only significantly increased 
after treatment with 300 µM chloroquine (Figure 1A). Rotenone treatment was used as a 
positive control for induction of apoptosis, and yielded a significant increase in percentage of 
early apoptotic cells (3.2±0.61%). Of the four pH modulating conditions tested, the increases 




Figure 1.  Apoptosis and cell death induced by pH modulation. A, Mean percentage of annexin V+/PI- 
fibroblasts, reflecting early apoptotic cells. B, Mean percentage of Annexin-V positive/PI positive 
fibroblasts, reflecting cell death. Mean ± SEM of repeated experiments in two strains. *p≤0.05 **p≤0.01 
***p≤0.001” 
 
for bafilomycin A1 (mean increase ± SD: 0.02±0.27%) compared with treatment with nigericin 
(0.49±0.63%), 100 µM chloroquine (0.31±0.47%) and 300 µM chloroquine (0.77±0.47%). In 
Figure 1B, increases in the percentage of annexin V+/PI+ fibroblasts, followed a similar trend 
as shown in Figure 1A. All pH-modulating agents yielded an increase in the percentage of 
annexin V+/PI+ fibroblasts. This increase was not significant for bafilomycin A1 and nigericin 
(1.34±1.35% and 2.29±3.2% respectively). Chloroquine treatment induced a significant 
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increase in percentage of annexin V-positive/ PI-positive fibroblasts (100 µM: 2.92±2.37%, 
300 µM: 7.48±2.88%) as did rotenone treatment (1.13±0.87%). 
 
C12FDG conversion 
To determine if the pH modulators would affect the ability to discriminate between degrees of 
SA-β-gal activity, senescence was induced with rotenone and SA-β-gal activity was assessed 
using C12FDG. Figure 2 shows representative histograms of both non-stressed and rotenone-
stressed fibroblast strains. Discrimination between non-stressed and stressed fibroblasts was 
best when the pH was modulated using Baf A1 (Median Fluorescence Intensity [MdFI] in 
arbitrary units, non-stressed: 1475±154, stressed: 2405±260, p=0.008). Other pH modulators 
also showed changes in MdFI (nigericin: non-stressed: 502±16, stressed: 698±7, p=0.0001; 
300 µM chloroquine: 350±48 vs. 482±28, p=0.012), except for 100 µM chloroquine (997±68 





Figure 2.  Change in SA-β-gal activity measured by the flow cytometric method in fibroblast strains after 
induction of stress-induced premature senescence. Histograms are representative examples of SA-β-gal 
activity in non-stressed and rotenone-stressed fibroblast strains (n=2, duplicate experiments). Samples 




Even though pH modulation appeared not to be essential to SA-β-gal activity quantification 
with the flow cytometric method as shown in Figure 2, it is a necessary step for the 
cytochemical method. When no pH modulation is applied all cells would stain blue, making it 
impossible to distinguish senescent from non-senescent cells. Modulation of the lysosomal 
pH was thus applied in further experiments, to better compare the flow cytometric method 
with the cytochemical method. Based on toxicity and SA-β-gal activity, we concluded that Baf 
A1 was the agent of choice for pH modulation and was thus used in all subsequent 
experiments. 
 
Rotenone induced senescence increases SA- β-gal activity and p16 expression 
Figure 3 displays a representative photograph of fibroblasts positive for both SA-β-gal activity 
and p16. The absence and presence of SA-β-gal activity and p16 expression were assessed 
for three fibroblast strains, both under non-stressed and stressed conditions.  
 
     A                                   B 
                    
Figure 3.  SA-β-gal activity and p16 expression at 3 days after rotenone treatment. A, Phase-contrast 
photograph showing a SA-β-gal positive (blue) and a SA-β-gal negative fibroblast. B, Immunofluorescent 
photograph showing a p16 positive (green) and a p16 negative fibroblast. Blue: DAPI. 
 
The combined results for these three strains are presented in Table 1. Under non-stressed 
conditions, 54% of the fibroblasts were double-negative for SA-β-gal activity and p16 
expression (66%, 47% and 50% for the three strains respectively) whereas under rotenone-
stressed conditions, 43% of the fibroblasts were double-positive (33%, 40% and 55%). High 
passage fibroblasts were included in the experiment as positive control (47%). Despite the 
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considerable concordance, discordance remained present. Specificity and sensitivity were 
calculated to be 78% and 37% respectively for non-stressed fibroblasts and 62% and 73% 
respectively for stressed fibroblasts. 
 
Table 1.  SA-β-gal activity and p16 expression of three fibroblast strains, under non-stressed 
and rotenone stressed conditions and in one strain at high passage.  
  SA-β-gal negative 
# cells (%) 
SA-β-gal positive 
# cells (%) 
Total 
# cells (%) 




p16 negative 163 (54) 57 (19) 220 (73) 
p16 positive 47 (16) 33 (11) 80 (27) 





p16 negative 79 (26) 45 (15) 124 (41) 
p16 positive 48 (16) 128 (43) 176 (59) 
Total 127 (42) 173 (58) 300 (100) 
High passage     
p16 negative 23 (23) 10 (10) 33 (33) 
p16 positive 20 (20) 47 (47) 67 (67) 
Total 43 (43) 57 (57) 100 (100) 
For each strain, 100 cells were counted. High passage strain was stained after 79 population doublings. 
 
 
Comparison of flow cytometric- and cytochemical met hod  
Twenty fibroblast strains, ten fibroblast strains from young and ten from very old subjects, 
were used to determine the relation between the flow cytometric and the cytochemical 
method. The two methods were performed simultaneously for each fibroblast strain, both 
under non-stressed and stressed conditions. Rotenone induced a significant increase in SA-
β-gal activity for both methods as shown in Figure 4A and B. Figure 4C and D show the three 




plotted against the corresponding SA-β-gal MdFI values determined by the flow cytometric 
method.  
Under non-stressed conditions (Figure 4C), significant increases in flow cytometric SA-β-gal 
activity between tertiles of the cytochemical method were found (trend: p=0.01). When 
analyzed continuously, the MdFI correlated significantly with the percentages of SA-β-gal 
positive fibroblasts (r2=0.31, p=0.014). Under stressed conditions (Figure 4D) no relation was 
found between the flow cytometric method and cytochemical method (trend p=0.82). Even  
though both methods detect a significant increase of SA-β-gal activity upon rotenone 
treatment, we found no relation between the two methods under stressed conditions.  
 
To clarify which of the two methods is the method of choice, both methods measuring SA-β-
gal activity were used to discriminate fibroblasts from young and old donors. Figure 5A shows 
the significant difference in SA-β-gal activity that was found in fibroblasts from young and 
very old subjects under non-stressed conditions using the flow cytometric method (MdFI in 
arbitrary units, young: 2161±643, old: 3125±903, p=0.013). When analyzed with the cytoche-
mical method (Figure 5B), the same difference in SA-β-gal activity in young and very old 
subjects was found, though this difference was not statistically significant (young: 
18.7±5.84%, old: 28.3±13.65%, p=0.056). Upon induction of senescence with rotenone, the 
difference in SA-β-gal activity between young and very old subjects remained by using the 
flow cytometric method (MdFI in arbitrary units, 3438±689 vs. 4617±880, p=0.004), but was 
absent when the cytochemical method was performed (44.3±10.7% vs. 47.3±16.1%, 
p=0.634). 
 





Figure 4.  A/B, SA-β-gal activity measured with the cytochemical and flow cytometric methods under non-
stressed conditions and after stress with rotenone. A, cytochemical method. B, flow cytometric method. 
C/D, correlation between SA-β-gal activity measured by the flow cytometric method and cytochemical 
method. C, Non-stressed fibroblasts, ANOVA for trend p=0.01. D, rotenone-stressed fibroblasts, ANOVA 





Figure 5.  SA-β-gal activity of fibroblast strains from young and very old subjects measured by: A, the flow 
cytometric method and B, the cytochemical method. Bar-charts display SA-β-gal activity of fibroblast 
strains from young (Y, n=10) and very old (O, n=10) subjects, in non-stressed and rotenone-stressed 





The cytochemical detection of SA-β-gal activity is a widely used marker for cellular 
senescence and was firstly described by Dimri et al. (6). Although the cytochemical method is 
widely used, it is subjective, prone to inter-rater variability and time-consuming. Kurz et al. 
(10) described a method to measure SA-β-gal activity in HUVECs by flow cytometry, using a 
fluorogenic substrate. Using this method, cells are neither strictly negative nor positive for 
SA-β-gal activity but each cell in a population is quantified separately, resulting in more 
accurate evaluation of differences in SA-β-gal activity within and between populations of 
cells. This method was validated with the conventional cytochemical method as described by 
Dimri et al. (6). Because cellular senescence is widely studied in human diploid fibroblasts, 
we aimed to optimize the flow cytometric method using this cell type.  
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Rotenone was chosen as senescence-inducing agent because it acts on mitochondrial 
complex I, leading to increased levels of intracellular Reactive Oxygen Species (ROS) (17), 
which is supposed to mimic the physiological process of ROS induced damage that underlies 
the aging process (18). Armstong et al. showed the apoptotic effect of rotenone when applied 
in high concentrations (19). When used in lower concentrations, we found that rotenone 
induces senescence as measured by colocalisation of increased p16 expression and 
increased SA-β-gal activity. As a positive control, we also observed colocalisation of 
increased p16 expression coinciding with increased SA-β-gal activity in high passage 
fibroblasts as was previously observed by Itahana et al. (16). In line with these results, Duan 
et al. (20) showed that antisense p16 postponed senescence and decreased SA-β-gal 
activity, indicating that SA-β-gal activity is indeed a good marker of senescence. However, 
the discordance in SA-β-gal activity and p16 expression as described in Table 1 shows that 
increased p16 expression is not a prerequisite for an increase in SA-β-gal activity and that 
SA-β-gal activity does not always depend on p16 expression. Although various markers have 
been described that identify senescent cells, the current consensus is that none of these 
markers is specific for senescence only (21). One of the hallmarks of senescence is growth 
arrest, which can be mediated by two main pathways: the p53/p21 and the p16/pRB 
pathways. Although p16 is expressed by many senescent cells, it is not exclusive for 
senescence (16;22), which is a possible explanation for the SA-β-gal negative/p16 positive 
fibroblasts observed in our experiments. The SA-β-gal positive/p16 negative fibroblasts could 
well be the result of senescence induced by pathways other than p16, for example p53. 
Additionally, examples of senescence have been described that are independent of p16 and 
p53 (23;24). 
 
Both the flow cytometric and the cytochemical method showed significant increases in SA-β-
gal activity after exposure to stress. Under non-stressed conditions, both methods were able 
to detect a difference between fibroblast strains derived from young subjects compared with 
strains from very old subjects. When these fibroblast strains were exposed to stress, only the 
flow cytometric method was able to identify differences in SA-β-gal activity between 
fibroblasts from young and very old subjects. This could be due to the marked differences 




β-gal activity of individual fibroblasts is assessed dichotomously, whereas the flow cytometric 
method measures SA-β-gal activity in the fibroblasts on a continuous fluorescence scale. It 
may thus be well conceivable that two samples measured cytochemically might yield similar 
percentages of SA-β-gal positive fibroblasts while the intensity of the stained fibroblasts is 
different between the samples. This difference between samples would be detected by the 
flow cytometric method since every fibroblast is measured on a continuous scale. Another 
important difference is that the cytochemical method is performed on fixed fibroblasts 
whereas flow cytometry is applied to living fibroblasts. Enzyme activity depends on a proper 
configuration of the protein involved. It is likely that in fixed fibroblasts, enzyme activity will be 
affected by protein cross-linking and it may thus be hypothesized that measuring SA-β-gal 
activity with the flow cytometric method in living fibroblasts may better reflect biology. 
 
Since the flow cytometric method described relies on living fibroblasts, we tested the pH 
modulators for toxicity. We found that Baf A1 was not toxic for fibroblasts whereas 
chloroquine and nigericin were. Kurz et al. (10) show that the SA-β-activity is indeed 
lysosomal, so we preferred to selectively change lysosomal pH (Baf A1 and chloroquine), as 
opposed to cytosolic pH (nigericin buffer). Since Baf A1 was virtually non-toxic, whereas 
chloroquine was not, Baf A1 was our pH-modulator of choice.  
 
Our results suggest that under most conditions, both methods show changes in SA-β-gal 
activity, but we found the flow cytometric method superior to discriminate between 
populations of fibroblasts, showing different levels of induced SA-β-gal activity being 
associated with senescence. Taking into account that the flow cytometric is also less labor-
intensive and more time- and cost-effective than the cytochemical method, we strongly 
recommend flow cytometry for measuring SA-β-gal activity in cultured fibroblasts. 
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Unlike various model organisms, cellular responses to stress have not been related to human 
longevity. We investigated cellular responses to stress in skin fibroblasts that were isolated 
from young and very old subjects, and from offspring of nonagenarian siblings and their 
partners, representatives of the general population. Fibroblast strains were exposed to 
rotenone and hyperglycemia and assessed for Senescence Associated-β-galactosidase (SA-
β-gal) activity by flow cytometry. Apoptosis/cell death was measured with the Annexin-V/PI 
assay and cell-cycle analysis (Sub-G1 content) and growth potential was determined by the 
colony formation assay. Compared with fibroblast strains from young subjects, baseline SA-
β-gal activity was higher in fibroblast strains from old subjects (p=0.004) as were stress-
induced increases (rotenone: p<0.001, hyperglycemia: p=0.027). For measures of 
apoptosis/cell death, fibroblast strains from old subjects showed higher baseline levels 
(AnnexinV+/PI+ cells: p=0.040, Sub-G1: p=0.014) and smaller stress-induced increases 
(Sub-G1: p=0.018) than fibroblast strains from young subjects. Numbers and total size of 
colonies under non-stressed conditions were higher for fibroblast strains from young subjects 
(p=0.017 and p=0.006 respectively). Baseline levels of SA-β-gal activity and apoptosis/cell 
death were not different between fibroblast strains from offspring and partner. For fibroblast 
strains from offspring, stress-induced greater were smaller for SA-β-gal activity (rotenone: 
p=0.064, hyperglycemia: p<0.001) and greater for apoptosis/cell death (Annexin V+/PI- cells: 
p=0.041, AnnexinV+/PI+ cells: p=0.008). Numbers and total size of colonies under non-
stressed conditions were higher for fibroblast strains from offspring (p=0.001 and p=0.024 
respectively) whereas rotenone-induced decreases were smaller (p=0.008 and p=0.004 
respectively). These data provide strong support for the hypothesis that in vitro cellular 
responses to stress reflect the propensity for human longevity.  





Organisms are continuously exposed to intrinsic and environmental stressors. Many of these 
stressors result in the formation of Reactive Oxygen Species (ROS) that are thought to play 
an important role in aging and age-related diseases (1). Low levels of ROS may be essential 
to maintain` homeostasis, but excess ROS will cause damage to important macromolecules, 
including DNA, proteins and lipids (2). Organisms with self-renewable tissues can replace 
damaged cells, rejuvenating tissues to maintain body homeostasis, depending on the 
balance between cell proliferation and cell death. However, as proliferating cells can 
transform into cancer cells as a result of genomic damage, several protective mechanisms 
have evolved to prevent cells from becoming neoplastic (3;4). Faced with damage, a 
proliferating cell can take several routes, depending on the cell type, and the type and extent 
of damage that has occurred. First, it can arrest the cell cycle, repair the damage and 
continue to proliferate. Second, it can permanently stop proliferating and become senescent 
(5;6). Third, it can be removed in a controlled manner by apoptosis or in an uncontrolled 
manner by necrosis (7). 
Though ROS-induced damage can cause cells to go into apoptosis or senescence, little is 
known about the relative contributions of these cellular fates in response to stressors and 
how these change with age. Conversely, mechanisms that determine cellular repair and cell 
turnover may directly influence the rate of aging. Amongst others, these may include (epi-) 
genetic factors that determine cellular responses to stressors. So far, evidence for a direct 
link between cellular stress responses and the rate of aging has come only from model 
organisms. Between species, fibroblasts from longer living animals (i.e. different genetic 
background) have a higher resistance to stress in vitro (8;9), and within species, fibroblasts 
from various mutant, long-lived mice were found to be more stress-resistant than their wild-
type counterparts (10). Conversely, mutant mice having an enhanced p53 response, 
associated with excessive induction of apoptosis and senescence, were shown to have a 
higher cancer resistance but a shortened longevity (11). 
In humans, in vitro cellular stress responses have not been related to longevity so far. To 
study how cellular responses to stress may change during aging, we compared stress-




young and very old subjects. We also studied fibroblast strains from offspring of 
nonagenarian siblings and their partners with a similar chronological age but who represent 
the average of the general population. We hypothesized that fibroblasts from old subjects 
would be more prone to go into senescence and into apoptosis when compared with 
fibroblasts from young subjects and that fibroblasts from subjects with the propensity for 
longevity (i.e. biologically younger) would show more resistance to go into senescence and 
apoptosis compared with fibroblasts of their partners. 
 
 
Materials and Methods 
 
Study design 
The Leiden 85-Plus Study (12) is a prospective population-based study in which all 
inhabitants aged 85 year or older of the city of Leiden, the Netherlands, were invited to take 
part. Between September 1997 and September 1999, 599 out of 705 eligible subjects (85%) 
were enrolled. All participants were followed for mortality and 275 subjects survived to the 
age of 90 years. During the period December 2003 up to May 2004, a biobank was 
established from fibroblasts cultivated from skin biopsies from 68 of the 275 surviving 90-
year-old participants. During the period August to November 2006, we also established a 
biobank from biopsies taken from 27 young subjects (23-29 years old). Given the extreme 
age difference of almost 65 years between the groups of old and young subjects, a relatively 
small sample size of 10 subjects per age group was chosen, consisting of 5 fibroblast strains 
from the 42 nonagenarian females, 5 strains from the 26 nonagenarian males, 7 strains 24 
young females and the 3 available strains of young males (Table 2). 
 
The Leiden Longevity Study (13) was set up to investigate the contribution of genetic factors 
to healthy longevity by establishing a cohort enriched for familial longevity. From July 2002 to 
May 2006, 420 families were recruited consisting of 991 long-lived Caucasian siblings 
together with their 1705 of their offspring and 760 of the partners thereof. There were no 
selection criteria on health or demographic characteristics. Compared with their partners, the 
offspring were shown to have a 30% lower mortality rate and a lower prevalence of cardio-
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metabolic diseases (13;14). During the period November 2006 and May 2008, a biobank was 
established from fibroblasts cultivated from skin biopsies from 150 offspring-partner pairs. 
Because it was expected that the difference in biological age between the offspring and 
partner groups would be much smaller than the extreme difference in chronological age 
between the groups of old and young subjects, a relatively large sample size of 80 strains 
from 40 couples was chosen, consisting of 20 fibroblast strains from the 65 female offspring, 
20 strains from the 86 male offspring, as well as 20 strains from the 86 female partners and 
20 strains from the 63 male partners (Table 2).   
 
Fibroblast Cultures 
Three-mm (Leiden 85-plus Study) and 4-mm skin biopsies (LLS) were taken from the sun 
unexposed medial side of the upper arm. Fibroblasts were grown in D-MEM:F-12 (1:1) 
medium supplemented with 10% fetal calf serum (FCS), 1 mM MEM sodium pyruvate, 10 
mM HEPES, 2 mM glutamax I, and antibiotics (100 Units/mL penicillin, 100 µg/mL 
streptomycin, and 0.25–2.5 µg/mL amphotericin B), all obtained from Gibco, Breda, the 
Netherlands. Different FCS batches were used for fibroblasts from the Leiden 85-plus Study 
(Gibco, batch no. 40G4932F) and for fibroblasts from the LLS (Bodinco, Alkmaar, the 
Netherlands, batch no. 162229). This medium will be referred to as standard medium. 
Fibroblasts were incubated at 37°C with 5% CO 2 and 100% humidity. All cultures that are 
used in the present study were grown under predefined, highly standardized conditions as 
published earlier (15) and frozen at low passage.  
 
Experimental setup 
Experiments were set up in batches of maximally 10 fibroblast strains which were thawed 
from frozen stocks on day zero. On day one, the medium was changed and on day four 
fibroblasts were passaged 1:4 and passaged further in equal numbers on days six and eight 
to have similar confluences for experiments. On day 11, fibroblasts were seeded for 
experiments.  
To induce stress we used rotenone and hyperglycemia. Rotenone is known to induce ROS at 
the mitochondrial level (16) and increased ROS can induce senescence (17). Hyperglycemia 




senescence in human skin fibroblasts (19). In pilot experiments, fibroblasts were stressed 
with 0.2 µM and 1 µM rotenone and with 111 mM glucose for three days and seven days. 
Senescence was measured by SA-β-gal activity and apoptosis by sub-G1 cell debris and by 
Annexin V/PI assay. Exposure to 1 µM rotenone induced apoptosis after three days and most 
fibroblasts had died after seven days. Exposure to 0.2 µM rotenone and 111 mM glucose did 
not induce appreciable apoptosis after three or seven days, but did induce senescence after 
seven days, more so than after three days. Based on these results, it was decided to 
measure apoptosis at three days and senescence at seven days after exposure to stress. 
 
Stock solutions of rotenone were prepared in DMSO (both from Sigma, St Louis, MO, USA) 
at a concentration of 100 µM and stored at -40oC in aliquots. Initial tests showed that DMSO 
(0.2%) did not affect the results. Hyperglycemic medium was prepared by adding 17 g/L D-
glucose (Sigma, St Louis, MO, USA) to standard medium, resulting in a final concentration of 
20 g/L (111 mM) glucose. For the seven-day time point, medium was replaced with freshly 
supplemented medium after three days. 
Experiments were repeated for each fibroblast strain and each condition. The experimental 
conditions and measured parameters are summarized in Table 1.  
 
Table 1.  Experimental conditions and measured parameters. 
 Stressor 




nd Annexin V+/PI- cells (%) 
Annexin V+/PI+ cells (%) 
FACS SA-β-gal activity (MdFI) 
nd 
0.2 µM rotenone 
111 mM glucose Colony Formation assay  
(# colonies & total area in mm2) 
nd: not done. 
 




To determine cellular senescence we used the widely described marker SA-β-gal activity. 
Earlier we demonstrated the validity and superiority of the flow cytometric method over the 
cytochemical method measuring SA-β-gal activity in human fibroblasts (20). In short, 
fibroblasts were seeded at 130 cells/cm2 in 75-cm2 flasks and were prepared as described by 
Kurz et al. (21). To change the lysosomal pH to pH 6, fibroblasts were incubated with 
medium containing 100 nM bafilomycin A1 (VWR, Amsterdam, the Netherlands) for one hour 
and then incubated with 33 µM of the β-gal substrate C12FDG (Invitrogen, Breda, The 
Netherlands) in the presence of 100 nM bafilomycin A1. After trypsinisation, fibroblasts were 
washed once and resuspended in 200 µl ice cold phosphate buffered saline (PBS) and 




Fibroblasts were seeded at 1000 cells/cm2 in 75-cm2 flasks. Sample preparation was 
performed on ice. Aspirated medium and washes were collected to include any floating cells 
and cell debris indicating cell death in the analysis. Fibroblasts were trypsinized and washed 
with PBS. The suspension was divided over two tubes, one for Annexin V/propidium iodide 
(PI) analysis and one for cell cycle analysis.  
For the flow cytometric Annexin V/PI analysis, the TACS Annexin V-FITC kit was used (R&D 
Systems, Abingdon, United Kingdom). Fibroblasts were processed according to the 
manufacturer’s guidelines. Analysis was performed on a LSRII flow cytometer (Becton 
Dickinson, Franklin Lakes, USA). The Annexin V-FITC signal was measured in the FITC-
channel and the PI signal in the PE-Texas Red channel. Events were gated into quadrants 
and Annexin V positive/PI negative (Annexin V+/PI-) and Annexin V positive/PI positive 
(Annexin V+/PI+) fibroblasts were analyzed as percentages of the total cell population.  
For the flow cytometric cell cycle analysis, fibroblasts were centrifuged at 1000 rpm for 5 
minutes, washed by resuspending in PBS, centrifuged again and resuspended in 200 µl 70% 
ethanol. Samples were kept at -40°C at least overni ght. After adding 1 mL PBS, fibroblasts 
were centrifuged at 2000 rpm for 5 minutes and resuspended in 200 µl PBS containing 50 




overnight at 4°C and measured in the PE-Texas Red c hannel. In the resulting histograms, 
Sub-G1 events (dead cells and cell debris) were gated and analyzed as percentages of the 
total cell population. 
 
Colony formation assay  
After having been exposed to the stressors for seven days and allowed to grow in standard 
medium for another week, medium was removed from the dishes, fibroblasts were washed 
with PBS and fixed with 0.25% gluteraldehyde for 30 minutes. Fibroblasts were washed with 
water and stained with 0.6 mg/ml Coomassie in 1:6 methanol/water overnight, washed again 
with water and air dried. Dishes were then scanned with a high resolution Agfa XY-15 flatbed 
scanner (Agfa Gevaert, Mortsel, Belgium) and colonies were manually scored with the freely 
available image analysis software package ImageJ 1.37v. 
 
Statistics 
All analyses were performed with the software package SPSS 14.00 (SPSS Inc., Chicago, 
IL). Differences in cellular characteristics between non-stressed and stressed fibroblast 
strains were compared by Student’s t-test and were represented as mean±SD. Stress-
induced increases were calculated by subtracting the values from non-stressed fibroblasts 
from those of stressed fibroblasts for each strain separately. Non-stressed levels and stress-
induced increases were then compared between fibroblast strains from young and old 
subjects (Leiden 85-plus Study, SA-β-gal activity: n=20, apoptosis/cell death: n=20) and 
between fibroblast strains from offspring and partners (LLS, SA-β-gal activity: n=40, 
apoptosis/cell death: n=80). Stress-induced increases were represented as mean ±SE. 
Since experiments were performed in batches of maximally ten fibroblast strains 
simultaneously, group differences were also compared using linear mixed-effect models 
(LMMs) to account for repeat experiments and batch effects. Cumulative frequency plots 
were made for flow cytometry results of SA-β-gal activity to inspect possible changes in 
distributions of MdFI values of SA-β-gal activity resulting from exposure to stress and from 
differences between young and old subjects, offspring and partners. 
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Results   
 
Table 2 shows characteristics for the randomly selected subset of subjects from whom 
fibroblast strains were tested. Partners and offspring were of similar age, height and weight. 
As observed in the whole cohort, the prevalences of cardio-metabolic disease were lower in 
the offspring group as compared with the partners group (14), perhaps illustrating the lower 
rate of aging among the long-lived families. 
 
Table 2.  Comparison of clinical characteristics in young and old subjects from the Leiden 85-
plus Study and in offspring and partners from the Leiden Longevity Study. 
 Leiden 85-plus Study  Leiden Longevity Study 
 Young Old  Offspring Partners 
Demog raphic data       
N (female) 10 (7) 10 (5)  40 (20) 40 (20) 
Age (years, mean±SD) 25.5 (1.8) 90.2 (0.3)  58.2 (7.4) 57.1 (8.5) 
Anthropometric data       
Height (cm, mean±SD) 177 (10) 164 (7)  171 (8) 173 (8) 
Weight (kg, mean±SD) 69.9 (11.1) 67.5 (9.8)  77 (11) 78 (13) 
Current smoking – no. 1/8 3/10  3/40 8/39 
Diseases       
Myocardial infarction – no./total known 0/10 3/9   0/35 (0) 1/37 
Stroke – no./total known 0/10 1/9  1/37 (2.9) 1/35 
Hypertension – no./total known. 0/10 7/9  6/35 (17.1) 10/37 
Diabetes mellitus – no./total known. 0/10 1/9  1/34 (2.9) 2/36 
Malignancies – no./total known 0/10 0/9  1/33 (3.0) 1/35 
Chronic obstructive pulmonary disease – 
no./total known 
0/10 1/10   1/34 (2.9) 1/37 






Stress induced changes in markers of senescence, ap optosis/cell death and colony 
formation 
There were significant increases in the distributions of MdFI values (i.e. SA-β-gal activity) in 
fibroblast strains from young and old subjects after seven days of exposure to stress (non-
stressed: 272±90 [mean±SD] MdFI, 0.2 µM rotenone: 544±262 MdFI, 111 mM glucose: 
375±261 MdFI, Figure 1A). Similar significant increases were observed in fibroblast strains 
from offspring and partners (non-stressed: 263±78 MdFI, 0.2 µM rotenone: 400±112 MdFI, 
111 mM glucose: 323±94 MdFI, Figure 2A). For fibroblasts from young and old subjects and 
from offspring and partners, exposure to 1 µM rotenone for three days resulted in significant 
increases of sub-G1 cell debris (young/old, non-stressed: 14.8±6.4%, 1 µM rotenone 
47.3±5.0%; offspring/partners, non-stressed: 18.9±5.6%, 1 µM rotenone: 44.8±6.5%), 
Annexin V+/PI- fibroblasts (young/old, non-stressed: 0.13±0.10%, 1 µM rotenone 7.33±2.7%; 
offspring/partners, non-stressed: 0.43±0.31%, 1 µM rotenone: 8.40±3.06%) and An- 
nexin V+/PI+ fibroblasts (young/old, non-stressed: 0.19±0.13, 1 µM rotenone 2.77±0.88%; 
offspring/partners, non-stressed: 0.43±0.20 %, 1 µM rotenone: 1.99±0.85%). 
There were significant decreases in colony number for fibroblast strains from young and old 
subjects after seven days of exposure to stress (non-stressed: 115±78, 0.2 µM rotenone: 
80±56, mean±SD) and for fibroblast strains from offspring and partners (non-stressed: 
164±44, 0.2 µM rotenone: 72±43, 111 mM glucose: 83±47 MdFI, mean±SD). All stress 
induced changes mentioned above were highly significant (p<0.0001) for all parameters 
measured and showed considerable interindividual variation. 
 
Markers of senescence, apoptosis/cell death and col ony formation dependent on 
differences in chronological and biological age 
Under non-stressed conditions, fibroblast strains from old subjects showed significantly 
higher levels of SA-β-gal activity when compared with fibroblast strains of young subjects 
(Table 3, Figure 1B). Under non-stressed conditions, there were significantly lower levels of 
Sub-G1 cell debris for fibroblast strains from young subjects compared with strains from old 
subjects (Table 3). After exposure to 0.2 µM rotenone or 111 mM glucose, fibroblast strains 
from old subjects showed greater increases in SA-β-gal activity than fibroblast strains from 
young subjects (Table 3, Figure 1C and 1D). After exposure to 1 µM rotenone, there were  
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Figure 1  Cumulative frequency plots of SA-β-gal activity in fibroblast strains. A, activity in fibroblast strains 
under non-stressed conditions, treated with 0.2 µM rotenone and with 111 mM glucose for three days 
(young and old subjects from the Leiden 85-plus study combined, n=20). B, activity under non-stressed 
condition in strains from young (n=10) and old (n=10) subjects. C, rotenone-induced increases of activity 
(stressed minus non-stressed) in young and old subjects. D, hyperglycemia -induced increases of activity 





Table 3.  Markers of senescence and apoptosis/cell death in fibroblast strains from young and 
old subjects (Leiden 85-plus Study) under non-stressed levels and stress-induced conditions. 
 mean (SE)   
 Young (n=10) Old (n=10) ∆a (SE) P 
Non-stressed      
7d     
SA-β-gal FACS (MdFI) 227 (21) 316 (21) -89 (29) 0.004 
3d     
Sub-G1 (%) 12.4 (1.4) 17.2 (1.5) -4.8 (1.9) 0.014 
Annexin V+ / PI- cells (%) 0.14 (0.04) 0.11 (0.04) +0.03 (0.05) 0.57 
Annexin V+ / PI+ cells (%) 0.14 (0.03) 0.23 (0.03) -0.09 (0.04) 0.040 
     
Stress -induced increase      
0.2 µM rotenone, 7d      
SA-β-gal FACS (MdFI) + 168 (36) + 377 (36) -209 (51) <0.001 
111 mM glucose, 7d      
SA-β-gal FACS (MdFI) + 26 (47) + 180 (47) -154 (67) 0.027 
1 µM rotenone, 3d      
Sub-G1 (%) +35.8 (2.6) +29.2 (2.6) +6.6 (2.6) 0.018 
Annexin V+/PI- cells (%) +7.32 (1.51) +7.10 (1.51) +0.22 (1.00) 0.83 
Annexin V+/PI+ cells (%) +2.78 (0.27) +2.39 (0.27) +0.39 (0.38) 0.30 
Fibroblast strains from young subjects (mean±SD age: 25.5±1.8) were compared with fibroblast strains 
from very old subjects (mean±SD age: 90.3±2.1). Stress-induced increases: stressed minus non-stressed, 
MdFI: median fluorescence intensity, a: difference between young and old (young minus old). 
 
significantly greater increases in levels of Sub-G1 cell debris for fibroblast strains from young 
subjects compared with fibroblast strains from old subjects (Table 3). Under non-stressed 
conditions, no differences in tested parameters were found between fibroblast strains from 
offspring and fibroblast strains from partners (Table 4, Figure 2B). After both rotenone- and 
hyperglycemia-treatment, fibroblast strains from offspring showed smaller increases in SA-β-
gal activity than fibroblast strains from partners (Table 4, Figure 2C and 2D), being 
statistically significant for hyperglycemia-stressed fibroblasts. When stress-induced increases 
in apoptotic parameters were compared between offspring and partners, increases were 
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consistently greater in fibroblast strains from offspring (Table 4), being statistically significant 
for Annexin V+/PI- fibroblasts and Annexin V+/PI+ fibroblasts. Under non-stressed 
conditions, significantly more colonies were formed in fibroblast strains from young subjects 
compared with strains from old subjects (Table 5). 
 
Table 4.  Markers of senescence and apoptosis/cell death in fibroblast strains from offspring 
and their partners (Leiden Longevity Study) under non-stressed and stress-induced 
conditions. 




Offspring Partner ∆a (SE) p 
Non-stressed       
7d      
SA-β-gal FACS (MdFI) 20/20 269 (23) 266 (23) 3 (16) 0.85 
3d      
Sub-G1 (%) 40/39 17.4 (0.8) 16.9 (0.8) + 0.5 (1.0) 0.64 
Annexin V+/PI- cells (%) 40/40 0.43 (0.05) 0.41 (0.05) + 0.02 (0.07) 0.68 
Annexin V+ PI+ cells (%) 40/40 0.42 (0.03) 0.43 (0.03) + 0.01 (0.03) 0.89 
      
Stress -induced increase       
0.2 µM rotenone, 7d       
SA-β-gal FACS (MdFI) 20/20 + 121 (19) + 156 (19) - 35 (19) 0.064 
111 mM glucose, 7d       
SA-β-gal FACS (MdFI) 20/20 + 30 (13) + 88 (13) - 55 (15) <0.001 
1 µM rotenone, 3d       
Sub-G1 (%) 40/39 + 26.1 (1.2) + 23.8 (1.2) + 2.3 (1.3) 0.115 
Annexin V+/PI- cells (%) 40/40 + 8.69 (0.59) + 7.77 (0.59) + 0.92 (0.45) 0.041 
Annexin V+/PI+ cells (%) 40/40 + 1.83 (0.15) + 1.51 (0.15) + 0.32 (0.12) 0.008 
Fibroblast strains from offspring (mean±SD age: 58.2±7.4years) were compared with fibroblast strains 
from partners (mean±SD age: 57.1±8.5 years).  Stress-induced increases: stressed minus non-stressed, 




Figure 2.  Cumulative frequency plots of SA-β-gal activity in fibroblast strains. A, activity in fibroblast 
strains under non-stressed conditions, treated with 0.2 µM rotenone and with 111 mM glucose for three 
days (offspring and partners from the Leiden Longevity Study combined, n=40). B, activity under non-
stressed conditions in strains from offspring (n=20) and partners (n=20). C, rotenone-induced increases of 
activity (stressed minus non-stressed) in offspring and partners. D, hyperglycemia-induced increases of 
activity in offspring and partners. MdFI: median fluorescence intensity 
Stress-induced responses of human skin fibroblasts in vitro reflect human longevity 
53 
 
Total colony size was also greater. After rotenone treatment, although not significant, a 
higher fraction of surviving colonies and a higher fraction of total colony size were observed 
for strains from young subjects compared with old subjects. Considering the contrast in 
biological age, the number and total size of colonies were significantly higher for fibroblast 
strains from offspring when compared with partners under non-stressed conditions (Table 5). 
After treatment with rotenone or hyperglycemia, significantly higher fractions of surviving 
colonies and bigger total colony sizes were observed in strains from offspring when 
compared with partners (Table 5). 
 
Table 5.  Differences in non-stressed levels and stress-induced decreases in growth potential 
observed with the colony formation assay dependent on differences in chronological (Leiden 
85-plus Study) and biological age (Leiden Longevity Study). 













Number of colonies        
Non-stressed, 7d  
(# colonies/plate) 
142 (16) 96 (16) 0.017 171 (7) 149 (7) 0.001 
Surviving fraction (%)       
0.2 µM rotenone, 7d 66 (5) 56 (5) 0.12 44 (3) 37 (3) 0.008 
111 mM glucose, 7d nd nd  50 (3) 45 (3) 0.056 
Total colony size        
Non-stressed, 7d  
(Total colony size in mm2/plate) 
1535 (167) 918 (167) 0.006 1980 (95) 1734 (95) 0.024 
Fraction remaining (%)       
0.2 µM rotenone, 7d 59 (5) 50 (5) 0.21 40 (2) 33 (2) 0.004 
111 mM glucose, 7d nd nd  44 (3) 40 (3) 0.16 
‘Fraction remaining’: total area of colonies per plate under stressed conditions divided by total area of 








In this study, we addressed the questions whether in vitro cellular responses to stress 
change with chronological age and whether in vitro cellular responses to stress depend on 
the propensity for longevity. To address these questions, we used fibroblast strains derived 
from young and old subjects, and from middle-aged offspring from nonagenarian siblings and 
their partners. Subjects of the last two groups were of similar chronological age and had 
equal distributions of men and women, thus any observed difference in cellular stress 
responses might be attributable to the biological age of the subjects, i.e. the propensity for 
longevity in the offspring.  
 
The main findings of our studies are as follows. First, under non-stressed conditions, we 
observed that, compared with fibroblast strains obtained from the very old, fibroblast strains 
from young subjects show lower levels of senescence, as observed with SA-β-gal activity, 
higher growth potential, and also lower levels of cell debris. In line with our findings, it has 
been shown in primates that the proportion of senescent skin fibroblasts increases with age 
in vivo, supporting the biological relevance of cellular senescence for this cell type (22-25). 
Both findings are consistent with the notion that cellular senescence and apoptosis increase 
with chronological age and play an important role in age-related pathology (7;26;27).  
Second, after induction of stress, either by rotenone or hyperglycemia, fibroblast strains from 
old subjects showed a higher increase in levels of senescence when compared with 
fibroblast strains from young subjects as observed with SA-β-gal activity and lower growth 
potential as measured with the colony formation assay. These results are in line with the 
findings of Ressler et al. who showed in vivo that with increasing age, an increasing number 
of  human skin cells (dermal and epidermal) become positive for p16, a protein involved in 
the regulation of stress induced premature senescence (25).  
Third, after stress, fibroblast strains from offspring of long-lived families showed lower 
increases in levels of senescence compared with fibroblasts from partners as observed with 
SA-β-gal activity and growth potential. Such a stress-resistant phenotype of fibroblasts has 
been reported for long-lived dwarf mice when compared with wild type mice (10), but, to the 
best of our knowledge, not for humans with different aging trajectories.  
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Rotenone was chosen as senescence-inducing agent because it acts on mitochondrial 
complex I, leading to increased levels of intracellular Reactive Oxygen Species (ROS) (16), 
which would mimic the physiological process of ROS induced damage that is hypothesized to 
underlie the aging process. When used in lower concentrations, we have found earlier that 
rotenone induces senescence as measured by colocalisation of increased p16 expression 
and increased SA-β-gal activity (20). As a positive control, we have also observed 
colocalisation of increased p16 expression coinciding with increased SA-β-gal activity in high 
passage fibroblasts (20), as was previously observed by Itahana et al. (28). Various cellular 
stressors have also been reported by others to induce SA-β-gal activity coinciding with 
increased p16 expression (29-35). In addition it was shown that p16 inhibition by means of 
antisense p16 resulted in delayed expression of SA-β-gal activity (36). 
Glucose was chosen as an alternative stressor as it has been implicated to interfere in aging 
processes for a relatively long period of time. Many of the age-related disorders and diseases 
occur earlier in life in diabetics than in healthy people (37) and in various model organisms, 
glucose handling (insulin/IGF-signaling) has been shown to affect longevity (38). 
Furthermore, hyperglycemia has been shown to induce increased ROS at the cellular level 
(18) as well as premature senescence in human skin fibroblasts (19). Recently it was shown 
within the Leiden Longevity Study that the prevalence of diabetes was higher in partners 
compared with offspring (4.4% vs. 7.6%, p=0.004) and similar percentages are present in the 
randomly chosen set of subjects from whom fibroblast strains were tested (14). 
 
Contrary to our hypothesis we found arguments for stress-induced apoptosis to be more 
present in fibroblast strains from fibroblast strains from offspring compared their partners. 
The fact that fibroblast strains from biologically younger subjects are more prone to go into 
apoptosis than to become senescent, could be advantageous to the organism to prevent 
damaged cells from becoming neoplastic. Although both apoptosis and senescence will 
prevent damaged cells from becoming neoplastic, apoptosis is thought to lead to greater loss 
of cells that would need to be replaced by new cells from a pool of mitotically active cells or 
stem cells. In aging organisms, stem cells loose the ability to replace cells lost by apoptosis, 
partially explaining age-related decline of cellularity in tissues (39). Though the number of 




old subjects still show a high replicative capacity in vitro (15), making it unlikely that loss of 
cellularity in skin can be solely explained by exhaustion of replicative capacity. There is 
recent evidence that loss of cellularity in skin is more likely the result of the accumulation of 
senescent cells, which are capable to change the micro-environment. For instance, 
senescent cells have a secretory phenotype that promotes the invasiveness of premalignant 
epithelial cells (42).  
 
An important strength of our study is the large number of fibroblast strains obtained from 
subjects of various chronological and biological ages, collected and stored in a highly 
standardized manner. Another strength is the fact that we studied stress-induced senescence 
rather than replicative senescence, since it has been shown that the maximum number of 
population doublings does not reflect human life history trajectories (43). This suggests that 
replicative senescence in vitro may be significantly influenced by cell culture conditions and 
that stress-induced senescence might better differentiate between cellular phenotypes. 
During the lifetime of an organism, its cells will be subjected to endogenous and exogenous 
chronic stressors, leading to aging of cells and consequently the organism. For these 
reasons we used fibroblasts at subconfluent levels and mimicked natural chronic stress by 
exposing fibroblasts to low concentrations of stressors up to one week.  
 
In conclusion we report stress-induced responses of human cells in vitro reflect the 
propensity for human longevity of the subjects from whom these were derived.  
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Cellular senescence, an important factor in aging phenotypes, can be induced by replicative 
exhaustion or by stress. We investigated the relation between maximum replicative capacity, 
telomere length, stress-induced cellular senescence and apoptosis/cell death in human 
primary fibroblast strains obtained from nonagenarians of the Leiden 85-plus Study. 
Fibroblast strains were cultured until replicative senescence and stressed with rotenone at 
low passage. Telomere length, Senescence Associated-β-galactosidase (SA-β-gal) activity, 
Sub-G1 content and Annexin-V/PI positivity were measured in non-stressed and stressed 
conditions. Fibroblast strains with a higher replicative capacity had longer telomeres 
(p=0.054). In non-stressed conditions replicative capacity was not associated with β-gal 
activity (p=0.07) and negatively with Sub-G1 (p=0.008). In rotenone-stressed conditions 
replicative capacity was negatively associated with β-gal activity (p=0.034) and positively with 
Sub-G1 (p=0.07). Summarizing, fibroblast strains with a higher maximum replicative capacity 
have longer telomeres, are less prone to go into stress-induced cellular senescence and 
more prone to die after stress. 
 





Cellular senescence and apoptosis are suggested to be important drivers of aging 
phenotypes and age related diseases such as diabetes mellitus and coronary heart disease 
(1). Cellular senescence is characterized by an irreversible state of replication arrest and can 
be induced by two factors. Firstly, after a finite number of cell population doublings (PDs) 
cells will cease to divide, a phenomenon also known as the Hayflick limit or Replicative 
Senescence (RS) (2). Current knowledge indicates that this form of senescence is mostly 
telomere driven, which means that with every cell division the telomere length shortens until it 
reaches a critical length after which the cell stops dividing (3). Secondly, cells can become 
senescent by exposure to stress which is called Stress-Induced-Premature-Senescence 
(SIPS) (4). Reactive oxygen species (ROS) seem to play a major role in this process 
because they cause damage to DNA and proteins, resulting in an accelerated accumulation 
of mutations which eventually causes early senescence (5). 
 
Although cellular senescence can be induced by replicative exhaustion and by stress, the 
relation between RS and SIPS has remained largely unknown. It has been shown that 
fibroblasts aged in vitro, i.e. having undergone PDs in vitro, are more prone to go into stress-
induced cellular senescence than fibroblasts that have undergone less PDs (6). If this is 
indeed the case, fibroblast strains from subjects of the same chronological age but with 
different maximum replicative capacities may have undergone different numbers of PDs 
during in vivo life history, affecting the response to stress-induced cellular senescence in 
vitro. Factors determining a long-term cell fate decision, undergoing senescence or 
apoptosis, are not yet fully understood, but there seems to be a clear dependence on cell 
type and the nature and extent of the damage (7). The transcriptional regulator p53 plays an 
important role in both senescence and apoptosis and in the interaction between these 
processes. DNA-damage is one of the important stimuli activating p53, which subsequently 
regulates the expression and activity of the cell cycle inhibitors p21 (8) and later p16 (9). If 
the DNA-damage is reversible, p53 activity will decrease after quick repair. However, when 
repair is slow and/or incomplete, p53 activity is sustained and p16 will also be induced in 




stress-induced Senescence Associated β-galactosidase (SA-β-gal) positive fibroblasts are 
also p16-positive, but not exclusively so (10). Furthermore, p53 plays a major role in 
replicative senescence induced by telomere erosion (11;12). When telomeres reach a critical 
length they will resemble broken DNA-strands which cells will recognize as DNA-damage and 
will respond accordingly, in a p16-independent fashion (8).  
 
In order to investigate if there is a relation between RS and SIPS, we tested fibroblast strains 
with a range of maximum replicative capacities in non-stressed conditions and on their ability 
to react to oxidative stress. We are in the unique position to have access to a large number of 
fibroblasts strains which have been cultured to the end of their replicative potential, but which 
have also been stored frozen at low PDs. We hypothesize that fibroblast strains with a higher 
replicative capacity will have longer telomeres. Furthermore, if telomere shortening also plays 
an important role in SIPS, fibroblast strains with a higher replicative capacity will be more 




Materials and methods 
 
Study design 
The Leiden 85-Plus Study (13) is a prospective population-based study in which all 
inhabitants aged 85 year or older of the city of Leiden, the Netherlands, were invited to take 
part. Between September 1997 and September 1999, 599 out of 705 eligible subjects (85%) 
were enrolled. All participants were followed for mortality and 275 subjects survived to the 
age of 90 years. During the period December 2003 up to May 2004, a biobank was 
established from fibroblasts cultivated from skin biopsies from 68 of the 275 surviving 90-
year-old participants.  
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Cell strains and maximum replicative capacity 
Fibroblast strains were isolated from biopsies of the upper medial arm obtained from 68 
participants of the Leiden 85-plus Study at the age of 90 years (14). All fibroblast strains were 
cultured under highly standardized conditions and serially passaged until the onset of 
replicative cellular senescence. Maximum replicative capacity was defined as maximum PDs 
and differed significantly between individual strains (14). Thirty strains with maximum 
replicative capacity, ranging from 51 to 108 PDs, were randomly selected. One strain with the 
highest maximum replicative capacity was found to yield results that were not in line with the 
results for the other strains. Since the highest maximum replicative capacity differed 3.5xSD 
of the mean of the other strains, this strain was considered to be an outlier and was not 
included in further analyses.  
The relation between known maximum replicative capacity and markers of cellular 
senescence and apoptosis/cell death was determined at low passage, on average at PD 
21±3 (±SD, range 17-30). Since the fibroblast strains entered phase IIb at PD 52 on average, 




All fibroblasts cultures were grown in D-MEM:F-12 (1:1) medium supplemented with 10% 
fetal calf serum (FCS) (batch no. 40G4932F), 1 mM MEM sodium pyruvate, 10 mM HEPES, 
2 mM glutamax I, antibiotics (100 Units/mL penicillin, 100 µg/mL streptomycin, and 0.25–2.5 
µg/mL amphotericin B, all obtained from Gibco, Breda, the Netherlands) incubated at 37°C 
with 5% CO2 and 100% humidity. Trypsin (Sigma, St Louis, MO, USA) was used to split cells 
using a 1:4 ratio each time they reached 80-100% confluence.  
 
Experimental set-up 
To test the inducibility of SIPS, cells were thawed from frozen stocks on day zero. On day 
one, the medium was changed and on day four cells were passaged from 25-cm2 flasks to 
75-cm2 flasks. Cells were passaged further on days six and eight. To have similar 




On day 11, fibroblasts were seeded for the experiment, a remaining part was kept in culture 
for repeat experiments. 
Fibroblasts were stressed using 600 µM rotenone (Sigma, St Louis, MO, USA) for three days. 
Rotenone is known to induce ROS at the mitochondrial level (15) and increased ROS induce 
cellular senescence (16). Rotenone-induced increased levels of ROS were confirmed for the 
experiments described here (data not shown). Because rotenone is light-sensitive, experi-
ments were performed in darkness as much as possible. Samples were prepared three days 
after exposure to a stressor (day 14). Stock solutions of rotenone were prepared in DMSO at 
a concentration of 500 µM and stored at -40°C (aliquots). Initial tests sho wed that DMSO 
(0.2%) did not affect the results. Experiments were repeated for each cell strain and each 
condition and were performed in batches of maximally four strains simultaneously. 
 
Telomere length analysis 
Telomere length was measured for 19 of 30 randomly chosen fibroblast strains in non-
stressed conditions. To measure telomere length, a flow-FISH kit was used (DAKO, 
Heverlee, Belgium) and fibroblasts were treated according to the manufacturer protocol. In 
short, fibroblasts were trypsinized, mixed with the reference cell line (line 1301, Banca 
Biologica e Cell Factory, Genoa, Italy), hybridized without and with Cy3-labeled PNA-probe. 
After labeling with propidium iodide for DNA-content, samples were measured on a FACS 
Calibur II flow cytometer (Becton Dickinson, Franklin Lakes, USA). The probe-signal was 
measured in the FITC-channel and the PI signal in the PE-Texas Red channel. Results were 
calculated according to the manufacturer’s protocol. 
 
Flow cytometric measurement of SA- β-gal activity 
Cells were seeded at 1000 cells/cm2 in 25-cm2 flasks. Cells were prepared as described 
recently (10). In short, to change the lysosomal pH to pH 6, cells were incubated with 
medium containing 100 nM bafilomycin A1 (VWR, Amsterdam, the Netherlands) for one hour. 
Cells were then incubated with 33 µM of the β-galactosidase substrate C12FDG (Invitrogen, 
Breda, The Netherlands), in the presence of 100 nM bafilomycin. After trypsinisation, cells 
were washed once and resuspended in 200 µl ice cold PBS. Cells were measured in the 
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FITC-channel and analysis was performed on the median fluorescence intensity (MdFI) 
values. 
 
Flow cytometric Annexin V/PI analysis  
Cells were seeded at 1000 cells/cm2 in 75-cm2 flasks. Sample preparation was performed on 
ice. Aspirated medium and washes were collected so that any floating cells and cell debris 
indicating cell death would be included in the analysis. Cells were trypsinized and washed 
with phosphate buffered saline (PBS). The suspension was divided over two tubes, one for 
Annexin V/PI analysis and one for cell cycle analysis. For the Annexin V/propidium iodide (PI) 
analysis, the TACS Annexin V-FITC kit was used (R&D Systems, Abingdon, United 
Kingdom). Cells were processed according to the manufacturer’s guidelines. Analysis was 
performed on a FACS Calibur II flow cytometer (Becton Dickinson). The Annexin V-FITC 
signal was measured in the FITC-channel and the PI signal in the PE-Texas Red channel. 
Cells were gated into quadrants and Annexin V positive/PI negative (Annexin V+/PI-) and 
Annexin V positive/PI positive (Annexin V+/PI+) fibroblasts were analyzed as percentages of 
the total cell population.  
 
Flow cytometric cell cycle analysis 
After trypsinisation, fibroblasts were centrifuged at 1000 rpm for five minutes, washed by 
resuspending in PBS, centrifuged again and resuspended in 200 µl 70% ethanol. Samples 
were kept at -40°C at least overnight. After adding  1 mL PBS, fibroblasts were centrifuged at 
2000 rpm for 5 minutes and resuspended in 200 µl PBS containing 50 µg/mL PI and 20 
µg/mL RNAse (Sigma, St Louis, MO, USA). Fibroblasts were stored overnight at 4°C and 
measured in the PE-Texas Red channel. In the resulting histograms, Sub-G1 events (dead 
cells and cell debris) were gated and analyzed as percentages of the total cell population. 
 
Statistics 
All analyses were performed with the software package SPSS 16.0.01 (SPSS Inc., Chicago, 
IL). Fibroblast strains were tested in batches of maximally four strains simultaneously. No 
intra-experiment replicates were used but experiments were repeated for each strain (in the 




Figure 1.  Correlation between maximum replicative 
capacity (PDs) of human fibroblasts and telomere 
length (% of telomere length of reference cell line 
1301). P-value is result of linear mixed model. 
rotenone-treated conditions of each strain and parameter. The former was then subtracted 
from the latter to acquire rotenone-induced increases. For parameters of telomere length, 
cellular senescence and cell death/apoptosis, linear regression analysis was performed 
between values for the non-stressed condition and maximum replicative capacity and 
between rotenone-induced increases and maximum replicative capacity, using a linear mixed 
model taking into account the duplicate experiments as repeated measures and the batches 
of experiments as random effect. The different batches of strains were run in two rounds of 
multiple experiments. To be able to better compare the results of these two rounds, the data 
of the SA-β-gal assay were normalized by z-transforming the data within these rounds of 





Baseline characteristics of the subjects 
from whom the tested fibroblast strains 
were derived are summarized in Table 1. 
The mean maximum replicative capacity 
was 71±11 (mean±SD) PDs, ranging 
from 51 to 94. Table 2 shows the 
rotenone-induced increases in the 
measured parameters regardless of the 
maximum replicative capacity of the 
fibroblast strains. Telomere length was 
measured for fibroblast strains in non-
stressed conditions. A positive relation 
was found between maximum replicative 
capacity and telomere length (p=0.054, Figure 1), which was borderline significant. For non-
stressed fibroblasts no significant correlation was found between maximum replicative 
capacity and SA-β-gal activity (Table 3, Figure 2A), whereas rotenone-stressed fibroblasts 
showed a significant negative relation (Table 3, Figure 2B). 
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Table 1.  Clinical characteristics and fibroblast growth characteristics of subjects from the 
Leiden 85-plus Study (N=29). 
 Leiden 85-plus Study 
Demographic and anthropometric data  
N (female) 18 
Age (years, mean ± SD) 90.0 (0.6) 
Height (cm, mean ± SD) 162 (10) 
Weight (kg, mean ± SD) 72.0 (11) 
Current smokers – no./total known 2/29 
  
Growth characteristics of fibroblast strains  
PD at which strains were tested (mean ± SD, range)  21 (3), 17-30 
Onset phase IIb (PD, mean ± SD, range)* 52 (12), 26-79 
Onset phase III, replicative capacity (PD, mean ± SD, range)† 71 (11), 51-94 
Growth speed phase IIa (PD per day, mean ± SD, range)* 0.28 (0.04), 0.20-0.36 
Growth speed phase IIb (PD per day, mean ± SD, range)* 0.09 (0.04), 0.03-0.19 
* according to change-point model (14) 




Table 2.  Stress-induced increases in parameters measured in human fibroblasts (N=29 
strains). Values are given as mean (SE). 
Parameter  Non-treated 0.6 µM rotenone, 3 days  p 
β-gal FACS, z-score of  MdFI  -0.55 (0.83) 0.52 (0.79)  < 0.001 
Sub-G1 (%)  5.4 (0.7) 22.7 (0.7)  < 0.001 
Annexin V+/PI- cells, %  1.21 (0.38) 7.15 (0.38)  < 0.001 
Annexin V+/PI+ cells, %  3.02 (0.46) 6.67 (0.46)  < 0.001 
Data were analyzed with a linear mixed model, taking into account different batches of experiments and 





To determine the level of cell death, levels of Sub-G1 cell debris were measured. In non-
stressed conditions there was a significant negative correlation between maximum replicative 
capacity and Sub-G1 content (Table 3, Figure 2C). In rotenone-stressed conditions a positive 
correlation was found, which was borderline significant (Table 3, Figure 2D). Apoptosis was 
assessed by the Annexin V/PI assay. Results were tested for correlations between maximum 
replicative capacity and percentage Annexin V+/PI- (early apoptotic) and Annexin V+/PI+ 
(late apoptotic or necrotic) fibroblasts. For both Annexin Annexin V+/PI-and Annexin V+/PI+ 
fibroblasts, no significant correlations were found under non-stressed conditions nor under 
rotenone-stressed conditions (Table 3).  
 
Figure 2. Correlation between maximum replicative capacity and markers of cellular senescence (SA- β-
gal activity; A and B) and cell damage (sub-G1 cell debris; C and D) under non-stressed and rotenone-
stressed conditions. Due to batch differences SA-β-gal values were z-tranformed.   
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Table 3. Relation between maximum replicative capacity, telomere length and markers of 
stress induced cellular senescence (SA-β-gal activity), cell damage (Sub-G1 cell debris) and 
apoptosis (AnnexinV/PI) under non-stressed and rotenone-stressed conditions in human 
fibroblasts (N=29 strains). 
 Change/PD (SE) p 
Non-stressed    
Telomere length, % of ref.  cell line 1301 0.193 (0.095) 0.054 
SA-β-gal activity, z-score of  MdFI 0.022 (0.011) 0.070 
Sub-G1, % -0.080 (0.029) 0.008 
Annexin V+ / PI- cells, % -0.003 (0.007) 0.69 
Annexin V+ / PI+ cells, % -0.005 (0.019) 0.81 
600nM Rotenone, 3d    
SA-β-gal activity, z-score of  MdFI -0.024 (0.011) 0.034 
Sub-G1, % 0.121 (0.066) 0.070 
Annexin V+/PI- cells, % 0.044 (0.041) 0.29 
Annexin V+/PI+ cells, % -0.031 (0.031) 0.32 
Data were analyzed with a linear mixed model, taking into account different batches of experiments and 







The aim of this study was to investigate whether observed variations in maximum replicative 
capacities of fibroblast strains derived from the oldest old correlate with telomere length and 
inducibility of stress-induced parameters of cell death and cellular senescence in vitro. We 
found that fibroblast strains with a higher maximum replicative capacity have longer 
telomeres, are less prone to go into stress-induced cellular senescence and more prone to 




Telomere shortening and senescence 
There is much variation in maximum replicative capacity of human fibroblast in vitro (14). This 
could be due to interindividual differences in number of PDs obtained during in vivo life 
history and/or differences in intrinsic replicative capacity and telomere length, which is 
supported by the observation that telomere length varies already considerable very early in 
life (17). Telomeres clearly play an important role in cellular senescence since in vitro, every 
cell lacking the enzyme telomerase can undergo a limited number of cell divisions before 
becoming senescent. Even so, murine cells in vitro senesce after a few PDs despite 
expressing telomerase (7). Hence it is questionable whether data that have been used for 
establishing the maximum replicative capacity of cells in vitro are a reliable reflection of the 
real maximum replicative capacity in vivo.  
However, it has been described that telomere length is a good indicator for the maximum 
replicative capacity of fibroblasts (17). Indeed, we found that fibroblasts with a high maximum 
replicative capacity had long telomeres, although the correlation was borderline significant 
due to the small samples size tested. Thus, fibroblasts already having shorter telomeres (i.e. 
lower maximum replicative capacity) might enter the senescent state faster than fibroblasts 
with longer telomeres (i.e. higher maximum replicative capacity).  
Oxidative stress accelerates the rate of telomere shortening, mainly because of insufficient 
repair mechanisms (18;19). We did not measure telomere length after induction of acute 
stress, but it is unlikely that after three days of stress telomeres would have shortened 
measurably within a cell, since shortening of telomeres is the result of cell division.  
It has been shown that high passage fibroblasts in vitro (i.e. more PDs) show more stress-
induced cellular senescence when compared with low passage fibroblasts of the same strain 
(6). It could be argued that a fibroblast strain with a higher maximum replicative capacitiy in 
vitro, underwent less PDs in vivo (and as such has longer telomeres), and would thus be less 
inclined to go into stress-induced cellular senescence at low passage in vitro. Our results 
seem to be consistent with the data of other workers (6) since we found a significant negative 
correlation between maximum replicative capacity and stress-induced cellular senescence as 
measured by SA-β-gal activity, suggesting that fibroblasts with a higher maximum replicative 
capacity would indeed be less prone to go into cellular senescence. 
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Since there is debate about the validity of SA-β-gal as a marker of cellular senescence, we 
earlier performed a proof-of-principle experiment to ascertain to what extent our SA-β-gal 
results are consistent with the more conventional marker of cellular senescence p16 (10). 
From this we concluded that the increase in SA-β-gal activity after rotenone treatment does 
indeed reflect senescence. 
 
Apoptosis and senescence 
Cell death, and more specifically apoptosis, is an important factor in tissue dysfunction during 
the aging process (7;20). Possibly, apoptosis contributes even more to this process than 
cellular senescence because dysfunctional cells are removed altogether. In healthy tissues 
these cells are replaced with new ones from a pool of proliferative cells to prevent tissue 
atrophy. It has already been described that, in contrast to cellular senescence, in vitro aged 
fibroblasts are increasingly resistant to oxidative stress-induced apoptosis (7;21). This would 
be consistent with the fact that we found a positive correlation between maximum replicative 
capacity and amounts of stress-induced sub-G1 cell debris. Furthermore, under non-stressed 
conditions there was a negative correlation between maximum replicative capacity and the 
amount of sub-G1 cell debris. This is especially striking since earlier we described that 
fibroblasts derived from chronologically young subjects, when compared with fibroblasts from 
chronologically old subjects, also show less sub-G1 cell debris under non-stressed conditions 
and more stress-induced sub-G1 cell debris (22). This would suggest that fibroblast strains 
with a high maximum replicative capacity but derived from old subjects are more comparable 
to fibroblasts strains from young subjects than from old subjects (with average maximum 
replicative capacity), i.e. are biologically younger. The sub-G1 results were not corroborated 
by the Annexin V/PI results, for which no significant relations were found. Possibly, we 
missed the early phase of the apoptotic response and were only able to measure the end 
result (sub-G1 cell debris). 
 
Culture conditions 
To determine stress resistance in fibroblasts, strains were selected on their maximum 
replicative capacity in vitro (14). Not much is known about the process of culturing itself but it 




following the pathway of SIPS (23). An important factor in the process of culturing is the 
concentration of oxygen (pO2) to which fibroblasts are exposed. The pO2 in most tissues is 
much lower than the atmospheric pO2 which is often used for cell culture. These hyperoxic 
conditions are a significant stress for cells. Murine fibroblasts go into senescence after only a 
few PDs at 20% oxygen but proliferate much longer at 5% oxygen (24). Although less 
dramatic, a similar effect can be observed for human fibroblasts, which grow considerably 
slower in 20% oxygen when compared with 5% oxygen (25). Additionally, the density at 
which fibroblasts are grown determines to what extent hyperoxic conditions affect growth 
speed (25). Furthermore, when fibroblasts are explanted from skin biopsies, they are 
removed from their normal environment in which they were exposed to lower pO2, different 
levels and types of growth factors and many other factors (e.g. cytokines, metabolites).  
 
Summarizing, fibroblast strains with a higher maximum replicative capacity seemed to have 
longer telomeres, are less prone to go into stress-induced cellular senescence and more 
sensitive to stress-induced stimuli, as measured by levels of sub-G1 cell debris. These 
results suggest that replicative cellular senescence and stress-induced premature cellular 
senescence share interacting cellular pathways, which should be determined within individual 
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Respiratory chain function becomes less efficient with age resulting in increased levels of 
damaging reactive oxygen species (ROS). We compared rotenone-exposed fibroblast strains 
from young and old subjects, and from offspring of nonagenarian siblings and the partners of 
the offspring. Rotenone increased ROS levels, inhibited growth rate and increased telomere 
shortening (all p<0.05). Non-stressed strains from young subjects showed lower ROS levels 
(p=0.031) and higher growth rates (p=0.002) than strains from old subjects. Stressed strains 
from young subjects showed smaller increases in ROS levels (p=0.014) and larger decreases 
in growth rate (p<0.001) than strains from old subjects. Telomere shortening rates were not 
different between groups. Stress-induced decreases in growth rate were larger in strains from 
offspring than from partners (p=0.05). Strains from young and old subjects are differentially 
affected by chronic inhibition of the respiratory chain. Changed growth rates in strains from 
offspring resemble those from strains from young subjects.  
 





Aging is determined by accumulation of molecular damage and a paucity of well functioning 
differentiated cells that lead to the loss of bodily functions and various age-related diseases 
(1). During the lifespan of an organism, damage to cellular components accumulates. 
Depending on the type of cell and adverse conditions, cells can repair the damage, arrest 
proliferation irreversibly (senescence), undergo programmed cell death (apoptosis) or die in 
an uncontrolled manner (necrosis). Senescent cells affect the integrity of tissues by altering 
their morphology and by excreting factors that promote tumour invasiveness (2). 
Furthermore, when cells are removed by apoptosis or necrosis, tissues are compromised if 
cells are not replaced by the proliferative pool of progenitor cells. A decreased proliferative 
capacity of progenitor cells is thought to be one of the hallmarks of in vivo aging (3).  
 
There is much debate about the factors that determine if cells go into senescence. Telomere 
shortening has long been considered as a cellular clock (4). When telomeres are critically 
short, cells go into replicative senescence or, in case of loss of p53 function, die by necrosis 
after crisis (5). However, critically short telomeres are not a prerequisite for senescence since 
this state can also be induced by oxidative stress causing DNA-damage and changes in 
chromatin structure involving p53/Rb and p16/21 pathways. Furthermore, expression of 
certain oncogenes, mainly from the RAS pathways, can lead to senescence. Before cells 
undergo senescence, they show a decreased rate of proliferation. The fact that oxidative 
stress both accelerates telomere shortening (6) and can drive cells into senescence would 
imply that telomere length plays an important role in this stress-induced deceleration of 
proliferation. As early as 1956 Harman described that mitochondria become increasingly 
dysfunctional with age, leading to increased levels of reactive oxygen species (ROS) (7). It 
has been suggested that these increased ROS levels could accelerate telomere shortening 
(8). Conversely, it does not seem to be telomere length per se which determines the rate of 






Earlier we described that skin fibroblast strains derived from chronologically young subjects, 
when compared with fibroblast strains from very old subjects, are less prone to go into 
senescence and more prone to go into apoptosis, both under non-stressed and stressed 
conditions (10). These differences were mirrored by similar differences under stress-induced 
conditions between fibroblast strains derived from offspring of nonagenarian siblings within 
families enriched for longevity and their partners from the general population (11). Though of 
the same chronological age, these offspring were previously observed to be of a younger 
biological age than their partners as reflected by their beneficial glucose and lipid 
metabolism, preservation of insulin sensitivity and resistance to cellular stress (10;12;13). 
The fibroblast strains from these offspring resembled the responses of fibroblast strains from 
young subjects, i.e. were biologically younger. Here we study if chronic low-level inhibition of 
the respiratory chain induces increased rates of telomere shortening in human fibroblast 
strains and if this is related to growth rate, senescence and ROS levels. To allow telomere 
shortening, multiple population doublings are necessary and therefore we decided to culture 
fibroblasts for seven weeks rather than one week as described earlier (10). Our hypothesis is 
that chronic inhibition of the respiratory chain function by exposure to a low dose of rotenone, 
which decreases but does not arrest proliferation, leads to increased ROS levels, 
Senescence Associated-β-galactosidase (SA-β-gal) activity, decreased growth rates and 
concomitant acceleration of telomere shortening of fibroblasts depending on the 
chronological and biological age of the subject. For this study we compare the fibroblast 




Material and methods 
 
Study designs 
The Leiden 85-plus Study (14) is a prospective population-based study in which all 
inhabitants aged 85 years or older of the city of Leiden, the Netherlands, were invited to take 
part. Between September 1997 and September 1999, 599 out of 705 eligible subjects (85%) 
were enrolled. All participants were followed for mortality and 275 subjects survived to the 
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age of 90 years. During the period December 2003 up to May 2004, a biobank was 
established from fibroblasts cultivated from skin biopsies from 68 of the 275 surviving 90-
year-old participants (15). During the period August to November 2006, we also established a 
biobank of fibroblast strains established from biopsies taken from 27 young subjects (23-29 
years old).  
The Leiden Longevity Study (LLS) (11) was set up to investigate the contribution of genetic 
factors to healthy longevity by establishing a cohort enriched for familial longevity. From July 
2002 to May 2006, 421 families were recruited consisting of 944 long-lived Caucasian 
siblings together with their 1671 of their offspring and 744 of the partners thereof. There were 
no selection criteria on health or demographic characteristics. Compared with their partners, 
the offspring were shown to have a 30% lower mortality rate and a lower prevalence of 
cardio-metabolic diseases (11;12). During the period November 2006 and May 2008, a 
biobank was established from fibroblasts cultivated from skin biopsies from 150 offspring-
partner couples.   
 
Fibroblast Cultures 
Three-mm (Leiden 85-plus Study) and 4-mm skin biopsies (LLS) were taken from the sun 
unexposed medial side of the upper arm. Fibroblasts were grown in D-MEM:F-12 (1:1) 
medium supplemented with 10% fetal calf serum (FCS), 1 mM MEM sodium pyruvate, 10 mM 
HEPES, 2 mM glutamax I, and antibiotics (100 Units/mL penicillin, 100 µg/mL streptomycin, 
and 0.25–2.5 µg/mL amphotericin B), all obtained from Gibco, Breda, the Netherlands. 
Different FCS batches were used for fibroblasts from the Leiden 85-plus Study (Gibco, batch 
no. 40G4932F) and for fibroblasts from the LLS (Bodinco, Alkmaar, the Netherlands, batch 
no. 162229). This medium will be referred to as standard medium. Fibroblasts were 
incubated at 37°C with 5% CO2, under conditions of ambient oxygen and 100% humidity. All 
cultures that are used in the present study were grown under predefined, highly standardized 
conditions as published earlier (15). Trypsin (Sigma, St Louis, MO, USA) was used to split 
fibroblasts using a 1:4 ratio each time they reached 80-100% confluence to make sure that 






Fibroblasts were thawed from frozen stocks on day zero. Passage 11 fibroblasts were used 
from young and old subjects and passage seven fibroblast strains from offspring and 
partners. On day four, seven and eleven fibroblasts were further passaged in order to multiply 
fibroblasts. On day 18 the experiments were started. Fibroblast strains were seeded at 2000 
and 3300 cells/cm2 in 25 cm2 culture flasks for non-stressed and rotenone-stressed cultures 
respective-ly, in batches of eight strains per condition. To chronically stress fibroblast strains, 
medium was supplemented with rotenone (Sigma, St Louis, MO, USA), known to induce an 
increase in the intracellular production of ROS at the mitochondrial level (16). Since cell 
division was necessary for telomere shortening to occur, a low concentration of 20 nM was 
used in order to prevent complete arrest of proliferation. Because rotenone has a half-life of 
one to three days (17), medium was changed twice a week throughout a culture period of 
seven weeks. Fibroblast strains were counted every week and passaged at 2000 and 3300 
cells/cm2 again in new culture flasks. At day 49 fibroblast strains were seeded for assays 
measuring ROS levels, SA-β-gal activity and telomere length as described below. 
 
Flow cytometric measurement of ROS 
Levels of ROS were measured using the intracellular redox dye dihydrorhodamine 123 as 
described earlier (18). In short, fibroblasts were seeded at 2000 cells/cm2 in 25-cm2 flasks. 
After three days in culture fibroblasts were incubated in medium supplemented with 30 µM 
dihydrorhodamine 123 (Invitrogen, Breda, The Netherlands). One stock of dihydrorhodamine 
123 was prepared and aliquotted before the experiments to prevent changes in fluorescence 
intensity due to probe oxidation, leading to results that are independent of ROS generation 
(19). To reduce quenching of the fluorescent probe, ambient light in the laboratory was 
reduced as much as possible. After incubation with dihydrorhodamine 123, fibroblasts were 
trypsinized, washed in ice-cold PBS, pelleted and resupended in 200 µl ice-cold PBS. 
Fibroblasts were kept on ice before measurement of median fluorescence intensity (MdFI) in 
the FITC-channel. 
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Flow cytometric measurement of SA- β-galactosidase activity 
Fibroblasts were seeded at 2000 cells/cm2 in 25-cm2 flasks. Fibroblasts were prepared as 
described earlier (20). In short, to change the lysosomal pH to pH 6, fibroblasts were 
incubated with medium containing 100 nM bafilomycin A1 (VWR, Amsterdam, the 
Netherlands) for one hour. Fibroblasts were then incubated with 33 µM of the β-galactosidase 
substrate 5-dodecanoylaminofluorescein di-β-D-galactopyranoside  (C12FDG, Invitrogen, 
Breda, The Netherlands), in the presence of 100 nM bafilomycin. After trypsinisation, 
fibroblasts were washed once and resuspended in 200 µl ice cold PBS. Fibroblasts were 
measured in the FITC-channel and analysis was performed on the MdFI values. 
 
Telomere length analysis 
To measure telomere length, a flow-FISH kit was used (DAKO, Heverlee, Belgium) and 
fibroblasts were treated according to the manufacturer protocol. In short, fibroblasts were 
trypsinised, mixed 1:1 with the reference cell line (line 1301, Banca Biologica e Cell Factory, 
Genoa, Italy), hybridised without and with Cy3-labeled PNA-probe. After labeling with 
propidium iodide (PI) for DNA-content, samples were measured on a LSRII flow cytometer 
(Becton Dickinson, Franklin Lakes, USA). The probe-signal was measured in the FITC-
channel and the PI signal in the Cherry-Red channel. Results were calculated according to 
the manufacturer’s protocol and telomere length was expressed as percentage of the 
reference cell line. To determine telomere shortening rates, telomere length was also 
measured at the beginning of the experiment at day 18. The shortening rate was calculated 
by dividing the difference in telomere length after seven weeks of culturing by the number of 
cumulative population doublings and was expressed as percentage per PD. 
 
Statistics 
All analyses were performed with the software package SPSS 16.0.01 (SPSS Inc., Chicago, 
IL). To study the effect of rotenone during seven weeks culturing, results were first analyzed 
regardless of young/old and offspring/partner comparisons. Since the FCS used for fibroblast 
strains from the 85-plus Study was a different batch than the batch used for the LLS, 
fibroblast strains from the former (young and old) were analyzed separately from the latter 




telomere shortening rate between groups (young/old, offspring/partner) in non-stressed 
conditions were analyzed using linear mixed models. In strains from the 85-plus Study, 
results were adjusted for gender only and in strains from the LLS for gender and age. The 
same analyses were applied to rotenone-stressed differences (non-stressed subtracted from 
rotenone-stressed) in these parameters. 
Growth curves were produced by plotting cumulative population doublings against time. To 
analyze differences between groups, the slopes of the lines were compared by calculating 
the interaction terms time*young/old and time*offspring/partner in a linear mixed model, 






Baseline characteristics of subjects of different chronological and biological ages from whom 
fibroblast strains were established are shown in Table 1. Middle aged offspring from 
nonagenarian siblings and their partners were of similar age, height and weight.  
 
Effect of chronic exposure to rotenone on ROS level s, SA-β-gal activity, growth rate 
and rate of telomere shortening 
When compared with non-stressed fibroblast strains, levels of ROS and SA-β-gal activity 
were significantly increased in fibroblast strains stressed with rotenone for seven weeks 
(Table 2). Compared with non-stressed strains, growth rate was significantly decreased at all 
time points for rotenone-stressed fibroblast strains (Table 2, Figure 1A and B). For the strains 
from young and old subjects, telomere length decreased during seven weeks from 22.2±1.2% 
to 16.9±0.7% (±SEM) in non-stressed fibroblasts and from 22.2±1.2% to 17.1±0.6% in 
stressed fibroblasts. For the strains from offspring and partners telomere length decreased 
during seven weeks, from 23.7±1.3% to 18.8± 0.7% in non-stressed fibroblasts and from 
23.7±1.3% to 19.2±0.6% in stressed fibroblasts. In all cases p<0.001 for the difference 
between 0 weeks and 7 weeks. Telomere length was not different between non-stressed 
fibroblast strains and rotenone-stressed fibroblasts after seven weeks of serial culturing. 
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However, since the rotenone-stressed fibroblast strains had undergone less population 
doublings (PDs), the rate of telomere shortening per PD was significantly higher in rotenone-
stressed fibroblast strains (Table 2).  
 
 
Table 1.  Clinical characteristics of young and old subjects from the Leiden 85-plus Study 
representing a difference in chronological age and of offspring and partners from the Leiden 
Longevity Study who differ in biological age.  











Demographic data      
Female 7 5  5 5 
Age, years (mean±SD) 25.5 (1.8) 90.2 (0.3)  57.3 (7.6) 57.4 (8.7) 
Anthropometric data      
Height, cm (mean±SD) 177 (10) 164 (7)  174 (12) 174 (7) 
Weight, kg (mean±SD) 69.9 (11.1) 69.0 (9.3)  76.3 (19.2) 74.5 (13.5) 
Current smoking - no./total known  1/8 1/10   2/10  1/10  
Diseases      
Myocardial infarction, no. 0 1  0 0 
Stroke, no. 0 1  0 1 
Hypertension, no. 0 6  1 2 
Diabetes mellitus, no. 0 1  0 3 
Malignancies, no. 0 0  1 0 
Chronic obstructive pulmonary 
disease, no. 
0 1  0 1 






Table 2.  Effect of chronic exposure to rotenone on levels of reactive oxygen species (ROS), 
Senescence Associated-β-galactosidase (SA-β-gal) activity, population doublings (PDs) and 
telomere length, measured after 7 weeks in human fibroblasts from the Leiden 85-plus Study 
and Leiden Longevity Study. Average rate of telomere shortening during 7 weeks was also 
calculated. Values are given as mean (SE). 

















ROS (MdFI) 1427 (109) 1571 (115) <0.001 1380 (78) 1551 (88) <0.001 
SA-β-gal (MdFI) 4116 (398) 4743 (348) <0.001 3964 (264) 4442 (284) <0.001 
PDs (no.) 16.13 (0.53) 10.85 (0.40) <0.001 15.12 (0.48) 9.83 (0.39) <0.001 
Telomere length 























-0.43 (0.16) 0.042 
 
MdFI: median fluorescence intensity. Data were analyzed with linear mixed models, adjusting for gender, 
batches of experiments, repeat measures and age (for offspring/partner comparison). 
 
 
Differential effect of chronic exposure to rotenone  on ROS levels, SA- β-gal activity, 
growth rate, telomere length and rate of telomere s hortening dependent on 
chronological and biological age  
 
Serial culturing under non-stressed conditions for seven weeks 
ROS levels were significantly lower in fibroblast strains from young subjects compared with 
old subjects, but no differences were found in SA-β-gal activity. Fibroblast strains from young 
subjects showed a significantly higher growth rate when compared with fibroblast strains from 
oldest old subjects (Figure 1C). Telomere length was not different between strains from 
young and old subjects at 0 weeks (24.0±2.6% and 23.6±2.6% respectively, p=0.54) or at 7 
weeks (17.0±0.9% and 17.3±0.9% respectively, p=0.86). Shortening rates were also not 
different between strains from young and old subjects (Table 3).  
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No statistically significant differences in ROS, SA-β-gal activity and growth rate were found 
between fibroblast strains from offspring and from their partners in non-stressed conditions, 
although ROS levels were consistently lower in fibroblast strains from offspring when 
compared with strains from partners (Table 3 and Figure 1D). Telomere length was not 
different between strains from offspring and partners at 0 weeks (25.2±2.5% and 25.1±2.5% 
respectively, p=0.93) or at seven weeks (19.2±0.8% and 18.7±0.8% respectively, p=0.61). 
Shortening rates were also not different between strains from offspring and partners (Table 
3).  
 
Chronic exposure to rotenone for seven weeks 
Stress-induced ROS levels and SA-β-gal activity were lower in fibroblast strains from young 
subjects when compared with strains from old subjects. Stress-induced decreases (rotenone-
stressed – non-stressed) in growth rate were larger for fibroblast strains from young subjects 
when compared with strains from old subjects (Figure 1E). No differences in telomere 
shortening rates were found between strains from young and old subjects after seven weeks 
culturing under stressed conditions (Table 3).  
Differences in stress-induced ROS levels between fibroblast strains from offspring of 
nonagenarian siblings and partners were not statistically significant but were consistently 
lower in fibroblast strains from offspring. SA-β-gal activity was not different between fibroblast 
strains from offspring and strains from partners. When fibroblast strains from offspring and 
their partners were compared, stress-induced decreases in growth rate were larger for 
fibroblast strains from offspring when compared with strains from partners (Figure 1F). 
Telomere shortening rates showed no difference between fibroblast strains from offspring 




Table 3.  Effect of chronic exposure to rotenone on ROS levels (ROS), Senescence 
Associated-β-gal (SA-β-gal) activity and rate of telomere shortening measured in human 
fibroblasts from young and old subjects from the Leiden 85-plus Study, representing a 
difference in chronological age, and of offspring and partners from the Leiden Longevity 
Study who differ in biological age.  














ROS (MdFI)       
Non-stressed 1282 (108) 1573 (183) 0.031 1329 (87) 1431 (132) 0.39 
Rotenone – Non-stressed +81 (59) +234 (35) 0.014 +146 (68) +207 (65) 0.43 
       
Bgal (MdFI)       
Non-stressed 3756 (319) 3814 (360) 0.47 4120 (423) 3790 (315) 0.67 
Rotenone – Non-stressed +472 (238) +960 (238) 0.076 +598 (166) +660 (120) 0.90 
      
Telomere shortening rate (%/PD)      
Non-stressed -0.43 (0.13) -0.41 (0.13) 0.85 -0.39 (0.16) -0.42 (0.16) 0.79 
Rotenone -0.68 (0.25) -0.64 (0.25) 0.72 -0.60 (0.30) -0.59 (0.30) 0.93 
MdFI: median fluorescence intensity. Data were analyzed with linear mixed models, adjusting for gender, 
batches of experiments, repeat measures and age (for the offspring/partner comparison). Values in bold 









Figure 1.  Cumulative population doublings under non-stressed conditions and chronic exposure to 
rotenone for 7 weeks comparing young/old subjects and off-spring/partner subjects (stress-induced 
decreases: rotenone stressed and non-stressed). A, rotenone effect on young and old subjects. B, 
rotenone effect on offspring and partners. C, young and old subjects compared under non-stressed 
conditions. D, offspring and partners compared under non-stressed conditions. E, rotenone-induced 
decrease compared between young and old subjects. F, rotenone-induced decrease compared between 
offspring and partners. Data were analyzed using linear mixed models adjusting for gender and batches of 







The main findings of our study are that chronic inhibition of the respiratory chain with 
rotenone differentially affects ROS levels, SA-β-gal activity and growth rate, but not telomere 
shortening rate, when fibroblast strains from young subjects are compared with strains from 
old subjects. Even more importantly, the stress-induced changes in growth rate of fibroblast 
strains from offspring of nonagenarian siblings resemble the changes in growth rate of strains 
from young subjects. 
 
According to the free radical theory of aging the respiratory chain function decreases with 
age, resulting in increased levels of ROS which will damage proteins and DNA (7). Indeed, 
the efficiency of oxidative phosphorylation in human skin fibroblasts becomes less efficient 
with chronological age (21). We aimed to simulate this process in vitro by inhibiting 
mitochondrial activity with the mitochondrial complex I inhibitor rotenone, which is known to 
decrease cellular respiration, paralleled by increased ROS levels (16). A low concentration of 
rotenone was used in order not to completely arrest proliferation. Also, it is known that long-
term inhibition of mitochondrial complex I with concentrations of rotenone inducing 100% 
inhibition, leads to secondary toxicity (22) resulting in massive cell death (16).  
 
As expected, fibroblast strains exposed to rotenone showed increased levels of ROS and 
increased SA-β-gal activity, indicating senescence (23), albeit not much is known about long-
term culturing conditions of fibroblasts under chronic oxidative stress. Koopman et al. showed 
that human fibroblast exposed to low concentrations of rotenone (100nM) for up to three days 
show depolarisation of the ∆ψ paralleled by increased levels of ROS (16). They also reported 
that despite unchanging numbers of mitochondria, rotenone-treatment did induce changes in 
the shape of mitochondria and the extent and speed of movement of mitochondria.   
 
Decreased growth rate due to oxidative stress was also found by von Zglinicki et al. who 
showed that hyperoxic condition markedly slowed proliferation (24). With the flow-FISH 
method we were able to measure that the telomere length shortened significantly after seven 
weeks of culturing. There were no differences in telomere length between non-stressed and 
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rotenone-stressed fibroblast strains after seven weeks of culturing, but taking into account the 
lower number of population doublings of the rotenone-stressed fibroblast strains, rotenone 
did induce a significantly faster telomere shortening rate per PD. This is consistent with the 
current consensus that increased oxidative stress accelerates telomere shortening (6;24).  
 
In line with our hypothesis, strains from young subjects showed lower ROS levels when 
compared with fibroblast strains from old subjects, both under non-stressed and stressed 
conditions. For non-stressed conditions these results are supported by recent findings from 
Koziel et al. who showed higher levels of ROS, coinciding with lower mitochondrial 
membrane potential (∆ψ), in fibroblast strains from old subjects (25). We used the fluorescent 
probe dihydrorhodamine 123 for the quantification of ROS. This assay is sensitive to such 
factors as plasma membrane efflux pumps (ABC transporters) (26), so it should be realized 
that any differences in these pumps between fibroblast strains from young and from old 
subjects may attribute to changes in the fluorescent signal. In vivo, ROS levels have been 
reported to increase with age in various tissues from animal models (27). We also found 
consistently lower ROS levels in strains from offspring when compared with strains from 
partners, albeit not significantly so. This is most probably due to the relatively low number of 
strains tested. Despite the lack of significance for the offspring-partner comparison, the 
results are support our earlier findings (10). Future studies with higher numbers of strains will 
have to confirm if fibroblast strains from offspring indeed show lower levels of rotenone-
induced ROS when chronically exposed. Additionally, to study differences in mitochondrial 
functionality, it would be insightful to compare ∆ψ and the number, shape and (speed of) 
movement of mitochondria and the effect of rotenone on ROS generation by mitochondria 
respiring on different substrates. In model organisms it has indeed been shown that isolated 
mitochondria respiring on different substrates will differentially represent in vivo the longevity 
of the organisms they were derived from (28). Furthermore, with aging the binding affinities of 
mitochondrial proteins in the electron transport chain decrease, causing increased ROS 
leakage (29). 
 
We did not find differences in SA-β-gal activity under non-stressed conditions between 




lower numbers of senescent fibroblasts for strains from young subjects (10). It should be 
noted that in the experiments described here, fibroblasts were cultured for seven weeks 
whereas in the experiments described earlier fibroblasts were cultured for one week. Since it 
is well known that the number of senescence fibroblasts increases with increased duration of 
culturing (30), higher background levels of senescence after seven weeks of culturing might 
mask the difference in SA-β-gal activity between strains from young and old subjects. Also 
we did not find differences in SA-β-gal activity between strains from offspring and strains from 
partners under non-stressed conditions. When chronically stressed with rotenone, increases 
in SA-β-gal activity in strains from young subjects were lower when compared with fibroblast 
strains from old subjects, but no differences in stress-induced increases in SA-β-gal activity 
were found between fibroblast strains from offspring and partners, probably due to the 
relatively low number of strains tested. 
 
Under non-stressed conditions the growth rate of fibroblast strains from young subjects was 
higher when compared with strains from old subjects. Similar in vitro results were described 
already in 1976 by Schneider et al. (31) and comparable differences were thought to exist in 
vivo (32). No differences in non-stressed growth rate were found between fibroblast strains 
from offspring of nonagenarian siblings when compared with strains from partners. It should 
be realized that we cultured the fibroblast strains under ambient oxygen conditions. The 
oxygen concentration in most tissues is much lower than the atmospheric oxygen 
concentration which is often used for cell culture. Human fibroblasts grow considerably 
slower in 20% oxygen when compared with 5% oxygen (33). Relatively large decreases in 
growth rate caused by the ambient oxygen conditions might mask the much smaller 
differences between fibroblast strains from offspring and partners. 
Stress-induced decreases in growth rate were larger for fibroblast strains from young 
subjects and offspring when compared with strains from old subjects and partners, 
respectively, so in this respect fibroblast strains from offspring resemble the responses of 
strains from young subjects, both being more responsive to oxidative stress when compared 
with strains from old subjects and partners, respectively. Again these results confirm our 
earlier findings that fibroblast strains from offspring seem to be biologically younger than 
strains from their partners (10).  




Contrary to our hypothesis, telomere shortening rates were not different between fibroblast 
strains from young subjects and fibroblast strains from old subjects. These results suggest 
that higher ROS levels in fibroblast strains from old subjects do not lead to measurably higher 
telomere shortening rates compared with young subjects. It is important to differentiate 
between in vivo age (chronological age of donors of fibroblast strains) and in vitro age 
(number of cumulative population doublings in vitro of those strains). After seven weeks of 
culturing we found stress-induced acceleration of telomere shortening which coincided with 
increased ROS levels, suggesting that with increasing in vitro age, ROS levels are related to 
accelerated telomere shortening. Indeed, it has already been described that ROS levels 
increase in human fibroblasts in later proliferation stages in vitro (34). However, there seems 
to be an uncoupling of ROS and telomere shortening when fibroblasts strains are compared 
based on in vivo age of the subjects. The results described here suggest that increased ROS 
levels affect growth rate independently of telomere shortening rate. The differences in growth 
rate dependent on chronological age and biological age under stressed conditions were not 
accompanied by differences in telomere length, suggesting that changes in growth rate with 
increasing in vivo age of subjects do not depend on changes in telomere length. This finding 
is in line with the results of Karlseder et al. who suggested that it is not telomere length per se 
which induces senescence but rather the protected status of shortened telomeres (9). More 
recently these results were supported by Sahin et al. (35) who reported results supporting a 
link between telomere and mitochondrial biology. The flow-FISH method for measuring 
telomere length has been developed for blood cells. When applied to other cell types, for 
instance to epithelial cells with a large cytoplasm, the method is known to be less accurate 
(36). Although the flow-FISH method was found sensitive enough in this study to measure 
telomere shortening in human fibroblasts during seven weeks of culturing, it is important to 
realize that this method might not be sensitive enough to measure subtle differences between 
fibroblast strains from young and old subjects and from offspring and partners.  
 
Differences between cellular phenotypes of fibroblast are dependent on differences in gene 
expression. Fibroblast strains from old subjects were shown to express lower levels of mRNA 




enzymes whereas higher expression was seen for genes related to protein processing and 
docking, extracellular matrix, immune response, EGF-signaling and transcription (37;38). 
Similar findings were reported in vivo (39). Stress-induced differences in mRNA expression of 
these genes are also dependent on the age of the subject, showing blunted responses in 
fibroblast strains from old subjects (40). Age-dependent differences in transcription are 
reflected in differences in translation, as suggested by considerable age-dependent 
differences in cytoplasmic levels of proteins involved in metabolism and stress response (e.g. 
heat shock and anti-oxidant proteins) (41). Taken together, these findings support the theory 
that aging is the result of accumulation of random damage (42) to the (mitochondrial) genome 
and to synthetic and degradative pathways, modulating the whole cell machinery. 
 
An important strength of this study is the long-term character of the experiments, mimicking 
age-related decreases in mitochondrial function by inhibiting mitochondrial respiratory chain 
function. Furthermore, the tested strains were obtained from subjects of various chronological 
and biological ages, collected and stored in a highly standardized manner. We chose to study 
stress-induced senescence rather than replicative senescence, since it has been shown that 
the maximum number of population doublings does not reflect human life history trajectories 
(43). This suggests that stress-induced senescence might better differentiate between 
cellular phenotypes of individual subjects. A weakness of the study is the relatively low 
number of strains tested.  
 
In conclusion we report that chronic inhibition of the respiratory chain differentially affects 
ROS levels, SA-β-gal activity and growth rate, but not telomere shortening when fibroblast 
strains from young subjects are compared with strains from old subjects. Even more 
importantly, the stress-induced changes in growth rate of fibroblast strains from offspring of 
nonagenarian siblings resemble the changes in growth rate of strains from young subjects, 
indicating that these offspring are biologically younger when compared with the general 
population. When fibroblast strains from offspring are compared with strains from partners, 
the effects of the biological age difference are likely to be smaller than those resulting from 
the 70 years difference between strains from young and old subjects. This might partly 
explain the lack of differences in ROS-levels and SA-β-gal acitivity between fibroblast strains 
Chronic inhibition of the respiratory chain & chronological vs biological age 
97 
 
from offspring and partners. On the other hand the differences between the chronological and 
biological age contrasts could involve different biological phenomena. Future work will have 





(1)  Krtolica A. Stem cell: balancing aging and cancer. Int J Biochem Cell Biol 2005;37:935-941. 
(2)  Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi 
J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of 
oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6:2853-2868. 
(3)  Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-
derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 
2008;129:163-173. 
(4) Oeseburg H, de Boer RA, van Gilst WH, van der HP. Telomere biology in healthy aging and 
disease. Pflugers Arch 2010;459:259-268. 
(5)  Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. 
Nat Rev Mol Cell Biol 2007;8:729-740. 
(6)  Richter T, von Zglinicki T. A continuous correlation between oxidative stress and telomere 
shortening in fibroblasts. Exp Gerontol 2007;42:1039-1042. 
(7)  Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 
1956;11:298-300. 
(8) von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27:339-344. 
(9)  Karlseder J, Smogorzewska A, de LT. Senescence induced by altered telomere state, not 
telomere loss. Science 2002;295:2446-2449. 
(10)  Dekker P, Maier AB, van HD, de Koning-Treurniet C, Blom J, Dirks RW, Tanke HJ, Westendorp 
RG. Stress-induced responses of human skin fibroblasts in vitro reflect human longevity. Aging 
Cell 2009;8:595-603. 
(11)  Schoenmaker M, de Craen AJM, de Meijer PHEM, Beekman M, Blauw GJ, Slagboom PE, 
Westendorp RGJ. Evidence of genetic enrichment for exceptional survival using a family 
approach: the Leiden Longevity Study. Eur J Hum Genet 2006;14:79-84. 
(12)  Westendorp RG, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, Blauw GJ, Beekman M, 
Heijmans BT, de Craen AJ, Slagboom PE. Nonagenarian siblings and their offspring display 
lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. 
J Am Ger Soc 2009;57:1634-1637. 
(13)  Wijsman CA, Rozing MP, Streefland TC, Le CS, Mooijaart SP, Slagboom PE, Westendorp RG, 
Pijl H, van HD. Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 2010;10-
9726. 
(14)  Bootsma-van der Wiel A, Gussekloo J, de Craen AJM, van Exel E, Bloem BR, Westendorp 
RGJ. Common chronic diseases and general impairments as determinants of walking disability 
in the oldest-old population. J Am Ger Soc 2002;50:1405-1410. 
Chronic inhibition of the respiratory chain & chronological vs biological age 
99 
 
(15)  Maier AB, le Cessie S, Koning-Treurniet C, Blom J, Westendorp RG, van Heemst D. 
Persistence of high-replicative capacity in cultured fibroblasts from nonagenarians. Aging Cell 
2007;6:27-33. 
(16)  Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, Willems 
PH. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species 
generation. Antioxid Redox Signal 2010;12:1431-1470. 
(17)  Cabras P, Caboni P, Cabras M, Angioni A, Russo M. Rotenone residues on olives and in olive 
oil. J Agric Food Chem 2002;50:2576-2580. 
(18)  Wondrak GT, Roberts MJ, Cervantes-Laurean D, Jacobson MK, Jacobson EL. Proteins of the 
extracellular matrix are sensitizers of photo-oxidative stress in human skin cells. J Invest 
Dermatol 2003;121:578-586. 
(19)  Boulton S, Anderson A, Swalwell H, Henderson JR, Manning P, Birch-Machin MA. Implications 
of using the fluorescent probes, dihydrorhodamine 123 and 2',7'-dichlorodihydrofluorescein 
diacetate, for the detection of UVA-induced reactive oxygen species. Free Radic Res 
2011;45:139-146. 
(20)  Noppe G, Dekker P, Koning-Treurniet C, Blom J, van Heemst D, Dirks RJ, Tanke HJ, 
Westendorp RG, Maier AB. Rapid flow cytometric method for measuring Senescence 
Associated â-galactosidase activity in human fibroblasts. Cytometry A 2009;75:910-916. 
(21)  Greco M, Villani G, Mazzucchelli F, Bresolin N, Papa S, Attardi G. Marked aging-related decline 
in efficiency of oxidative phosphorylation in human skin fibroblasts. FASEB J 2003;17:1706-
1708. 
(22)  Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell 
physiology. J Biol Chem 1999;274:16188-16197. 
(23)  Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-
induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp 
Gerontol 2000;35:927-945. 
(24)  von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits 
proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220:186-193. 
(25) Koziel R, Greussing R, Maier AB, Declercq L, Jansen-Durr P. Functional interplay between 
mitochondrial and proteasome activity in skin aging. J Invest Dermatol 2011;131:594-603. 
(26)  Prochazkova J, Kubala L, Kotasova H, Gudernova I, Sramkova Z, Pekarova M, Sarkadi B, 
Pachernik J. ABC transporters affect the detection of intracellular oxidants by fluorescent 
probes. Free Radic Res 2011;45:779-787. 
(27)  Sohal RS, Ku HH, Agarwal S, Forster MJ, Lal H. Oxidative damage, mitochondrial oxidant 
generation and antioxidant defenses during aging and in response to food restriction in the 
mouse. Mech Ageing Dev 1994;74:121-133. 
(28)  Melvin RG, Ballard JW. Intraspecific variation in survival and mitochondrial oxidative 




(29)  Ames BN. Optimal micronutrients delay mitochondrial decay and age-associated diseases. 
Mech Ageing Dev 2010;131:473-479. 
(30)  Dimri GP, Lee XH, Basile G, Acosta M, Scott C, Roskelley C, Medrano EE, Linskens M, Rubelj 
I, Pereirasmith O, Peacocke M, Campisi J. A Biomarker That Identifies Senescent Human-Cells 
in Culture and in Aging Skin In-Vivo. P Natl Acad Sci USA 1995;92:9363-9367. 
(31)  Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. 
P Natl Acad Sci USA 1976;73:3584-3588. 
(32)  Rubin H. Cell aging in vivo and in vitro. Mech Ageing Dev 1997;98:1-35. 
(33) Balin AK, Fisher AJ, Anzelone M, Leong I, Allen RG. Effects of establishing cell cultures and cell 
culture conditions on the proliferative life span of human fibroblasts isolated from different 
tissues and donors of different ages. Exp Cell Res 2002;274:275-287. 
(34)  Lee HC, Yin PH, Chi CW, Wei YH. Increase in mitochondrial mass in human fibroblasts under 
oxidative stress and during replicative cell senescence. J Biomed Sci 2002;9:517-526. 
(35)  Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, 
Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin 
ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson 
R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. Telomere dysfunction induces 
metabolic and mitochondrial compromise. Nature 2011;470:359-365. 
(36)  Wieser M, Stadler G, Bohm E, Borth N, Katinger H, Grillari J, Voglauer R. Nuclear flow FISH: 
isolation of cell nuclei improves the determination of telomere lengths. Exp Gerontol 
2006;41:230-235.
(37)  Braam B, Langelaar-Makkinje M, Verkleij A, Bluyssen H, Verrips T, Koomans HA, Joles JA, 
Post JA. Anti-oxidant sensitivity of donor age-related gene expression in cultured fibroblasts. 
Eur J Pharmacol 2006;542:154-161. 
(38)  Ly DH, Lockhart DJ, Lerner RA, Schultz PG. Mitotic misregulation and human aging. Science 
2000;287:2486-2492. 
(39)  Lener T, Moll PR, Rinnerthaler M, Bauer J, Aberger F, Richter K. Expression profiling of aging in 
the human skin. Exp Gerontol 2006;41:387-397. 
(40)  Kyng KJ, May A, Kolvraa S, Bohr VA. Gene expression profiling in Werner syndrome closely 
resembles that of normal aging. P Natl Acad Sci USA 2003;100:12259-12264. 
(41) Boraldi F, Bini L, Liberatori S, Armini A, Pallini V, Tiozzo R, Pasquali-Ronchetti I, Quaglino D. 
Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of 
different ages. Proteomics 2003;3:917-929. 
(42)  Kirkwood TB. Molecular gerontology. J Inherit Metab Dis 2002;25:189-196. 
(43)  Maier AB, Westendorp RG. Relation between replicative senescence of human fibroblasts and 











Microarray-based identification of age-dependent differen ces 
in gene expression of human dermal fibroblasts 
 
 
Pim Dekker, David Gunn, Tony McBryan, Roeland W. Dirks, Diana van Heemst, Fei-Ling 
Lim, Aart G. Jochemsen, Matty Verlaan-de Vries, Julia Nagel, Peter D. Adams, Hans J. 
Tanke, Rudi G.J. Westendorp, Andrea B. Maier 
 
 













Senescence is thought to play an important role in the progressive age-related decline in 
tissue integrity and concomitant diseases, but not much is known about the complex interplay 
between upstream regulators and downstream effectors. We profiled whole genome gene 
expression of non-stressed and rotenone-stressed human fibroblast strains from young and 
oldest old subjects, and measured Senescence Associated-β-gal (SA-β-gal) activity. 
Microarray results identified gene sets involved in carbohydrate metabolism, Wnt/β-catenin 
signaling, the cell cycle, glutamate signaling, RNA-processing and mitochondrial function as 
being differentially regulated with chronological age. The most significantly differentially 
regulated mRNA corresponded to the p16 gene. p16 was then investigated using qPCR, 
Western blotting and immunocytochemistry (ICC). In conclusion, we have identified cellular 
pathways that are differentially expressed between fibroblast strains from young and old 
subjects. 





In addition to apoptosis, senescence is thought to contribute to the progressive age-related 
decline in tissue integrity and the concomitant diseases (1). It was found that various types of 
stressors (e.g. cytokines, oxidative agents) could induce premature senescence, implying a 
significant role for environmental factors in accelerating the aging process. In the past, 
studying senescence in vivo was thwarted by the lack of markers that indubitably identify 
senescent cells. Meanwhile studies into the signal transduction pathways of senescence 
have led to identification of many proteins that have overlapping roles in senescence, 
apoptosis and DNA-damage sensing (2).  
 
Despite the fact that senescence, apoptosis and DNA-damage repair have been shown to 
play pivotal roles in the aging process, not much is known about the complex interplay 
between upstream and downstream pathways that operate intracellularly and between 
tissues on the systemic level. Gene expression array technologies may help to find a specific 
profile of differential gene expression as a marker of senescence. Comparisons of gene 
expression profiles have been made between various tissues of chronologically young and 
old mammalian model organisms (3-13) and humans (14-24). These studies show that 
different tissues in various species show similar changes in expression of genes involved in 
DNA-damage repair, cell cycle progression, senescence, apoptosis, stress response, 
immune response and metabolism. However, there are also many species-dependent and 
tissue-dependent differences that these studies did not address, and it is also not clear which 
changes are the results of the aging process and which drive the aging process. We have 
already reported that human skin fibroblast strains derived from chronologically young 
subjects, when compared with fibroblast strains from oldest old subjects (90 years of age), 
are less prone to go into senescence and more prone to go into apoptosis, both under non-
stressed and stressed conditions (25). Also, fibroblast strains from middle aged offspring of 
nonagenarian siblings exhibited less senescence and more apoptosis when compared with 
fibroblasts from the partners of the offspring, representing the general population. Thus, 
fibroblasts from the offspring demonstrated younger cellular characteristics than fibroblasts 





Here, we aimed to identify the cellular pathways that drive the differences with chronological 
age in cell senescence and apoptosis. We performed whole genome gene expression 
profiling of non-stressed and rotenone-stressed human fibroblast strains from young and old 
subjects. We expected the rotenone treatment to exacerbate differences in gene mRNA 
levels with age and, in particular, affect genes involved in senescence, apoptosis, DNA-
damage repair, cell cycle progression, stress responses and metabolism. We validated the 
most significant mRNA change by qPCR and then performed a replication experiment in 




Material and methods 
 
Study design 
The Leiden 85-plus Study (26) is a prospective population-based study in which all 
inhabitants aged 85 years or older of the city of Leiden, the Netherlands, were invited to take 
part. Between September 1997 and September 1999, 599 out of 705 eligible subjects (85%) 
were enrolled. All participants were followed for mortality and 275 subjects survived to the 
age of 90 years. During the period December 2003 up to May 2004, a biobank was 
established from fibroblasts cultivated from skin biopsies from 68 of the 275 surviving 90-
year-old participants (27). These participants were in good physical and mental condition and 
were able to come to the research institute, where the same qualified physician carried out 
the procedures. During the period August to November 2006, we also established a biobank 
of fibroblast strains established from biopsies taken from 27 young subjects (23-29 years 
old).  
 
Fibroblast cultures and experimental setup 
Three-mm biopsies were taken from the sun unexposed medial side of the upper arm. 
Fibroblasts were grown in D-MEM:F-12 (1:1) medium supplemented with 10% fetal calf 
serum (FCS, Gibco, batch no. 40G4932F), 1 mM MEM sodium pyruvate, 10 mM HEPES, 2 
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mM glutamax I, and antibiotics (100 Units/mL penicillin, 100 µg/mL streptomycin, and 0.25–
2.5 µg/mL amphotericin B), all obtained from Gibco, Breda, the Netherlands. This medium 
will be referred to as standard medium. Fibroblasts were incubated at 37oC with 5% CO2 and 
100% humidity. All cultures that are used in the present study were grown under predefined, 
highly standardized conditions as published earlier (27) and frozen at low passage. Trypsin 
(Sigma, St Louis, MO, USA) was used to split fibroblasts using a 1:4 ratio each time they 
reached 80-100% confluence. 
Passage 11 fibroblasts were thawed from frozen stocks on day zero. On day four, seven and 
11 fibroblasts were further passaged in order to multiply fibroblasts. On day 18 the 
experiments were started. For the microarray experiments, fibroblast strains were seeded at 
5200 and 7500 cells/cm2 for non-stressed and rotenone-stressed cultures respectively. For 
the replication experiments, fibroblast strains were seeded at 2300 and 3900 cells/cm2 for 
non-stressed and rotenone-stressed cultures respectively. Strains were seeded in batches of 
eight strains per condition.  
To chronically stress fibroblast strains, medium was supplemented with 0.6 µM rotenone 
(Sigma, St Louis, MO, USA), known to induce an increase in the intracellular production of 
reactive oxygen species (ROS) at the mitochondrial level (28). After three days fibroblast 
strains were assessed for SA-β-gal, ROS, microarray experiments, p16 on the mRNA level 
and the protein level as described below. In order to check early response genes samples 
were also taken at three hours for the microarray experiments.  
 
 
Flow cytometric measurement of SA- β-galactosidase activity 
Fibroblasts were prepared as described earlier (29). In short, to change the lysosomal pH to 
pH 6, fibroblasts were incubated with medium containing 100 nM bafilomycin A1 (VWR, 
Amsterdam, the Netherlands) for 1 hour. Fibroblasts were then incubated with 33 µM of the 
β-galactosidase substrate C12FDG (Invitrogen, Breda, The Netherlands), in the presence of 
100 nM bafilomycin. After trypsinisation, fibroblasts were washed once and resuspended in 
200 µl ice cold PBS. Fibroblasts were measured in the FITC-channel and analysis was 





Flow cytometric measurement of ROS 
Fibroblasts were incubated in medium supplemented with 30 µM dihydrorhodamine 123 
(Invitrogen, Breda, The Netherlands). They were then trypsinized, washed in ice-cold PBS, 
pelleted and resupended in 200 µl ice-cold PBS. Fibroblasts were kept on ice before 
measurement of MDI in the FITC-channel. 
 
Microarray Analysis 
All products were purchased from Agilent Technologies UK Ltd (Wokingham, Berkshire, UK) 
and used according to manufacturer’s protocol unless stated otherwise. All samples (n=12) 
were isolated and run on microarrays separately. Total mRNA was isolated using the RNeasy 
Mini Kit (Qiagen Ltd, Crawley, UK) and 300ng was mixed with an appropriate amount of One-
Color RNA Spike-In RNA and converted into labelled cRNA (One-Color Low RNA Input 
Linear Amplification Kit PLUS). Labelled cRNA was purified using an RNeasy Mini Kit 
(Qiagen Ltd, Crawley, UK) and 2µg was hybridised to Agilent human whole genome Oligo 
Arrays (G4112F; 41094 probes) using reagents supplied in the Agilent Hybridisation Kit (One-
Color Microarray-Based Gene Expression Analysis Protocol). Microarray slides were 
hybridised for 17 h at 65 ºC and subsequently washed in acetonitrile for 1 min followed by 
30s in Agilent Stabilisation and Drying Solution. Scanning of the slides was performed with 
the Agilent G2565BA Microarray Scanner System. The Agilent G2567AA Feature Extraction 
Software (v.9.1) was used to extract data and check the quality. To comply with MIAME 
requirements the data discussed in this publication have been deposited in NCBI's Gene 
Expression Omnibus (GEO) (30;31) and are accessible through GEO Series accession 
number GSE28300 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28300). 
 
Validation/replication of p16 by qPCR 
cDNA syntheses of total RNA extracted from non-stressed fibroblast strains or rotenone-
stressed fibroblast strains was carried out using 0.5µg total RNA per reaction. Synthesis of 
cDNA was via AMV first strand synthesis kit (Roche Applied Science, Hertfordshire, UK) 
according to the manufacturer’s instructions. All PCR mixes were prepared in triplicate, 
comprising 0.1µl of freshly prepared cDNA, 1 x SYBR Green PCR master mix (Bio-Rad 
Laboratories Ltd, Hemel Hempstead, UK) and 1 x QuantiTect PCR primers (Qiagen Ltd, 
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Crawley, UK) specific for the genes CDKN2A/p16 (QT00089964) or to PPIA/cyclophilin A 
(QT00062311). Semi-quantitative PCR was performed on a Bio-Rad iCycler. Transcript levels 
were normalized to PPIA and data analysis was performed using the comparative cycle 
threshold method (∆∆CT).  
 
p16 immunoblotting 
Fibroblasts were lysed in RIPA buffer (20mM Triethanolamine-HCL, ph 7.8, 140 mM NaCl, 
0.1% Natrium deoxycholaat, 0.1% Natrium dodecylsulfaat (SDS) and 0.1% Triton X-100) with 
protease inhibitors (SIGMAFAST TM Protease Inhibitor Cocktail Tablets, EDTA-free) used 
according to the manufacturer’s protocol. Proteinlysates of the fibroblasts were stored at  
-80°C. Protein content was determined by Pierce BCA  Protein Assay Kit (Thermo Scientific, 
Breda, the Netherlands). Proteins were fractionated by 10% and 15% SDS-polyacrylamide 
gel electrophoresis. For every strain the loaded amounts of protein were the same for the 
unstressed and for the rotenone-stressed condition. Samples of three subjects were not used 
for immunoblots because of very low protein content. Proteins were blotted onto a PVDF 
membrane (Immobilon-P, Millipore, Billerica, USA). Membranes were blocked in Tris-
Buffered Saline Tween-20 (TBST) containing 10% non-fat dry milk. Primary antibodies were 
prepared in TBST solution with 10% dry milk. Membranes were incubated overnight at 4°C 
with the following primary antibodies:  α-p16 JC8 (Santa Cruz Biotechnology, 1:500) and α-
Hausp Pab (Bethyl laboratories, Montgomery 1:1000). After incubation, membranes were 
washed three times with TBST and incubated with goat anti-mouse or goat anti-rabbit 
antibody coupled to horse-radish-peroxidase for one h at room temperature. Antibody binding 
was visualized using Super Signal West Dura (Thermo Scientific, Breda, the Netherlands) 
and exposure to X-ray film. The software package Odyssey (LI-COR Biosciences, Lincoln, 
USA) was used to quantify the values from the Immunoblot signals, the values of which were 
expressed in arbitrary units (AU). All values were normalized for loading control before they 
were used further for statistical analyses.                                                                                                                                             
 
Immunocytochemical staining for p16  
Fibroblasts were fixed with 4% paraformaldehyde in PBS for four minutes. After permeabili-




blocked with blocking buffer (3% BSA in PBS) for one hour at room temperature and 
incubated for two hours with anti-p16 (JC8) antibody (Santa Cruz Biotechnology Inc., Santa 
Cruz, USA), diluted 1/100 in blocking buffer. After five washes with PBS, cells were treated 
with 0.3% H2O2 in methanol to reduce background peroxidase activity. Fibroblasts were then 
stained using an anti-mouse IgG Vectastain Elite ABC kit (Vector laboraties, Burlingame, CA, 
USA) and a DAB Peroxidase Substrate Kit (Vector laboraties, Burlingame, CA, USA), 
according to the manufacturer’s protocols. Fibroblasts were counterstained with Hematoxylin 
(Vector laboraties, Burlingame, CA, USA) for five minutes and incubated with NH4OH in 70% 
ethanol for one minute. After washing in water, slides were mounted with Faramount 
Mounting Medium (DAKO, Heverlee, Belgium) and photographed with a Leica microscope 
(Leica Microsystems, Rijswijk, the Netherlands). Per sample 500 randomly chosen cells were 
assessed for p16 positivity. 
 
Statistics 
Raw data produced from microarrays were imported into R version 2.11.0 (2010-04-22) (32), 
an open source statistical analysis program, using custom code. Background correction was 
performed using the normexp+offset method and data were log-transformed (33). Differential 
expression of genes was determined by fitting a linear model using the lmFit function from the 
limma package and moderated t-statistics were computed using the ebayes function (34). 
The linear model included parameters for treatment, age, gender and batch effects. 
Bonferroni-Holm multiple testing correction was also applied (FDR(p) < 0.05). 
For the probes showing significant differences in expression of mRNA between fibroblast 
strains from young and old strains, variation in expression between strains from different 
subjects was presented as a heatmap. 
The Bonferroni-Holm data set was uploaded into the Ingenuity application 
[www.ingenuity.com]. Each probe identifier was mapped to its corresponding object/gene in 
Ingenuity's Knowledge Base. These molecules, called Network Eligible molecules, were 
overlaid onto a global molecular network developed from information contained in Ingenuity’s 
Knowledge Base. Networks of Network Eligible Molecules were then algorithmically 
generated based on their connectivity. The Functional Analysis identified the biological 
functions and/or diseases that were most significant to the data set. Right-tailed Fisher’s 
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exact test was used to calculate a p-value determining the probability that each biological 
function and/or disease assigned to that data set is due to chance alone. Canonical pathways 
analysis identified the pathways from the Ingenuity Pathways Analysis library of canonical 
pathways that were most significant to the data set. The significance of the association 
between the data set and the canonical pathway was measured in 2 ways: 1) A ratio of the 
number of molecules from the data set that map to the pathway divided by the total number 
of molecules that map to the canonical pathway is displayed. 2) Fisher’s exact test was used 
to calculate a p-value determining the probability that the association between the genes in 
the dataset and the canonical pathway is explained by chance alone. 
 
Gene Set Enrichment Analysis (GSEA; www.broad.mit.edu\gsea) (35;36) was applied for 
functional pathway analysis between comparative conditions. Probes from the microarray 
were collapsed into 17517 gene features and ordered by signal to noise ratio into a rank 
ordered list (L). For each gene set (S) an enrichment score (ES) is calculated which reflects 
the degree to which it is overrepresented at the extremes (top or bottom) of the entire ranked 
list L based on the Kolmogorov-Smirnov statistic. Briefly, the score is calculated by traversing 
the list L and increasing a running-sum statistic when a gene is encountered which is in S 
and decreasing it when genes are encountered which are not in S. The magnitude of the 
increment corresponds to the degree that the gene correlates to the phenotype. Statistical 
significance (nominal P-value) of the ES is determined by empirical phenotype-based 
permutation; specifically the phenotype labels are permuted and the ES of the gene set is 
recalculated to generate a null distribution for the ES. Nominal p-value is computed relative to 
this null distribution. Significance levels are then adjusted to account for multiple hypotheses 
testing first by normalizing the ES for each gene set to account for the size of the set (NES) 
and then by controlling the proportion of false positives by calculating the FDR corresponding 
to each NES. Gene sets were obtained from the Broad Institute Molecular Signatures 
Database. 
 
All other analyses were performed with the software package SPSS 16.0.01 (SPSS Inc., 
Chicago, IL). Since the AU values from the Western blotting results were not normally 




analysed using linear mixed models (LMMs), adjusting for batches of experiments, repeat 
experiments and gender (and also age in case of offspring/partner comparison). Differences 
between groups (young/old, offspring/partner) in non-stressed and rotenone-stressed 





Microarray analysis dependent on chronological age 
SA-β-gal activity was measured in fibroblasts from young and old subjects under non-
stressed and stressed conditions to assure that rotenone treatment for three days would 
increase levels of senescence, as previously observed (29). Six young subjects and six old 
subjects were randomly chosen (age: 23.1±1.6 [mean±SD] and 90.3±0.5 years, respectively, 
three males and three females for both young and old). All subjects were in good physical 
and mental condition and were able to come to the research institute. There was a significant 
increase in SA-β-gal activity in all fibroblast strains after three days of exposure to 0.6 µM 
rotenone (non-stressed: 2365±236 [MdFI in arbitrary units; mean±SE], rotenone: 4366±489, 
p<0.001). Furthermore, strains from old subjects showed a higher SA-β-gal activity under 
non-stressed conditions and a higher stress-induced increase in SA-β-gal activity 
(Supplemental table 2). 
Gene expression profiles were generated using fibroblast strains from young and old subjects 
under non-stressed conditions and stressed for three hours and three days with rotenone. 
After quantile normalisation of the data, a linear regression model was used in conjunction 
with a Bonferroni-Holm multiple testing correction (p<0.05) to detect mRNAs that were 
differentially expressed between fibroblast strains from young and old subjects.  A total of 215 
out of 41094 probes were identified whose expression was significantly different between the 
fibroblast strains from young and old subjects (Supplemental table 1). Variation in expression 
between strains from different subjects was presented as a heatmap (Supplemental figure 1).  
These differences between young and old were present in the untreated samples as well as 
in the samples obtained after treatment with rotenone for three hours and after treatment with 
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rotenone for three days. The 215 differentially expressed probes could be mapped to 106 
genes (Table 1).   
 
Pathway analysis 
To identify cellular pathways that could be responsible for the age-dependent changes in 
gene expression, Ingenuity Pathway Analysis was performed using all data and applying a 
Bonferroni-Holm cutoff to generate a target list for further study. The 215 probes could be 
mapped to 106 genes eligible for Ingenuity network analysis and 100 genes allowing function 
and canonical pathway analysis. Twelve over-represented gene networks were identified, 
with the most significant Ingenuity network containing p16 (CDKN2A) at its centre (Figure 1) 
and corresponding to the biological functions Tumour Morphology, Cell Cycle progression 
and Cellular Development. The biological function most significantly enriched in the 100 
genes was Carbohydrate Metabolism. For the canonical pathway analysis Wnt/β-Catenin 
signaling was the most significantly enriched. The top 10 functions and canonical pathways 
derived from these analyses are shown in Figure 2.  
 
To complement the Ingenuity analysis, a GSEA-based analysis was performed as this 
approach uses significance data across all the probes rather than a division of the list via a 
significant cutoff. When the data from old subjects were compared with that from young 
subjects, 446 of 967 gene sets were more highly expressed in the strains from the old 
subjects. Using a false discovery rate (FDR) cutoff of 0.25, the Glutamate Signaling Pathway 
appeared to be significantly enriched (nominal p-value: 0.006, FDR: 0.22, ES: 0.68, NES: -
17.7) due to the differential regulation of the genes HOMER2, GRIA3, GRIN2B and GRIK2. In 
fibroblast strains from young subjects, 521 of 967 gene sets were more highly expressed 
when compared with strains from old subjects and 29 gene sets were significantly enriched at 
a FDR cutoff of 0.25 (Table 2). These gene sets were mainly involved in mitochondrial pro-






Figure 1.  Top network generated by the use of Ingenuity Pathway Analysis (IPA), carried out 
on comparing young with old subjects with the Bonferroni-Holm cutoff applied (p<0.05). 
Molecules are represented as nodes, and the biological relationship between two nodes is 
represented as a line. The intensity of the node color indicates the degree of up- (red) or 
down- (green) regulation in fibroblast strains from young subjects. Nodes are displayed using 
various shapes that represent the functional class of the gene product (diamond: enzyme, 
horizontal oval: transcription factor, circle: other).  




Figure 2. Ingenuity analysis. A, top 10 biological functions; B, top ten canonical pathways. 
Analysis was carried out on comparing young with old subjects with the Bonferroni-Holm cutoff 






Table 1.  List of genes to which the 215 differentially expressed probes could be mapped. 
ID Symbol Entrez Gene Name Location Type(s) 
A_23_P14515 ACOT4 acyl-CoA thioesterase 4 Cytoplasm enzyme 
A_23_P374082 ADAM19 ADAM metallopeptidase domain 19 Plasma 
Membrane 
peptidase 
A_24_P935103 ADCY9 adenylate cyclase 9 Plasma Membrane enzyme 
A_23_P68665 ADRM1 adhesion regulating molecule 1 Plasma Membrane other 
A_23_P317105 AKAP10 A kinase (PRKA) anchor protein 10 Cytoplasm other 
A_23_P158231 APBA2 amyloid beta (A4) precursor protein-binding, family A, 
member 2 
Cytoplasm transporter 
A_23_P41166 B3GALNT1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) Cytoplasm enzyme 
A_23_P159952 BEX1 brain expressed, X-linked 1 Cytoplasm other 
A_23_P22735 BEX2 brain expressed X-linked 2 Nucleus other 
A_23_P35427 BTRC beta-transducin repeat containing Cytoplasm enzyme 
A_24_P201404 C11orf54 chromosome 11 open reading frame 54 Nucleus other 
A_32_P162183 C2 complement component 2 Extracellular Space peptidase 
A_23_P40315 C20orf12 chromosome 20 open reading frame 12 unknown other 
A_32_P142700 C22orf15 chromosome 22 open reading frame 15 unknown other 
A_32_P160972 C6orf115 chromosome 6 open reading frame 115 unknown other 
A_23_P73012 C9orf3 chromosome 9 open reading frame 3 Cytoplasm peptidase 
A_23_P155106 CCDC134 coiled-coil domain containing 134 unknown other 
A_23_P24870 CD44 CD44 molecule (Indian blood group) Plasma 
Membrane 
other 
A_24_P42633 CDC42 cell division cycle 42 (GTP binding protein, 25kDa) Cytoplasm enzyme 
A_23_P43484 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) Nucleus 
transcription 
regulator 
A_24_P360674 CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) Nucleus transcription regulator 
A_32_P99171 CHST11 carbohydrate (chondroitin 4) sulfotransferase 11 Cytoplasm enzyme 
A_24_P351435 CRBN cereblon Cytoplasm enzyme 
A_24_P76666 CSNK2A1 casein kinase 2, alpha 1 polypeptide Cytoplasm kinase 
A_23_P202448 CXCL12 chemokine (C-X-C motif) ligand 12 Extracellular 
Space 
cytokine 
A_23_P257871 DAB2 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) 
Plasma 
Membrane other 
A_32_P230547 DOCK7 dedicator of cytokinesis 7 Plasma Membrane other 
A_23_P217079 DPM2 dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit Cytoplasm enzyme 
A_23_P103232 DUSP23 dual specificity phosphatase 23 Cytoplasm phosphatase 
A_24_P375609 EIF5A eukaryotic translation initiation factor 5A Cytoplasm translation 
regulator 
A_23_P154806 EPB41L1 erythrocyte membrane protein band 4.1-like 1 Plasma Membrane other 
A_24_P166613 EPDR1 ependymin related protein 1 (zebrafish) Nucleus other 
A_23_P71981 ERAL1 Era G-protein-like 1 (E. coli) Cytoplasm other 
A_24_P314451 F8 coagulation factor VIII, procoagulant component Extracellular Space other 
A_32_P39093 FAM108C1 family with sequence similarity 108, member C1 unknown enzyme 
A_23_P167599 FAM134B family with sequence similarity 134, member B Cytoplasm other 
A_24_P38316 FOXP2 forkhead box P2 Nucleus transcription 




A_23_P11543 FUCA1 fucosidase, alpha-L- 1, tissue Cytoplasm enzyme 
A_23_P25964 GALC galactosylceramidase Cytoplasm enzyme 
A_24_P217489 GLRB glycine receptor, beta Plasma 
Membrane 
ion channel 
A_23_P416581 GNAZ guanine nucleotide binding protein (G protein), alpha z polypeptide 
Plasma 
Membrane enzyme 





A_23_P139864 GSG1 germ cell associated 1 Cytoplasm other 
A_23_P98431 HMBS hydroxymethylbilane synthase Cytoplasm enzyme 
A_32_P50924 HNRNPA1L2 heterogeneous nuclear ribonucleoprotein A1-like 2 Nucleus other 
A_23_P170687 HSPBP1 HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 unknown other 
A_23_P48513 IFI27 interferon, alpha-inducible protein 27 Cytoplasm other 
A_23_P343954 IGF2BP1 insulin-like growth factor 2 mRNA binding protein 1 Cytoplasm translation 
regulator 
A_23_P19987 IGF2BP3 insulin-like growth factor 2 mRNA binding protein 3 Cytoplasm translation regulator 
A_23_P257956 ILF2 interleukin enhancer binding factor 2, 45kDa Nucleus transcription regulator 
A_32_P87872 IMMP2L IMP2 inner mitochondrial membrane peptidase-like (S. 
cerevisiae) 
Cytoplasm peptidase 
A_23_P19852 IQCE IQ motif containing E Cytoplasm other 
A_23_P324523 IQCK IQ motif containing K unknown other 
A_23_P112201 KDM4C lysine (K)-specific demethylase 4C Nucleus other 
A_32_P151544 KRT18 keratin 18 Cytoplasm other 
A_23_P93750 LSM5 LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) Cytoplasm other 
A_24_P314640 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 
Plasma 
Membrane other 
A_23_P61945 MITF microphthalmia-associated transcription factor Nucleus transcription 
regulator 
A_23_P135474 MRPL37 mitochondrial ribosomal protein L37 Cytoplasm enzyme 
A_32_P117170 NAPEPLD N-acyl phosphatidylethanolamine phospholipase D Cytoplasm enzyme 
A_24_P367752 NDST1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 Cytoplasm enzyme 
A_23_P300600 NEFH neurofilament, heavy polypeptide Cytoplasm other 
A_23_P91328 NOP56 NOP56 ribonucleoprotein homolog (yeast) Nucleus other 
A_23_P59547 NT5C3 5'-nucleotidase, cytosolic III Cytoplasm phosphatase 
A_24_P360206 PCDHA11 protocadherin alpha 11 Plasma Membrane other 
A_32_P116857 PDE11A phosphodiesterase 11A Cytoplasm enzyme 
A_23_P411723 PLAG1 pleiomorphic adenoma gene 1 Nucleus transcription regulator 
A_23_P17914 PNPLA3 patatin-like phospholipase domain containing 3 Cytoplasm enzyme 





A_23_P60458 PPP2R4 protein phosphatase 2A activator, regulatory subunit 4 Cytoplasm phosphatase 
A_23_P146554 PTGDS prostaglandin D2 synthase 21kDa (brain) Cytoplasm enzyme 
A_23_P203729 RAB6A RAB6A, member RAS oncogene family Cytoplasm enzyme 
A_23_P166087 RASSF2 Ras association (RalGDS/AF-6) domain family member 2 Nucleus other 




A_23_P133596 DROSHA drosha, ribonuclease type III Nucleus enzyme 
A_24_P199500 RNF2 ring finger protein 2 Nucleus transcription 
regulator 
A_23_P6802 RRP9 ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast) Nucleus other 
A_32_P161762 RUNX2 runt-related transcription factor 2 Nucleus transcription regulator 
A_23_P259741 SATB1 SATB homeobox 1 Nucleus transcription 
regulator 
A_23_P152548 SCPEP1 serine carboxypeptidase 1 Cytoplasm peptidase 
A_23_P150092 SEPHS1 selenophosphate synthetase 1 unknown enzyme 
A_23_P106299 SERF2 small EDRK-rich factor 2 unknown other 
A_32_P4595 SGCD sarcoglycan, delta (35kDa dystrophin-associated 
glycoprotein) 
Cytoplasm other 
A_23_P139260 SLC22A18 solute carrier family 22, member 18 Plasma Membrane transporter 
A_23_P436179 SLC25A5 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 Cytoplasm transporter 
A_23_P24345 SLC39A13 solute carrier family 39 (zinc transporter), member 13 unknown transporter 
A_23_P50167 SLC39A6 solute carrier family 39 (zinc transporter), member 6 Plasma 
Membrane 
transporter 
A_23_P154675 SNRPB small nuclear ribonucleoprotein polypeptides B and B1 Nucleus other 
A_32_P43711 SOCS7 suppressor of cytokine signaling 7 Cytoplasm other 
A_32_P89755 SSR1 signal sequence receptor, alpha Cytoplasm other 
A_23_P36076 SSRP1 structure specific recognition protein 1 Nucleus other 
A_23_P43164 SULF1 sulfatase 1 Cytoplasm enzyme 
A_23_P96965 SYNC syncoilin, intermediate filament protein Cytoplasm other 
A_32_P66881 TLR4 toll-like receptor 4 Plasma Membrane 
transmembrane 
receptor 
A_23_P103282 TMEM59 transmembrane protein 59 Plasma Membrane other 
A_23_P216522 TMEM8B transmembrane protein 8B Plasma 
Membrane 
other 





tropomyosin 1 (alpha) Cytoplasm other 
A_23_P16683 TRMT1 TRM1 tRNA methyltransferase 1 homolog (S. cerevisiae) unknown enzyme 
A_23_P79510 VPS24 vacuolar protein sorting 24 homolog (S. cerevisiae) Cytoplasm other 
A_23_P141394 WIPI1 WD repeat domain, phosphoinositide interacting 1 Cytoplasm other 
A_23_P211926 WNT5A wingless-type MMTV integration site family, member 5A Extracellular Space cytokine 
A_32_P34516 XKR6 XK, Kell blood group complex subunit-related family, 
member 6 
unknown other 
A_23_P134527 YKT6 YKT6 v-SNARE homolog (S. cerevisiae) Cytoplasm enzyme 
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Table 2. Gene sets more higly expressed in fibroblast strains from young subjects when 
compared with strains from old subjects, and significantly enriched at FDR<0.25, identified by 
GSEA.  
Gene set  p FDR ES NES 
MITOCHONDRIAL_INNER_MEMBRANE 0.010 0.163 -0.58 -17.72 
SPINDLE 0.000 0.217 -0.85 -16.00 
NUCLEAR_EXPORT 0.024 0.218 -0.54 -15.76 
PORE_COMPLEX 0.027 0.220 -0.63 -16.04 
MICROTUBULE_ORGANIZING_CENTER 0.010 0.225 -0.58 -15.81 
SPINDLE_POLE 0.004 0.226 -0.84 -15.77 
SPLICEOSOME 0.048 0.228 -0.55 -15.92 
MITOCHONDRIAL_PART 0.054 0.229 -0.44 -16.05 
RNA_DEPENDENT_ATPASE_ACTIVITY 0.008 0.230 -0.71 -16.15 
MITOCHONDRIAL_RIBOSOME 0.052 0.231 -0.62 -1.62 
MICROTUBULE_ORGANIZING_CENTER_PART 0.024 0.231 -0.65 -15.82 
RNA_BINDING 0.017 0.233 -0.36 -15.86 
MITOCHONDRIAL_MEMBRANE 0.008 0.235 -0.52 -17.75 
MICROTUBULE_CYTOSKELETON 0.020 0.235 -0.57 -1.55 
NUCLEOLUS 0.008 0.235 -0.48 -16.61 
SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX 0.012 0.239 -0.66 -17.21 
MITOCHONDRIAL_MEMBRANE_PART 0.076 0.239 -0.52 -15.51 
CYTOSKELETAL_PART 0.018 0.239 -0.52 -15.48 
MITOCHONDRIAL_ENVELOPE 0.039 0.240 -0.46 -1.63 
NUCLEAR_LUMEN 0.010 0.240 -0.41 -15.31 
VIRAL_REPRODUCTIVE_PROCESS 0.006 0.242 -0.64 -16.05 
ORGANELLE_INNER_MEMBRANE 0.020 0.244 -0.53 -17.03 
FEMALE_GAMETE_GENERATION 0.029 0.244 -0.72 -15.32 
RNA_HELICASE_ACTIVITY 0.013 0.246 -0.68 -16.42 
VIRAL_REPRODUCTION 0.011 0.246 -0.59 -15.40 
RIBOSOMAL_SUBUNIT 0.063 0.247 -0.63 -15.51 
ORGANELLAR_RIBOSOME 0.052 0.247 -0.62 -1.62 
ATP_DEPENDENT_HELICASE_ACTIVITY 0.004 0.247 -0.69 -16.67 
TRANSLATION_FACTOR_ACTIVITY__NUCLEIC_ACID_BINDING 0.044 0.248 -0.53 -15.36 






An expression probe corresponding to p16 was the most significantly differentially expressed 
probe between fibroblast strains from young and old subjects, being higher in strains from old 
subjects. Rotenone-treatment resulted in decreases in p16 mRNA expression after three 
hours and even more so after three days which were similar for fibroblast strains from young 
and old subjects, i.e. there was no significant rotenone-age interaction. This was validated by 
qPCR (non-stressed=1, fold change 3 hours rotenone [mean±SE]: 0.74±0.04, fold change 3 
days rotenone: 0.67±0.04, p<0.001). For each condition, p16 mRNA levels were found to be 
higher in fibroblast strains from old subjects (Supplemental table 2). To verify these results, 
we performed a replication experiment on fibroblast strains from a new set of ten young and 
ten old subjects (age: 25.5±1.8 [mean±SD] and 90.2±0.3 years). To assess the rotenone-
induced stress response, levels of reactive oxygen species (ROS [MdFI in arbitrary units] 
non-stressed: 1580±70 [mean±SE], rotenone: 2181±124, p<0.001) and SA-β-gal activity 
([MdFI in arbitrary units] non-stressed: 2793±278, rotenone: 4278±330, p<0.001) were 
measured. There was no difference in SA-β-gal activity between strains from young and old 
subjects, but strains from old subjects did show a greater rotenone-induced increase in SA-β-
gal activity (Supplemental table 2). Under non-stressed conditions ROS levels were higher in 
strains from old subjects (MdFI in arbitrary units, young: 1500±150, old: 1656±148, p=0.027), 
but there were no differences in rotenone-induced increases. p16 was measured by qPCR, 
Western blotting and immunocytochemistry (ICC). Consistent with the microarray 
experiments, p16 mRNA expression decreased (non-stressed=1, rotenone: 0.74±0.04, 
p<0.001). Under non-stressed conditions, fibroblast strains from old subjects showed 
significantly lower levels of p16 mRNA when compared with strains of young subjects 
(Supplemental table 2), contrary to the microarray results of the microarray experiment. 
Under stressed conditions there was no difference in p16 mRNA expression or protein levels. 
Western blotting demonstrated neither rotenone-induced changes in p16 protein levels, nor 
any differences between strains from young and old subjects. ICC showed rotenone-induced 
increases in p16 positive fibroblasts (Non-stressed: 2.40±0.31%, rotenone: 7.02±0.72%, 
p<0.001). Under non-stressed conditions percentages of p16-positive fibroblasts were higher 
for strains from old subjects when compared with strains from young subjects (young: 
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+1.39±0.31%, old: +3.05±0.31%, p<0.001), as were rotenone-induced increases in p16 





In this study we addressed which pathways could be responsible for the reported differences 
in senescence and apoptosis between fibroblast strains from young and old subjects (25;37) 
using microarray methodology. Age-dependent differences were found in pathways involved 
in carbohydrate metabolism, Wnt/β-catenin signalling, the cytoskeleton, cell cycle, RNA-
processing and mitochondrial function. No significant rotenone-age interactions were 
detected in this analysis indicating that the differences with age in mRNA levels were 
generally similar in stressed and non-stressed conditions. 
 
Ingenuity analysis 
Ingenuity analysis identified carbohydrate metabolism as the biological function that was 
most differentially expressed between strains from young and old subjects. The most 
significant pathway within this function was modification of glycosaminoglycans (GAGs), 
which are important components of the extracellular matrix (ECM). In support of this finding, it 
has been reported that physiological aging is associated with ECM remodeling, reflected by 
plasma GAGs concentrations (38). Genes involved in carbohydrate metabolism identified by 
Ingenuity were, amongst others, CD44, CXCL12 and TLR4. CD44 is a cell-surface 
glycoprotein important for cell-cell interactions, cell adhesion and migration (39;40). In aged 
fibroblasts, TGF-1-induced association between CD44 and EGF-R is lost with resultant 
suppression of ERK1/2 activation (41) and this might explain the lower CD44-expression in 
fibroblast strains from old subjects that we observed. In addition, CD44 is a receptor for 
hyaluran (HA), which is an important component of the ECM. HA acts through TLR4 and 
CD44 to stimulate an immune response against the septic response (42). Lower TLR4 
activity has also been linked to reduced inflammatory response and successful aging (43), 




the study reported here. CXCL12/SDF-1 is a chemotactic cytokine involved in cell motility 
(44) and showed lower expression in fibroblast strains from old subjects, correlating well with 
the decreased expression with age reported in animal models (45). Taken together, these 
results suggest that differences in cell to cell signaling might explain the differential regulation 
of carbohydrate metabolism between fibroblast strains from young and old subjects. 
 
The most significant canonical pathway identified by the Ingenuity analysis was the Wnt/β-
catenin pathway, which is frequently deregulated in cancer (46;47) and consists of, amongst 
others, the genes B-TRCP, CK2, CDKN2A (or p14/p16: see below) and WNT5A. WNT5A-
expression was higher in fibroblast strains from old subjects, consistent with reduced cell 
proliferation in fibroblast strains from old subjects (25) and age-dependent increased 
WNT5A-expression reported for animal models (48). In support of this, the top Ingenuity 
network indicated reduced cell proliferation in fibroblast strains from old subjects via the 
increases found in p15, p16 and RUNX2 mRNA. However, the expression levels of some 
genes were opposite to that expected. For example, B-TRCP is involved in ubiquitination and 
degradation of β-catenin which, as a consequence, leads to cell cycle arrest (49) and CK2 is 
activated by Wnt/β-catenin signalling (50). We found lower B-TRCP and CK2 expression in 
fibroblast strains from old subjects, suggesting increased cell proliferation. Thus, although the 
Ingenuity analysis indicated reduced cellular proliferation in fibroblast strains from old 




GSEA pathway analysis resulted in gene sets such as spindle, spindle pole and microtubule 
organizing centre showing lower expression in fibroblast strains from old subjects, supporting 
the view that there was inhibition of the cell cycle in fibroblast strains from the old subjects. In 
addition, there was an increased activity of pathways linked to RNA processing in the young 
strains, consistent with the idea that with cellular aging (senescence) the expression of many 
genes required for the cell cycle decrease (51). Indeed, fewer senescent fibroblasts are 
observed in strains from young subjects (25). Combined with the Ingenuity analysis, these 
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results suggest a reduced cellular proliferation rate in fibroblast strains from old subjects, as 
we indeed showed recently (37). 
 
Mitochondrial function was also detected by the GSEA analysis. This was striking because 
rotenone binds to the electron transport chain in mitochondria, disrupting the production of 
ATP (52). Our previous results demonstrated that rotenone treatment exacerbated 
differences in the number of fibroblasts entering cellular senescence and apoptosis between 
strains from young and old subjects (25). Thus, as mitochondrial membrane potential is 
impaired in fibroblasts from old subjects (53), rotenone insult could lead to greater ROS 
production in the fibroblasts from the old subjects and consequently more cellular 
senescence. 
 
GSEA analysis also identified the Glutamate Signaling Pathway gene set as the most 
differentially upregulated pathway in the fibroblast strains from the old subjects. Although 
fibroblasts are known to utilize glutamate signaling (54), very little is known about the role 
glutamate signaling plays in fibroblast function. These results are the first to indicate that 
glutamate signaling is upregulated with age in skin fibroblasts and the consequences of these 
changes on fibroblast function now requires further examination. 
 
Boraldi et al. (55) also compared fibroblast strains from young and old subjects (ex vivo aging 
model) at early and late CPDs (in vitro aging model). While showing the majority of 
differences, like stress response, endoplasmic reticulum and cell membrane compartments 
and post-translational protein modifications, for in vitro aging, they did not observe many 
differences dependent on the age of subjects. It must be noted, though, that they used only 
three strains per age group. Although the effect was more pronounced in in vitro aging, they 
did find that deterioration of the redox balance depended on the subjects’ age, consistent with 
the difference in expression of genes involved in mitochondrial function that reported here. 
Furthermore, elastin and fibulin-5 expression, both important ECM components, were 
differently expressed in cultures between fibroblast strains from young and old donors, 
consistent with the different expression of genes involved in ECM remodeling, cell-cell 





The gene most differentially expressed between fibroblast strains from young and old 
subjects was p16 and this microarray finding was confirmed by qPCR. p16 is regarded as a 
robust marker for cellular aging and senescence (2;56) and increasing numbers of p16-
positive cells can indeed be found in mitotic aging of aging primates (57;58). We 
hypothesized that increased numbers of senescent cells (SA-β-gal activity) would be 
paralleled by p16 mRNA after rotenone-treatment. However, a decrease was observed in 
both the microarray experiment and the replication experiment. Furthermore, Western blot 
analyses could not show rotenone-induced differences in p16 protein levels whereas ICC did 
show rotenone-induced increased numbers of p16-positive fibroblasts. Thus, p16 mRNA 
levels were not reflected by p16 protein levels as measured by Western blot analysis and 
ICC.  
 
Regulation of p16 activity can occur at different levels: transcription, mRNA stability, 
translation and protein stability. p16 mRNA stability is controlled by genes regulating the 
degradation of p16 mRNA which are down-regulated in late passage fibroblasts (59;60). In 
addition, p16 protein levels can increase in the absence of changes to p16 mRNA levels via 
changes to p16 protein stability (61;62). Thus, in senescent cells p16 mRNA and protein 
levels are likely to be stable whereas p16 protein stabilization rather than increased p16 
mRNA levels could be responsible for non-senescent cells entering cell arrest. Another 
explanation could be that the microarray and qPCR probes both corresponded to the 3’ end 
of the gene which is common to at least two gene transcripts (p14 and p16) whereas the 
proteins transcribed from the locus are unique in sequence (63). Thus, differential regulation 
of the different transcripts between the two experiments might well dissociate any 
concordance that actually exists between p16 mRNA and protein levels. The discrepancies 
between ICC and Western blotting could be explained by the fact that the ICC method scores 
each fibroblast dichotomously, while Western blotting measures the average level of all 
fibroblasts, underestimating the p16 positivity of some fibroblasts and overestimating the 
negativity of other fibroblasts, resulting in no average change. 
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In the microarray experiments the fibroblast strains from the old subjects showed higher 
levels of p16 mRNA expression for all three conditions (non-stressed, 3 hours and 3 days 
rotenone) consistent with increasing numbers of p16-positive fibroblasts in aging primates 
(57;64). No differences in the rotenone-induced fold changes in p16 mRNA expression were 
detected. In contrast to the microarray experiments the replication experiments showed lower 
expression of p16 mRNA in strains from old subjects (non-stressed) and rotenone induced a 
smaller decrease in p16 mRNA expression in these strains. The consistency of the p16 
mRNA results across strains within each experiment, and the concordance of the ICC results 
across experiments indicated that the cause of this difference was technical in nature and 
specific to the mRNA. For example, a higher seeding density (to maximize mRNA yield) used 
for the microarray experiment compared with the replication experiments could have lead to 
differential regulation of p16 expression (65). Alternatively, changes to the expression of the 
housekeeping gene used in the qPCR experiments could have resulted in different qPCR 
results. Further detailed work investigating differences in p16 mRNA between fibroblast 
strains from young and old subjects, along with epistatic control of p16 mRNA levels is now 
required. However, as the most accurate reflection of p16 function, the ICC results reflected 
the gene array pathway analyses, the SA-β-gal activity and previous reported work (29) that 
cell cycle arrest is higher in fibroblasts strains from old subjects compared with young 
subjects. These results suggest that mRNA is not necessarily the best marker of p16 and ICC 
might be a better candidate. 
 
In conclusion, from the microarray analyses emerged pathways involved in carbohydrate 
metabolism, cell cycle, mitochondrial function, glutamate signaling and RNA processing. The 
cell cycle inhibitor p16, involved in senescence, was the most significantly differentially 
expressed mRNA between fibroblast strains from young and old subjects. The discrepancies 
between the microarray experiments and the replication experiments could be explained by 
non-representative strain selection and/or technical issues regarding seeding density. Future 
work with higher numbers of fibroblast strains will need to identify common pathways 
between the contrast in chronological age and biological age (e.g. familial longevity). These 
pathways might then be manipulated, resulting in biologically old cells becoming biologically 
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Supplemental Table 1.  List of 215 probes which were differentially expressed between 










































































34090 -0.38 -1.46 7.48 -13.71 1.44E-14 6.49E-10 22.33 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
1631 -0.21 -1.24 5.79 -11.82 6.64E-13 2.99E-08 18.93 NM_000132 F8 coagulation factor VIII, procoagulant component (hemophilia A) 
9872 -1.08 -2.94 7.21 -11.53 1.23E-12 5.52E-08 18.38 NM_000063 C2 complement component 2 
14382 0.20 1.22 5.84 11.39 1.67E-12 7.50E-08 18.10 NM_053042 KIAA1729 KIAA1729 protein 
27247 -0.38 -1.46 7.58 -11.09 3.24E-12 1.46E-07 17.50 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
16994 -0.30 -1.35 8.27 -10.87 5.29E-12 2.38E-07 17.05 NM_025163 PIGZ phosphatidylinositol glycan anchor biosynthesis, class Z 
44819 -0.36 -1.44 7.33 -10.71 7.49E-12 3.37E-07 16.73 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
16344 -0.37 -1.45 7.58 -10.62 9.23E-12 4.16E-07 16.54 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
13213 -0.38 -1.46 7.55 -10.56 1.05E-11 4.73E-07 16.42 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
23491 -0.61 -1.84 6.30 -10.18 2.57E-11 1.16E-06 15.60 NM_001034850 FLJ20152 hypothetical protein FLJ20152 
33922 -0.42 -1.52 5.95 -9.76 6.82E-11 3.07E-06 14.70 NM_000063 C2 complement component 2 
38638 -0.34 -1.40 8.59 -9.58 1.06E-10 4.77E-06 14.29 NM_001116 ADCY9 adenylate cyclase 9 
7444 0.21 1.23 8.03 9.31 2.04E-10 9.16E-06 13.68 NM_004704 RRP9 RRP9, small subunit (SSU) processome component, homolog (yeast) 
32445 -0.32 -1.38 7.61 -9.15 3.04E-10 1.37E-05 13.31 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
8451 0.41 1.50 5.90 9.10 3.46E-10 1.56E-05 13.18 NM_006546 IGF2BP1 insulin-like growth factor 2 mRNA binding protein 1 
20244 -0.41 -1.51 6.11 -9.05 3.88E-10 1.75E-05 13.08 NM_138554 TLR4 toll-like receptor 4 
41115 -0.21 -1.23 5.77 -8.99 4.51E-10 2.03E-05 12.94 NM_153487 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 
13770 0.36 1.43 5.56 8.76 7.94E-10 3.57E-05 12.41 NM_005503 APBA2 amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like) 
21416 0.48 1.62 5.81 8.61 1.18E-09 5.32E-05 12.03 NM_198159 MITF microphthalmia-associated transcription factor 
36293 -0.51 -1.66 8.85 -8.54 1.38E-09 6.22E-05 11.89 NM_032823 C9orf3 chromosome 9 open reading frame 3 
32467 -0.73 -2.07 6.33 -8.43 1.86E-09 8.38E-05 11.61 NM_053276 VIT vitrin 
36113 -0.74 -2.09 8.71 -8.42 1.91E-09 8.58E-05 11.58 AF010236 
  
23396 -0.33 -1.40 7.66 -8.41 1.93E-09 8.67E-05 11.57 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
11285 -0.25 -1.29 5.58 -8.39 2.06E-09 9.29E-05 11.51 NM_001034850 FLJ20152 hypothetical protein FLJ20152 
8703 0.14 1.15 6.31 8.33 2.42E-09 1.09E-04 11.36 NM_177559 CSNK2A1 casein kinase 2, alpha 1 polypeptide 
17352 -0.88 -2.41 5.83 -8.31 2.49E-09 1.12E-04 11.33 BC041856 LOC400879 hypothetical gene supported by AK096951 
8334 -0.34 -1.40 5.86 -8.29 2.62E-09 1.18E-04 11.28 NM_138554 TLR4 toll-like receptor 4 
42807 -0.24 -1.28 6.28 -8.24 3.02E-09 1.36E-04 11.15 NM_052937 PCMTD1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 
29312 -0.48 -1.62 7.14 -8.23 3.09E-09 1.39E-04 11.13 A_32_P225328   
29118 -0.32 -1.37 7.54 -8.23 3.09E-09 1.39E-04 11.13 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
2500 -0.30 -1.35 5.78 -8.22 3.16E-09 1.42E-04 11.11 NM_138554 TLR4 toll-like receptor 4 
12396 0.63 1.87 6.37 8.21 3.29E-09 1.48E-04 11.07 BC018626   
36691 -0.33 -1.39 5.78 -8.06 4.84E-09 2.18E-04 10.70 NM_138554 TLR4 toll-like receptor 4 
41441 -0.52 -1.68 6.04 -8.00 5.58E-09 2.51E-04 10.57 NM_017549 EPDR1 ependymin related protein 1 (zebrafish) 
31781 -0.34 -1.40 5.88 -7.97 6.16E-09 2.77E-04 10.48 NM_138554 TLR4 toll-like receptor 4 
22430 0.19 1.20 5.56 7.96 6.27E-09 2.82E-04 10.46 THC2657663   
41609 -0.31 -1.36 5.73 -7.95 6.36E-09 2.86E-04 10.45 NM_138554 TLR4 toll-like receptor 4 
12121 0.30 1.35 5.87 7.90 7.28E-09 3.27E-04 10.32 NM_022897 RANBP17 RAN binding protein 17 
38751 -0.17 -1.18 5.95 -7.76 1.05E-08 4.72E-04 9.97 NM_001099407 C20orf12 chromosome 20 open reading frame 12 
15998 -0.35 -1.41 7.49 -7.76 1.06E-08 4.76E-04 9.97 BC012888 NDST1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 
44393 -0.23 -1.26 10.21 -7.76 1.07E-08 4.81E-04 9.96 NM_017983 WIPI1 WD repeat domain, phosphoinositide interacting 1 
14866 -0.50 -1.66 7.35 -7.75 1.07E-08 4.83E-04 9.95 NM_000147 FUCA1 fucosidase, alpha-L- 1, tissue 
9503 -0.32 -1.37 5.84 -7.67 1.34E-08 6.03E-04 9.74 NM_138554 TLR4 toll-like receptor 4 
44741 -0.15 -1.16 6.55 -7.63 1.49E-08 6.70E-04 9.64 NM_198181 FLJ40113 golgi autoantigen, golgin subfamily a-like pseudogene 
39212 1.05 2.86 7.39 7.62 1.55E-08 6.97E-04 9.60 NM_006547 IGF2BP3 insulin-like growth factor 2 mRNA binding protein 3 
32971 0.84 2.31 6.65 7.57 1.76E-08 7.90E-04 9.48 NM_021076 NEFH neurofilament, heavy polypeptide 200kDa 
10808 0.15 1.16 9.91 7.54 1.89E-08 8.51E-04 9.41 NM_006559 KHDRBS1 KH domain containing, RNA binding, signal transduction associated 1 
31481 -0.29 -1.34 5.82 -7.54 1.92E-08 8.63E-04 9.40 NM_138554 TLR4 toll-like receptor 4 
21362 -0.62 -1.86 7.54 -7.52 1.98E-08 8.91E-04 9.37 NM_025225 PNPLA3 patatin-like phospholipase domain containing 3 
9389 1.43 4.19 8.44 7.52 2.01E-08 9.06E-04 9.35 XR_018843 LOC649233 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
38867 1.28 3.59 7.16 7.46 2.37E-08 1.06E-03 9.20 XR_019231 LOC442249 hypothetical LOC442249 
40424 0.57 1.77 5.95 7.44 2.47E-08 1.11E-03 9.16 NM_198159 MITF microphthalmia-associated transcription factor 
22402 -0.34 -1.41 5.91 -7.42 2.64E-08 1.19E-03 9.10 NM_138554 TLR4 toll-like receptor 4 
10241 0.22 1.24 11.21 7.39 2.84E-08 1.28E-03 9.03 NM_000610 CD44 CD44 molecule (Indian blood group) 
36253 0.18 1.20 7.84 7.38 2.90E-08 1.31E-03 9.01 NM_044472 CDC42 cell division cycle 42 (GTP binding protein, 25kDa) 
11681 0.14 1.15 6.33 7.36 3.06E-08 1.38E-03 8.96 NM_177559 CSNK2A1 casein kinase 2, alpha 1 polypeptide 
11737 -0.52 -1.69 6.93 -7.35 3.17E-08 1.42E-03 8.92 NM_002073 GNAZ guanine nucleotide binding protein (G protein), alpha z polypeptide 
1686 0.30 1.35 6.00 7.34 3.27E-08 1.47E-03 8.90 NM_182520 C22orf15 chromosome 22 open reading frame 15 
28832 -0.38 -1.46 6.19 -7.31 3.47E-08 1.56E-03 8.84 NM_020777 SORCS2 sortilin-related VPS10 domain containing receptor 2 
2909 -0.31 -1.36 5.59 -7.29 3.69E-08 1.66E-03 8.78 NM_000063 C2 complement component 2 
44689 1.20 3.32 6.96 7.27 3.94E-08 1.77E-03 8.72 A_24_P383660 LOC643471 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
42458 -0.40 -1.50 8.91 -7.26 3.99E-08 1.79E-03 8.71 NM_012156 EPB41L1 erythrocyte membrane protein band 4,1-like 1 
36702 -0.27 -1.31 7.95 -7.26 4.01E-08 1.80E-03 8.70 NM_001002009 NT5C3 5'-nucleotidase, cytosolic III 
34895 1.19 3.29 7.03 7.21 4.64E-08 2.09E-03 8.56 A_24_P418687 LOC731794 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
12527 1.43 4.17 8.55 7.20 4.69E-08 2.11E-03 8.55 NM_000224 KRT18 keratin 18 
33355 1.31 3.72 7.68 7.20 4.69E-08 2.11E-03 8.55 A_24_P161733 
  
6848 1.34 3.81 7.42 7.20 4.75E-08 2.13E-03 8.54 NM_000224 KRT18 keratin 18 
9893 0.26 1.29 10.20 7.20 4.77E-08 2.14E-03 8.54 NM_001152 SLC25A5 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 
10253 -0.76 -2.14 5.74 -7.19 4.87E-08 2.19E-03 8.52 BG118529 
  
16140 -0.17 -1.19 6.42 -7.18 4.96E-08 2.23E-03 8.50 NM_052937 PCMTD1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain 
containing 1 
38804 1.79 6.00 7.06 7.15 5.43E-08 2.44E-03 8.41 NM_018476 BEX1 brain expressed, X-linked 1 




6264 0.26 1.30 8.83 7.12 5.88E-08 2.64E-03 8.34 NM_198216 SNRPB small nuclear ribonucleoprotein polypeptides B and B1 
12633 -0.08 -1.08 5.41 -7.12 5.96E-08 2.68E-03 8.32 NM_000132 F8 coagulation factor VIII, procoagulant component (hemophilia A) 
23023 0.23 1.25 8.08 7.09 6.44E-08 2.89E-03 8.25 NM_178001 PPP2R4 protein phosphatase 2A, regulatory subunit B' (PR 53) 
19790 -0.39 -1.48 8.51 -7.08 6.59E-08 2.96E-03 8.23 NM_032823 C9orf3 chromosome 9 open reading frame 3 
1258 0.13 1.14 5.71 7.08 6.65E-08 2.99E-03 8.22 NM_014598 SOCS7 suppressor of cytokine signaling 7 
14815 -0.19 -1.21 10.06 -7.07 6.78E-08 3.05E-03 8.20 NM_198868 TBC1D9B TBC1 domain family, member 9B (with GRAM domain) 
14598 0.15 1.16 9.18 7.06 6.87E-08 3.09E-03 8.19 NM_012247 SEPHS1 selenophosphate synthetase 1 
25318 0.26 1.29 12.20 7.05 7.10E-08 3.19E-03 8.16 NM_001037808 EIF3S8 eukaryotic translation initiation factor 3, subunit 8, 110kDa 
37363 -0.32 -1.37 6.37 -7.04 7.24E-08 3.25E-03 8.14 NM_031289 GSG1 germ cell associated 1 
20510 0.48 1.62 8.14 7.04 7.29E-08 3.28E-03 8.13 NM_001970 EIF5A eukaryotic translation initiation factor 5A 
37652 -0.21 -1.23 11.25 -7.03 7.46E-08 3.35E-03 8.11 NM_152264 SLC39A13 solute carrier family 39 (zinc transporter), member 13 
44533 -0.14 -1.15 5.34 -7.03 7.58E-08 3.40E-03 8.10 AK056135   
21753 -0.27 -1.31 6.26 -7.02 7.82E-08 3.51E-03 8.07 ENST00000270457 ZNF160 zinc finger protein 160 
29622 -0.30 -1.35 6.29 -7.01 7.85E-08 3.53E-03 8.06 NM_000824 GLRB glycine receptor, beta 
4527 -0.32 -1.38 7.33 -6.96 9.01E-08 4.05E-03 7.93 NM_153208 IQCK IQ motif containing K 
7859 0.45 1.57 11.13 6.96 9.17E-08 4.12E-03 7.91 NM_199168 CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 
33380 -0.40 -1.49 8.41 -6.95 9.45E-08 4.25E-03 7.88 NM_000153 GALC galactosylceramidase 
38585 0.18 1.20 9.28 6.94 9.54E-08 4.29E-03 7.88 NM_016491 MRPL37 mitochondrial ribosomal protein L37 
20182 1.83 6.24 7.58 6.94 9.57E-08 4.30E-03 7.87 NM_032621 BEX2 brain expressed X-linked 2 
39594 -0.23 -1.26 9.69 -6.92 1.01E-07 4.55E-03 7.82 NM_016079 VPS24 vacuolar protein sorting 24 homolog (S, cerevisiae) 
2154 -0.23 -1.26 7.04 -6.91 1.04E-07 4.68E-03 7.79 NM_005036 PPARA peroxisome proliferator-activated receptor alpha 
2770 1.04 2.84 6.48 6.89 1.11E-07 5.01E-03 7.73 XR_016695 LOC345430 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
32638 -0.35 -1.42 9.39 -6.88 1.13E-07 5.09E-03 7.71 NM_006291 TNFAIP2 tumor necrosis factor, alpha-induced protein 2 
17317 -1.16 -3.19 8.59 -6.87 1.18E-07 5.28E-03 7.68 NM_017549 EPDR1 ependymin related protein 1 (zebrafish) 
304 -0.11 -1.12 5.62 -6.86 1.20E-07 5.37E-03 7.66 AK091348   
4565 0.20 1.22 8.25 6.82 1.33E-07 5.97E-03 7.56 NM_007002 ADRM1 adhesion regulating molecule 1 
7041 -0.15 -1.16 6.16 -6.82 1.33E-07 5.97E-03 7.56 NM_152331 ACOT4 acyl-CoA thioesterase 4 
31016 -0.31 -1.37 5.90 -6.81 1.36E-07 6.10E-03 7.54 NM_138554 TLR4 toll-like receptor 4 
6486 0.17 1.18 10.75 6.80 1.43E-07 6.43E-03 7.49 NM_001011724 RP11-78J21,1 heterogeneous nuclear ribonucleoprotein A1-like 
19297 -0.35 -1.42 9.20 -6.78 1.47E-07 6.62E-03 7.46 NM_030786 SYNC1 syncoilin, intermediate filament 1 
14513 0.15 1.16 9.61 6.78 1.49E-07 6.69E-03 7.45 NM_021243 C6orf115 chromosome 6 open reading frame 115 
42541 -0.13 -1.14 6.32 -6.77 1.55E-07 6.94E-03 7.42 NM_002869 RAB6A RAB6A, member RAS oncogene family 
12338 1.23 3.42 7.21 6.76 1.58E-07 7.08E-03 7.40 XR_019330 LOC647162 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
27679 1.14 3.13 6.93 6.76 1.59E-07 7.14E-03 7.39 XR_019568 LOC343326 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
5415 0.15 1.16 6.22 6.75 1.64E-07 7.37E-03 7.36 NM_033637 BTRC beta-transducin repeat containing 
26043 -0.30 -1.35 6.06 -6.74 1.68E-07 7.57E-03 7.33 AA428090   
18066 -0.37 -1.44 8.09 -6.73 1.73E-07 7.75E-03 7.31 AK057167 
  
14884 1.16 3.18 6.81 6.72 1.75E-07 7.84E-03 7.30 XR_016590 LOC647913 similar to keratin complex 1, acidic, gene 18 
22348 1.28 3.58 7.69 6.72 1.77E-07 7.97E-03 7.28 XR_018193 LOC391819 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
41523 -0.24 -1.27 7.30 -6.71 1.79E-07 8.05E-03 7.28 NM_003144 SSR1 signal sequence receptor, alpha (translocon-associated protein alpha) 
3098 0.25 1.28 6.94 6.71 1.79E-07 8.06E-03 7.27 XM_001718519   
6769 0.25 1.28 9.03 6.71 1.84E-07 8.25E-03 7.25 NM_012322 LSM5 LSM5 homolog, U6 small nuclear RNA associated (S, cerevisiae) 
13046 -0.24 -1.28 7.67 -6.70 1.89E-07 8.48E-03 7.23 AK095603 KIAA1822 KIAA1822 
5070 0.23 1.26 10.54 6.69 1.91E-07 8.58E-03 7.21 NM_003146 SSRP1 structure specific recognition protein 1 
19228 -0.44 -1.55 6.86 -6.68 1.95E-07 8.76E-03 7.19 AF131762   
29456 -0.28 -1.33 7.38 -6.68 1.96E-07 8.81E-03 7.19 AV721971 
  
18366 -0.07 -1.08 5.38 -6.67 2.01E-07 9.02E-03 7.17 NM_018902 PCDHA11 protocadherin alpha 11 
2943 0.16 1.18 6.25 6.67 2.04E-07 9.17E-03 7.15 NM_177559 CSNK2A1 casein kinase 2, alpha 1 polypeptide 
6232 0.15 1.16 8.03 6.67 2.05E-07 9.19E-03 7.15 NM_003863 DPM2 dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit 
20957 0.35 1.42 8.90 6.66 2.09E-07 9.36E-03 7.13 NM_033274 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 
12807 1.24 3.44 7.41 6.65 2.13E-07 9.57E-03 7.11 XR_018311 LOC139060 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
38821 -0.33 -1.39 9.04 -6.65 2.14E-07 9.59E-03 7.11 NM_024692 RSNL2 restin-like 2 
21311 0.42 1.52 8.67 6.65 2.14E-07 9.62E-03 7.11 NM_001970 EIF5A eukaryotic translation initiation factor 5A 
649 1.08 2.94 6.61 6.65 2.15E-07 9.64E-03 7.10 XR_018938 LOC132391 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
34773 -0.31 -1.37 6.35 -6.63 2.25E-07 1.01E-02 7.06 NM_078487 CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 
19295 0.47 1.60 5.92 6.61 2.37E-07 1.06E-02 7.01 THC2535223   
35951 -0.93 -2.55 8.21 -6.61 2.39E-07 1.07E-02 7.00 NM_005532 IFI27 interferon, alpha-inducible protein 27 
10887 1.19 3.27 6.95 6.61 2.42E-07 1.08E-02 6.99 XR_017211 LOC651696 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
33899 -0.30 -1.34 7.12 -6.60 2.45E-07 1.10E-02 6.98 NM_002971 SATB1 special AT-rich sequence binding protein 1 (binds to nuclear matrix/scaffold-associating DNA's) 
4209 0.14 1.15 5.52 6.59 2.51E-07 1.13E-02 6.95 XR_018641 LOC649545 similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keraton-8) (K8) 
38629 1.06 2.88 6.62 6.59 2.52E-07 1.13E-02 6.95 XR_019037 LOC391271 hypothetical LOC391271 
40982 0.89 2.43 6.21 6.58 2.61E-07 1.17E-02 6.92 A_24_P6850 
  
36957 -0.19 -1.21 8.06 -6.58 2.61E-07 1.17E-02 6.92 NM_014781 RB1CC1 RB1-inducible coiled-coil 1 
14987 -0.20 -1.23 8.01 -6.57 2.66E-07 1.20E-02 6.90 NM_012319 SLC39A6 solute carrier family 39 (zinc transporter), member 6 
40074 -0.15 -1.16 7.16 -6.56 2.71E-07 1.22E-02 6.88 NM_016302 CRBN cereblon 
30487 1.06 2.88 6.70 6.56 2.71E-07 1.22E-02 6.88 XR_018749 LOC442405 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
40222 0.31 1.36 6.92 6.56 2.73E-07 1.22E-02 6.88 NM_021214 LOC58489 hypothetical protein from EUROIMAGE 588495 
18800 -0.24 -1.28 8.44 -6.56 2.74E-07 1.23E-02 6.87 NM_021626 SCPEP1 serine carboxypeptidase 1 
34991 -0.73 -2.08 6.89 -6.55 2.84E-07 1.27E-02 6.84 NM_014737 RASSF2 Ras association (RalGDS/AF-6) domain family 2 
31712 -0.12 -1.12 5.49 -6.54 2.90E-07 1.30E-02 6.82 NM_080676 C20orf133 chromosome 20 open reading frame 133 
41927 -0.38 -1.46 11.98 -6.52 3.07E-07 1.38E-02 6.76 NM_212482 FN1 fibronectin 1 
39571 -0.22 -1.25 5.96 -6.51 3.11E-07 1.40E-02 6.75 ENST00000328711  
10395 0.41 1.50 11.20 6.51 3.19E-07 1.43E-02 6.73 NM_199168 CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 
34939 -0.13 -1.13 6.57 -6.49 3.35E-07 1.50E-02 6.68 THC2505349 
  
3557 -0.32 -1.37 7.03 -6.48 3.42E-07 1.53E-02 6.66 NM_032549 IMMP2L IMP2 inner mitochondrial membrane peptidase-like (S, cerevisiae) 
16302 -0.16 -1.17 7.04 -6.48 3.44E-07 1.54E-02 6.65 XR_019214 LOC649551 similar to nuclear receptor binding factor 2 
4882 0.23 1.26 10.04 6.48 3.45E-07 1.55E-02 6.65 THC2509446 
  
11654 0.17 1.18 11.39 6.46 3.61E-07 1.62E-02 6.61 NM_000610 CD44 CD44 molecule (Indian blood group) 
9170 -0.89 -2.45 8.34 -6.46 3.66E-07 1.64E-02 6.60 NM_005532 IFI27 interferon, alpha-inducible protein 27 
37711 -0.26 -1.30 7.24 -6.44 3.88E-07 1.74E-02 6.54 NM_001038628 B3GALNT1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) 
32308 1.25 3.47 7.36 6.43 3.89E-07 1.74E-02 6.54 NM_173624 FLJ40504 hypothetical protein FLJ40504 
Age-dependent differences in gene expression of human dermal fibroblasts 
133 
 
4695 -0.35 -1.42 12.09 -6.41 4.22E-07 1.89E-02 6.46 NM_212482 FN1 fibronectin 1 
12773 0.09 1.09 9.82 6.39 4.36E-07 1.95E-02 6.43 NM_013235 RNASEN ribonuclease III, nuclear 
1999 1.15 3.15 6.80 6.39 4.38E-07 1.96E-02 6.42 XR_019198 LOC391589 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
3756 -0.93 -2.53 8.18 -6.38 4.51E-07 2.02E-02 6.39 NM_005532 IFI27 interferon, alpha-inducible protein 27 
23972 -0.34 -1.41 11.58 -6.38 4.57E-07 2.05E-02 6.38 NM_015170 SULF1 sulfatase 1 
40185 -0.19 -1.21 10.94 -6.37 4.70E-07 2.11E-02 6.35 NM_001018108 SERF2 small EDRK-rich factor 2 
39793 0.16 1.18 8.03 6.36 4.73E-07 2.12E-02 6.35 NM_012267 HSPBP1 hsp70-interacting protein 
11020 1.23 3.42 7.43 6.36 4.79E-07 2.15E-02 6.34 THC2524582 
  
24675 -0.29 -1.34 12.21 -6.36 4.79E-07 2.15E-02 6.34 NM_212482 FN1 fibronectin 1 
13271 -0.12 -1.13 10.59 -6.35 4.97E-07 2.23E-02 6.30 NM_004872 TMEM59 transmembrane protein 59 
9064 -0.24 -1.28 7.10 -6.34 5.02E-07 2.25E-02 6.29 NM_014039 C11orf54 chromosome 11 open reading frame 54 
35349 -0.12 -1.13 5.85 -6.34 5.03E-07 2.26E-02 6.29 AK024516   
11062 0.20 1.23 8.46 6.33 5.23E-07 2.34E-02 6.25 NM_006555 YKT6 YKT6 v-SNARE homolog (S, cerevisiae) 
44582 -0.18 -1.19 8.03 -6.33 5.24E-07 2.35E-02 6.25 NM_033407 DOCK7 dedicator of cytokinesis 7 
28684 -0.15 -1.16 8.01 -6.32 5.31E-07 2.38E-02 6.24 NM_016446 C9orf127 chromosome 9 open reading frame 127 
41988 0.16 1.18 7.73 6.30 5.73E-07 2.57E-02 6.17 NM_044472 CDC42 cell division cycle 42 (GTP binding protein, 25kDa) 
14270 -0.33 -1.39 10.75 -6.28 6.00E-07 2.69E-02 6.12 NM_000366 TPM1 tropomyosin 1 (alpha) 
8943 -0.26 -1.30 7.56 -6.28 6.03E-07 2.70E-02 6.12 NM_058197 CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) 
13215 1.03 2.80 6.49 6.28 6.06E-07 2.72E-02 6.11 XR_018953 LOC391179 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
27651 0.38 1.47 6.96 6.27 6.15E-07 2.76E-02 6.10 NM_002655 PLAG1 pleiomorphic adenoma gene 1 
5168 -0.19 -1.21 8.13 -6.27 6.15E-07 2.76E-02 6.10 NM_178564 NRBP2 nuclear receptor binding protein 2 
27609 0.11 1.12 6.38 6.27 6.23E-07 2.79E-02 6.09 NM_177559 CSNK2A1 casein kinase 2, alpha 1 polypeptide 
43036 1.04 2.82 6.73 6.25 6.55E-07 2.94E-02 6.04 XR_018420 LOC391827 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
40951 0.24 1.27 6.77 6.24 6.63E-07 2.97E-02 6.03 NM_007212 RNF2 ring finger protein 2 
959 1.13 3.09 6.90 6.24 6.65E-07 2.98E-02 6.02 A_24_P281443 LOC649375 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
1296 1.31 3.72 7.65 6.24 6.71E-07 3.01E-02 6.02 XR_019191 LOC121054 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-
18) (K18) 
9569 0.98 2.67 6.41 6.24 6.76E-07 3.03E-02 6.01 XR_019060 LOC644030 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
6183 -0.34 -1.40 12.08 -6.23 6.87E-07 3.08E-02 5.99 NM_212482 FN1 fibronectin 1 
7752 -0.54 -1.72 9.02 -6.23 6.87E-07 3.08E-02 5.99 NM_003392 WNT5A wingless-type MMTV integration site family, member 5A 
16674 -0.32 -1.37 12.16 -6.22 7.02E-07 3.15E-02 5.97 NM_212482 FN1 fibronectin 1 
752 0.18 1.20 8.48 6.22 7.16E-07 3.21E-02 5.95 NM_017722 TRMT1 TRM1 tRNA methyltransferase 1 homolog (S, cerevisiae) 
36709 -0.34 -1.41 8.55 -6.22 7.17E-07 3.21E-02 5.95 NM_183233 SLC22A18 solute carrier family 22 (organic cation transporter), member 18 
25357 -1.18 -3.27 7.94 -6.22 7.17E-07 3.21E-02 5.95 NM_000954 PTGDS prostaglandin D2 synthase 21kDa (brain) 
15294 -0.24 -1.27 9.98 -6.20 7.52E-07 3.37E-02 5.91 NM_017823 DUSP23 dual specificity phosphatase 23 
34641 0.16 1.17 7.90 6.19 7.66E-07 3.43E-02 5.89 NM_044472 CDC42 cell division cycle 42 (GTP binding protein, 25kDa) 
19368 0.12 1.13 6.94 6.18 7.87E-07 3.53E-02 5.86 NM_005702 ERAL1 Era G-protein-like 1 (E, coli) 
2342 -0.13 -1.14 5.43 -6.18 7.96E-07 3.57E-02 5.85 NM_002302 LECT2 leukocyte cell-derived chemotaxin 2 
27606 0.14 1.15 9.48 6.17 8.07E-07 3.62E-02 5.84 NM_006392 NOL5A nucleolar protein 5A (56kDa with KKE/D repeat) 
3553 0.22 1.24 8.66 6.17 8.14E-07 3.65E-02 5.83 NM_018188 ATAD3A ATPase family, AAA domain containing 3A 
2158 0.05 1.05 5.32 6.16 8.44E-07 3.78E-02 5.80 XR_018787 LOC339396 similar to neurofilament, heavy polypeptide 
7946 0.18 1.19 8.61 6.16 8.46E-07 3.79E-02 5.79 NM_007002 ADRM1 adhesion regulating molecule 1 
2841 0.16 1.17 10.61 6.16 8.50E-07 3.81E-02 5.79 A_32_P179205 LOC402562 
similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing 
protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) 
(Topoisomerase-inhibitor suppressed) 
41866 -0.15 -1.17 6.46 -6.15 8.60E-07 3.85E-02 5.78 NM_007202 AKAP10 A kinase (PRKA) anchor protein 10 
30168 0.08 1.09 5.36 6.15 8.71E-07 3.91E-02 5.77 AK056119   
6538 -0.26 -1.30 9.98 -6.14 8.89E-07 3.99E-02 5.75 NM_001343 DAB2 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) 
41042 0.21 1.24 10.01 6.13 9.02E-07 4.04E-02 5.73 NM_004515 ILF2 interleukin enhancer binding factor 2, 45kDa 
7984 0.36 1.43 9.18 6.12 9.30E-07 4.17E-02 5.70 NM_021214 LOC58489 hypothetical protein from EUROIMAGE 588495 
44649 0.99 2.68 6.56 6.12 9.32E-07 4.18E-02 5.70 XR_018462 LOC391803 similar to Keratin, type I cytoskeletal 18 (Cytokeratin-18) (CK-18) (Keratin-18) (K18) 
13274 -0.32 -1.37 6.72 -6.12 9.40E-07 4.21E-02 5.69 ENST00000393500  
31708 0.20 1.22 6.56 6.12 9.51E-07 4.26E-02 5.68 NM_024821 CCDC134 coiled-coil domain containing 134 
33989 -0.18 -1.20 6.92 -6.11 9.68E-07 4.34E-02 5.67 NM_004348 RUNX2 runt-related transcription factor 2 
33242 -0.19 -1.21 6.88 -6.10 9.84E-07 4.41E-02 5.65 NM_001122838 NAPE-PLD N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D 
5588 0.22 1.25 9.37 6.10 9.93E-07 4.45E-02 5.64 NM_000190 HMBS hydroxymethylbilane synthase 
38712 -0.24 -1.27 9.88 -6.09 1.01E-06 4.52E-02 5.63 NM_005780 LHFP lipoma HMGIC fusion partner 
11818 -0.27 -1.31 5.45 -6.09 1.03E-06 4.60E-02 5.61 NM_016953 PDE11A phosphodiesterase 11A 
25250 -0.84 -2.33 8.25 -6.08 1.04E-06 4.64E-02 5.60 NM_005532 IFI27 interferon, alpha-inducible protein 27 
39603 -0.24 -1.27 6.09 -6.08 1.05E-06 4.72E-02 5.59 NM_001033045 GPR155 G protein-coupled receptor 155 
39313 -0.16 -1.18 5.46 -6.08 1.06E-06 4.73E-02 5.58 NM_181643 C1orf88 chromosome 1 open reading frame 88 
7675 0.17 1.19 5.67 6.07 1.07E-06 4.79E-02 5.57 NM_000679 ADRA1B adrenergic, alpha-1B-, receptor 
41277 -0.20 -1.22 7.08 -6.07 1.08E-06 4.86E-02 5.56 NM_015061 JMJD2C jumonji domain containing 2C 
36866 -0.27 -1.32 8.69 -6.06 1.10E-06 4.91E-02 5.55 NM_152558 IQCE IQ motif containing E 







Supplemental table 2.    ROS levels, Senescence Associated-β-gal activity and p16 
expression measured at the mRNA level in non-stressed and rotenone stressed human 









Micro-array experiments n=6 n=6  
SA-β-gal (MdFI)    
Non-stressed 2078 (357) 2634 (360) 0.045 
Rotenone-induced increase +11433 (463) 2395 (472) 0.056 
p16 (fold change)    
array 1 1.46 <0.0001 
qPCR Non-stressed 1 1.43 (0.08) 0.005 
qPCR Rotenone, 3h 1 1.37 (0.14) 0.060 
qPCR Rotenone, 3d 1 1.42 (0.11) 0.031 
    
Replication experiments n=10 n=10  
SA-β-gal (MdFI)    
Non-stressed 3146 (368) 22740 (363) 0.23 
Rotenone-induced increase +1132 (260) +1638 (255) 0.052 
p16 (fold change)    
qPCR Non-stressed, 3d  1 0.74 (0.05) <0.001 
qPCR Rotenone, 3d  1 0.99 (0.07) 0.52 
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Supplemental Figure 1.  Variation in expression between strains from different subjects 
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The offspring of nonagenarian siblings suffer less from age related conditions and have a 
lower risk of mortality compared with their partners. Fibroblast strains derived from such 
offspring in middle age show different in vitro responses to stress, more stress-induced 
apoptosis and less senescence when compared with strains of their partners. Aiming to find 
differences in cellular metabolism in vitro between these fibroblast strains, cell culture 
supernatants collected at 24-hours and five days were analyzed using 1H nuclear magnetic 
resonance (NMR)-based metabolic footprinting. Between 24-hours and five days of 
incubation, supernatants of all fibroblast strains showed decreased levels of glucose, 
pyruvate, alanine-glutamine (ala-gln), valine, leucine, isoleucine, serine and lysine and 
increased levels of glutamine, alanine, lactate and pyroglutamic acid. Strains from offspring 
and their partners were compared using a partial least squares-discriminant analysis (PLS-
DA) model based on the data of the five-day time point. The ala-gln and glucose 
consumption was higher for fibroblast strains derived from offspring when compared with 
strains of their partners. Also, production of glutamine, alanine, lactate and pyroglutamic acid 
was found to be higher for fibroblast strains derived from offspring. In conclusion, differences 
in NMR-based metabolic profiles of human cells in vitro reflect the propensity for human 










Life expectancy has dramatically increased in Western society, but there is much inter-
individual variation in life expectancy (1). Healthy longevity has been shown to be a 
combination of genetic, environmental and chance factors. To study the phenotype and 
genetic component of healthy aging we designed the Leiden Longevity Study (LLS), in which 
families with exceptional longevity were recruited (2). Nonagenarian siblings and their 
offspring showed a lower risk of mortality than controls from their birth cohort. As compared 
with their partners, this offspring show a lower prevalence of myocardial infarction, 
hypertension and diabetes mellitus (3) and features such as preservation of insulin sensitivity 
with age and a beneficial glucose handling (4;5) and lipid metabolism (6). The contrast 
between offspring of nonagenarian siblings that express the propensity for longevity and their 
partners was also found to be reflected by cellular characteristics in vitro. In dermal fibroblast 
strains from offspring, oxidative stress induced less reactive oxygen species (ROS), less 
senescence, more apoptosis and slower growth speed when compared with strains from the 
partners of the offspring (7;8). Furthermore, cytotoxic T cell responses were more 
pronounced in offspring (9). 
 
In accordance with other features of healthy metabolism we found that offspring had a lower 
thyroidal sensitivity to thyrotropin, affecting levels of the thyroid hormone, which is primarily 
responsible for regulation of protein, fat and carbohydrate metabolism (10). For model 
organisms it has been shown that caloric restriction extends life span, which has been 
suggested to be caused by a shift from carbohydrate to fatty acid metabolism. This is thought 
to result in decreased cellular damage, since fatty acid metabolism preferentially uses 
mitochondrial complex II, which is known to produce less damaging ROS than the other 
mitochondrial complexes I, III, IV and V (11).  However, for humans not much is known about 
the relation between cellular metabolism and longevity.  
 
We have already reported that skin fibroblast strains derived from offspring of nonagenarian 
siblings show a cellular phenotype in vitro that differs from their partners (7;8). We now 




vitro. To measure metabolic changes, we chose to measure the metabolites in the cell 
culture supernatants of the strains. Measurement of intracellular metabolites requires rapid 
quenching of metabolism and a time-consuming and often inadequate extraction and 
separation procedure (12). 1H-NMR-based metabolic footprinting (13) of cell culture 
supernatants requires minimal sample preparation, thus introducing fewer artefacts (14). This 
methodology will therefore also allow better correlation with in vivo techniques. Here we 
describe the results of 1H-NMR-based metabolic footprinting (13) of cell culture supernatants 
of human fibroblast strains in vitro from offspring and their partners.  
 
 
Material and methods 
 
Study design 
The LLS was set up to investigate the contribution of genetic factors to healthy longevity by 
establishing a cohort enriched for familial longevity (2). From July 2002 to May 2006, 421 
families were recruited consisting of 944 long-lived Caucasian siblings together with their 
1671 of their offspring and 744 of the partners thereof. There were no selection criteria on 
health or demographic characteristics. Compared with their partners, the offspring were 
shown to have a 30% lower mortality rate and a lower prevalence of cardio-metabolic 
diseases (2;3). During the period November 2006 and May 2008, a biobank was established 
from fibroblasts cultivated from skin biopsies from 150 offspring-partner couples. Because it 
was expected that the difference in biological age between the offspring and partner groups 
would be relatively small, a relatively large sample size of 68 fibroblast strains from 34 
couples was randomly chosen. In accordance with the Declaration of Helsinki we obtained 
informed consent from all participants prior to their entering the study. Good clinical practice 
guidelines were maintained. The study protocol was approved by the ethical committee of the 
Leiden University Medical Center before the start of the study. 
 




Four-mm skin biopsies were taken from the sun unexposed medial side of the upper arm. 
Fibroblasts were grown in D-MEM:F-12 (1:1) medium supplemented with 10% fetal calf 
serum (FCS, Bodinco, Alkmaar, the Netherlands, batch no. 162229), 1 mM MEM sodium 
pyruvate, 10 mM HEPES, 2 mM glutamax I, and antibiotics (100 Units/mL penicillin, 100 
µg/mL streptomycin, and 0.25–2.5 µg/mL amphotericin B), all obtained from Gibco, Breda, 
the Netherlands. This medium will be referred to as standard medium. Fibroblasts were 
incubated at 37oC with 5% CO2 and 100% humidity. All cultures that are used in the present 
study were grown under predefined, highly standardized conditions and frozen at low 
passage as published earlier (7;15) Trypsin (Sigma, St Louis, MO, USA) was used to split 
fibroblasts using a 1:4 ratio each time they reached 80-100% confluence. 
 
Experimental set-up 
Experiments were set up in batches of maximally 10 fibroblast strains, which were thawed 
from frozen stocks on day zero. On day one, the medium was changed and on day four 
fibroblasts were passaged 1:4 and passaged further in equal numbers on days six and eight 
to have similar confluences for experiments. On day 11, 9x104 fibroblasts were seeded in 25 
cm2 tissue culture flasks for experiments and after overnight incubation with standard 
medium, fibroblasts were washed with serum-free medium and 3 ml serum-free medium per 
flask was added. Cell culture supernatants were collected at 24 hours and five days and 
stored at -70oC. Cell-free/serum-free medium incubated at 37oC with 5% CO2 and 100% 
humidity for 24 hours and five days was used as control medium. 
 
Plating efficiency 
Plating efficiency could confound concentrations of metabolites in the cell culture 
supernatants. To test if plating efficiency between strains from offspring and partners was 
different, fibroblasts strains were also seeded in 96-well plates and fixed after four hours. 
Fibroblasts were washed with water and stained with 0.6 mg/ml Coomassie in 1:6 
methanol/water overnight, washed again with water and air dried. Plates were then scanned 
with a high resolution Agfa XY-15 flatbed scanner (Agfa Gevaert, Mortsel, Belgium) and cells 




ImageJ 1.37v. No differences in plating efficiency were found (75±4% [mean±SD] and 
76±4% for strains from offspring and partners, respectively, p=0.79). 
 
NMR methodology 
Preparation of cell culture supernatants for 1H-NMR Spectroscopy  
After thawing, cell culture supernatants were centrifuged with 3000g for 10 min at 4ºC for the 
removal of any cellular components. 540 µL supernatant was mixed with 60 µL of 1.5 M 
phosphate buffer (pH 7.4) in D2O containing 4.0 mM sodium 3-trimethylsilyl-
tetradeuteriopropionate (TSP) and 2.0 mM NaN3 (16). All reagents were purchased from 
Sigma-Aldrich, St Louis, MO, USA. The resulting samples were then centrifuged with 3000g 
for 10 min at 4ºC prior to manual transfer into 5 mm SampleJet sample tubes in 96 tube 
racks. Tubes were closed with polyoxymethylene (POM) balls and tube racks were placed on 
the sample changer where they were kept at 6ºC while queued for data acquisition. 
 
NMR Data Acquisition and Processing  
1H-NMR data was obtained using a Bruker 600 MHz AVANCE II spectrometer equipped with 
a 5 mm TCI cryo probe and a z-gradient system; a Bruker SampleJet sample changer 
system was used for sample transfer. One-dimensional (1D) 1H-NMR spectra were recorded 
at 300 K using the first increment of a NOESY pulse sequence (17) with presaturation (γB1 = 
50 Hz) during a relaxation delay of 4 sec and a mixing time of 10 msec for efficient water 
suppression (18). Duration of 90 degree pulses were automatically calibrated for each 
individual sample using a homonuclear-gated nutation experiment (19) on the locked and 
shimmed samples after automatic tuning and matching of the probe head. 64 scans of 
65,536 points covering 12,335 Hz were recorded and zero filled to 65,536 complex points 
prior to Fourier transformation, an exponential window function was applied with a line-
broadening factor of 1.0 Hz. The spectra were manually phase and baseline corrected and 
automatically referenced to the internal standard (TSP = 0.0 ppm). Phase offset artefacts of 
the residual water resonance were manually corrected using a polynomial of degree 5 least 
square fit filtering of the free induction decay (FID) (20).  
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Multivariate Data Analysis of NMR Spectroscopic Data  
A bucket table with a bucket size of 0.04 ppm was generated for the regions 10.0–5.1 and 
4.5–0.2 ppm, respectively, using AMIX version 3.5 (Bruker Biospin, Germany). Buckets were 
normalized to a total area of 1.0 and metadata was included after import of the data into MS 
Excel (version 2003; Microsoft). For multivariate statistical analysis SIMCA-P+ (version 12.0, 
Umetrics, Sweden) software package was used. Since high abundant metabolites are 
generally the major source of the overall variability within the data, NMR variables were 
Pareto scaled and centred prior to PCA and PLS-DA analysis in order to emphasize 
variability of minor components. Variables were centred but not scaled for PLS-DA analysis 
after OSC filtering since the filtering step does remove variability not related to the classes 
investigated and hence already accentuate relevant minor components. Likewise, data for 
outlier detection was not scaled since outliers were defined as data with “abnormal” variability 
of specific variables on an absolute scale. For initial analysis and outlier detection PCA was 
performed using eight components. Outliers were identified based on scores (Hotelling’s T2 
range) and distance of the observation in the training set to the X model plane values, as well 
as visual inspection of the individual NMR spectra during data processing. Spectra of 
insufficient quality due to poor water suppression or bad automated shim performance (broad 
lines) were excluded from the analysis. For OSC-filtering and PLS-DA analysis samples were 
categorized based on offspring/partner and time point, respectively. PLS-DA models were 
validated by random permutation of the response variable and comparison of the goodness 
of fit (R2Y and Q2Y) of 200 such models with the original model in a validation plot. R2Y and 
Q2Y of the original PLS models as well as intersects of the R2Y and Q2Y regression lines of 
the validation plots with the vertical axis were calculated as quality parameters. Relative 
changes in metabolites were identified based on coefficient plots and variable importance in 
the projection (VIP). The cutoff for changes to be considered significant was based on VIP 
and the confidence interval derived from jack knifing of the corresponding coefficients. Mean 
spectra were calculated from the original NMR data for individual classes of the obtained 
models in order to assist annotation of loadings and coefficient plots and to determine 
relative differences in metabolite concentrations between the classes and to determine 







Table 1 shows the characteristics of the randomly selected subset of subjects from whom 
fibroblast strains were tested. Partners and offspring were of similar age, height and weight. 
 
Initial PCA model and metabolic footprinting of fib roblast strains dependent on 
incubation period  
Principal component analysis (PCA) was applied to detect biochemical outliers and to identify 
variability within the data that correlates with offspring/partner status, time point and gender 
classification. After removal of spectroscopic outliers (Supplemental table 1), a PCA model  
 
 
Table 1.  Clinical characteristics of offspring and partners from the Leiden Longevity Study, 






Demographic data   
Female 19 15 
Age, years (mean±SD) 61.7 (6.7) 60.5 (7.5) 
Anthropometric data   
Height, cm (mean±SD) 170 (8) 174 (9) 
Weight, kg (mean±SD) 74 (13) 79 (14) 
Current smoking – no./total known 3/27 8/29 
Diseases   
Myocardial infarction – no./total known 0/33 0/33 
Stroke – no./total known 1/33 0/33 
Hypertension – no./total known 5/33 7/33 
Diabetes mellitus – no./total known 1/32 2/32 
Malignancies – no./total known 0/31 1/31 
Chronic obstructive pulmonary disease –  
no./total known 
1/32 1/33 
Rheumatoid arthritis – no./total known 0/33 0/33 
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based on data from 134 of 144 samples (34 offspring strains, 34 partner strains, four cell-free 
controls, all taken at 24 hours and five days), was built using eight components with an 
explained variability of 97.9% and a predicted variation of 94.0%. Already in the scores plot 
of the first two principal components (PCs) two dominating clusters correlating with the 
incubation time of 24 hours and five days, respectively, can be identified as shown in  
Figure 1. A strong time-dependent discrimination was already found in the first components 
of the PCA model since depletion of the medium components and accumulation of waste 
products over time are expected as main source of variability due to cellular metabolism. 
Furthermore, cell-free/serum-free medium (from here on referred to as control medium) did 
not change over time and the corresponding data for these control samples were found in the 
scores plot as separate sub-cluster at one side of the 24-hour cluster. Hence, a time 
trajectory emerged as indicated in Figure 1, starting from the control medium on the left and 
progressing to the right within the scores plot showing the cell culture supernatants incubated 
for 24 hours and five days.  
 
Figure 1.  Scores plot of first two principal 
components from PCA model built from 
complete data set. Data points are labeled 
according to fibroblast culture incubation 
duration of 24 hours () and five days () 
as well as cell-free medium incubated for 
24 hours () and five days (▼). Arrows 
indicate culture samples with accelerated 




For detection of biological outliers, a separate PCA model based on centred but not scaled 
data was built using eight components. The scores (Hotellings T2 range) and distance of the 
observation in the training set to the X model plane values identified one outlier for the 24 
hour incubation time point and three outliers for the five-day incubation time point 
(Supplemental figure 1). The three samples from the five-day time point, namely one male 
offspring, one female offspring and one female partner, respectively, already deviated from 
the other samples in the scores plot in Figure 1. The scores plot in Supplemental Figure 2 
and closer investigation of the medium profiles for these three subjects showed deviations 
already for the 24h time point samples. The observed differences indicate accelerated 
metabolism for the fibroblasts of these three strains accompanied by increased lactate 
production. All identified biological outliers were excluded from further analysis.  
The main metabolites responsible for the observed clustering in the initial PCA are shown in 
the loadings plot in Figure 2. In order to investigate the time dependent changes further, a 
separate PLS-DA two-class model was built with the time point as response variable. The 
scores plot of the first two components showed a clear discrimination between the two time 
points (Supplemental figure 3).  
 
Figure  2. Loadings plot of first two principal 
components from PCA model built from 
complete data set. Main metabolites 
responsible for variability are annotated. 
Metabolites with negative p[1] loadings (left) 
are decreased in the five-day samples 
compared with the 24-hour samples, 
whereas metabolites with positive p[1] 
loadings (right) are increased in the cell 
culture supernatants of five days compared 
with those of 24 hours.   
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A cumulative R2Y of 0.96 and Q2Y of 0.94 were calculated for the model and the model 
validation plot showed intercepts of the R2Y and Q2Y regression lines with the vertical axis at 
0.142 and -0.396, respectively, indicating a valid model. Based on coefficients (Supplemental 
figure 4) and loadings from this model the responsible metabolites for the discrimination of 
the two groups were identified. Decreased components in the five-day medium in comparison 
to 24-hour medium were grouped into energy metabolism compounds like glucose, pyruvate 
and the dipeptide ala-gln and amino acid building blocks like valine, leucine, isoleucine, 
serine and lysine. Increased metabolites in medium were lactate, alanine, glutamine, 
pyroglutamic acid, formic acid, glycine, 2-oxo-4-methyl pentanoic acid, 2-oxo-3-methyl 
pentanoic acid, 2-oxo-3-methyl butanoic acid and acetic acid. A direct link between ala-gln 
decrease and glutamine and pyroglutamic acid increase was established, suggesting ala-gln 
as an alternative energy source (Figure 3). An apparent increase of HEPES buffer was 
observed at the five-day time point when compared with the 24-hour time point. However, 
this increase can most likely be attributed to an inverse normalization effect, since 
consumption of major components will result in an apparent increase of invariant constituents 
after total area normalization. This is a well-known effect commonly observed in 





Figure 3.  Excerpt of 1D NOESY spectra from representative traces (six each) of cell-free control 
medium (blue) and cell culture supernatant after 24 hours (green) and five days (red) incubation time, 




PLS-DA model to detect differences in offspring/par tner  
Within the initial PCA model no additional clustering according to gender, age or 
offspring/partner classification was observed. To identify significant subtle differences 
between the metabolic profile of fibroblasts from offspring and partners, a PLS-DA model 
was built using data from the five-day time point. This time point was chosen to allow rather 
small differences to accumulate over time. However, the initial PLS-DA model did not 
discriminate between offspring and partner (data not shown). Therefore, a second PLS-DA 
two-class model after OSC-filtering using two components with a remaining sum of squares 
of 21.3% and an Eigenvalue of 11.1 was built. For two components, a cumulative R2Y of 0.51 
and Q2Y of 0.32 were obtained and model validation showed intercepts of the R2Y and Q2Y 
regression lines with the vertical axis of the validation plot at 0.049 and -0.131, respectively, 
indicating a valid model. The OSC filtering step was independently validated using a leave-
one-out cross validation procedure (see supplement material). Figure 4 shows the scores 
plot of the first and second components of this PLS-DA two-class model, indicating 
separation between offspring and partners with some degree of overlap between the two 
clusters. Based on coefficients and loadings from this model, molecular discriminators 
between metabolic footprint profiles of the fibroblast supernatants of offspring and partners 
were identified, as summarized in Table 2. The main differences were observed for 
metabolites involved in the energy metabolism.  
 
Figure  4. Scores plot of first two compo-
nents from PLS-DA two-class model built 
after OSC filtering of NMR data from 
fibroblast cell culture supernatants after 
incubation for five days. Data points are 
coloured according to partner (■) and 
offspring (▲) classification, respectively. 
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Table 2.  Metabolites in cell culture supernatants identified by PLS-DA model showing 
differences between offspring and partners from the LLS. 
Metabolite δ [ppm]a Relative difference 
offspring vs partnerb 
VIPc 
Energy Metabolism    
Ala-gln 2.34, 1.54 0.95 1.30, 1.37 
Alanine 1.50 1.02 2.67 







Glutamine 2.46 1.02 2.88 
Pyroglutamate 4.18, 2.42 1.03 0.55, 0.15 
Pyruvate 2.38 0.98 0.83 
Lactate 4.10,1.34 1.03 1.52,10.62 
a mean value of corresponding bucket 
b 
as determined from mean spectra of corresponding classes 




Our main finding is that fibroblast strains derived from offspring of nonagenarian siblings 
show different levels of metabolites in their cell culture supernatants when compared with 
those of their partners. The ala-gln and glucose consumption was higher for fibroblast strains 
derived from offspring when compared with strains of their partners. Also, production of 
glutamine, alanine, lactate and pyroglutamic acid was found to be higher for fibroblast strains 
derived from offspring.  
 
Changes in metabolic footprinting of fibroblast str ains dependent on the incubation 
period  
Between 24 hours and five days of incubation in serum-free medium, the cell culture 
supernatants of all fibroblast strains showed decreased levels of glucose, pyruvate and ala-




valine, leucine, isoleucine, serine and lysine, consistent with the literature (23). After five 
days of incubation, levels of glutamine, alanine, lactate and pyroglutamic acid had increased 
in supernatants of all fibroblast strains.  
 
The ala-gln dipeptide is an important additive in cell culture medium and an important source 
of glutamine and alanine (24).  Increasing levels of glutamine and alanine in the cell culture 
supernatants could be the result of the intracellular enzymatic digestion of the ala-gln 
dipeptide (24), after which the excess of both amino acids (i.e. not needed for metabolism) is 
excreted back into the medium. This would also account for the decrease of ala-gln.   
When available, glucose is the main source of energy of cells, explaining the decreasing 
levels of glucose in the cell culture supernatants of the fibroblast strains. Through the 
glucose-alanine cycle (25), alanine can be formed from glucose, possibly contributing to the 
increased levels of alanine observed in the cell culture supernatants. Indeed, it was reported 
earlier that in addition to the formation of lactic acid, alanine and glutamic acid are secreted 
into medium by murine fibroblasts (26). Furthermore, human fibroblasts were reported to 
convert a large proportion of glutamine in culture medium to lactate (27), dependent on cell 
density (23). 
 
Different metabolic footprint profile of fibroblast  strains from longevity family 
members   
The ala-gln and glucose consumption was higher for fibroblast strains derived from offspring 
of nonagenarian siblings, when compared with fibroblast strains from their partners. Indeed, 
earlier we showed that serum glucose metabolism and insulin sensitivity is different for the 
long-living families (4;5). Indeed, earlier we showed that, in vivo, the offspring group showed 
lower levels of thyroid hormone (T3 and T4) (10). Since thyroid hormone stimulates lipid 
metabolism (28), these data suggest that fibroblast strains from offspring have a lower lipid 
metabolism. It is also important to realize that the fibroblast strains were cultured in serum-
free medium. Serum is an important source of lipids in cell culture medium, so when it is 
removed, glucose will be the main energy substrate available. Since the fibroblast strains of 
offspring showed a higher glucose consumption, they might be better able to adapt to the 
serum free conditions when compared with the strains of the partners.   
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Production of glutamine, alanine, lactate and pyroglutamic acid was found to be higher for 
fibroblast strains derived from offspring, when compared with fibroblast strains from partners. 
The higher production of glutamine and alanine is consistent with the higher consumption of 
ala-gln and glucose since these are interconverted into each other by glycolysis and the 
glucose-alanine cycle. 
Research into the disease lactiacidemia has implied the role of mitochondrial function in 
serum lactate levels (29;30). The higher glucose-consumption in strains from offspring is 
consistent with the finding that respiration-deficient fibroblasts show a higher constitutive rate 
of glucose transport (31), since we found earlier that strains from offspring are more sensitive 
to inhibition of the respiratory chain by rotenone, when compared with strains of partners 
(7;8). Fibroblast strains from offspring were more prone to go into rotenone-induced 
apoptosis, but showed less rotenone-induced senescence. Also, strains from offspring 
showed a stronger rotenone-induced decrease in growth rate.  
Metabolites in energy metabolism have also been connected to cell damage, cell cycle, 
apoptosis and senescence. Lactate levels inhibit cell proliferation (32;33) and lactate 
dehydrogenase (LDH) mediates apoptosis in glucose-starved c-Myc transformed cells 
(34;35). High glucose levels have been shown to induce senescence in human fibroblasts 
(36). Fibroblast strains from offspring are more prone to go into stress-induced apoptosis but 
show less senescence when compared with strains from partners (7). This is consistent with 
the fact that we found lower levels of glucose for strains from offspring and could be 
explained by a process called hysteresis, described as metabolite-induced gene expression 
of the metabolic machinery, creating a molecular memory (11). 
 
In vitro models to study metabolism 
In vitro, the kinetics of metabolism are very much dependent on cell culture conditions. It has 
been suggested that treatments that induce cell proliferation activate enzymatic pathways 
leading to the formation of lactate (37). Removal of serum, as in our experiments, usually 
inhibits cell proliferation, implying decreased lactate production. Yet, fibroblast strains from 
offspring showed higher levels of lactate in the medium than those of their partners, possibly 
because strains from offspring are less sensitive to removal of factors which promote 




becoming senescent (38). As already alluded to, we showed that fibroblasts strains from 
offspring are indeed less sensitive to (stress-induced) senescence (7).  
 
Manipulation of single genes in model organisms has provided much insight in to the 
pathways regulating metabolism. Evidently, this genetic manipulation is limited in humans in 
vivo for ethical reasons. It is, however, possible to experiment with cells isolated from 
humans, providing a powerful tool to study the pathways regulating metabolism. 
Furthermore, it is difficult to measure metabolites at the cellular level in organisms in vivo, 
whereas this is much easier for cells in vitro. Care should be taken, though, in translating in 
vitro results to the in vivo situation, for two main reasons. First, in vitro characteristics of cells 
depend on culture conditions like the type of medium, batch and concentration of added 
serum, oxygen concentration and the number of PDs undergone in vitro, making it difficult to 
compare studies (39). Second, cells in vitro have been removed from their natural 
environment, being derived from many factors in the blood (e.g. cytokines and growth 
factors) and cell-cell and cell-matrix interactions (40). Despite these caveats, in vitro cultured 
cells derived from subjects of different populations reflect differences between these 
subjects, providing a powerful tool to study differences in metabolism between these subjects 
at the cellular level 
  
An important strength of our study is the large number of fibroblast strains obtained from 
subjects of various biological ages, collected and stored in a highly standardized manner. An 
important limitation of this study is the fact that the observed differences were small and that, 
despite being valid, the predictive power of the model proved limited. This may be due to the 
fact that not all offspring carry the longevity traits and hence the observation in the fibroblasts 
of a random group of offspring dilutes the effects of longevity associated mechanisms that 
could be observed. In addition, compounds present at much lower concentrations could be 
responsible for metabolic differences between fibroblast strains from offspring and partners, 
but the methods applied here were not sensitive enough to detect differences in these 
compounds.  
In conclusion, we report for the first time, that the NMR-based metabolic profiles of human 
cells in vitro reflect the propensity for human longevity of the subjects from whom these were 
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derived. Future work will have to elucidate the enzymes driving differences in metabolism 
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Supplemental material  
 
Supplemental table 1.  Outlier identification: Characteristics of Spectroscopic Outliers 
# Sample ID  TSP line width  Water Suppression  
89 Sample missing - - 
91 Sample missing - - 
109 50-24h Acquisition failed - 
169 111-24h OK (1.03 Hz) FAIL 
195 117-5d FAIL (4.06 Hz) OK 
197 118-24h FAIL (6.56 Hz) OK 
199 118-5d FAIL (3.44 Hz) OK 
203 119-5d FAIL (3.19 Hz) OK 
207 120-5d OK (1.15 Hz) FAIL 
235 127-5d OK (0.82 Hz) FAIL 
287 121-128-control-5d FAIL (7.43 Hz) OK 
289 129-136-control-24h FAIL (1.56 Hz) FAIL 
Visual inspection of the individual spectra during data processing was used to remove spectroscopic 
outliers. As parameter for shim quality, the half width of the TSP line was evaluated after processing 
without apodization. Water suppression quality was assessed by total height of the remaining water 
resonance and presence of shoulders at the base of the signal. A total of 10 datasets were removed prior 
to further analysis as summarized in Supplemental table1. Biological outliers were identified based on 
Hotelling’s T2 range (above 99% T2 critical value) and distance of the observation in the training set to the 






Supplemental figure 1.  Hotelling’s T2 plot (A) and DModX plot (B) for PCA model built using eight 
components from data without scaling of variables. Data points are labeled according to fibroblast 
culture incubation duration of 24 hours () and five days () as well as control medium incubated for 
24 hours () and five days ().  
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SIMCA-P+ 12 - 2011-05-06 18:18:05 (UTC+1)  
Supplemental figure 2.  Scores plot of first two principal components from PCA model built from complete 
data set without scaling of variables. Data points are labeled according to fibroblast culture incubation 
duration of 24 hours () and five days () as well as cell-free/serum-free medium (control medium) 
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Supplemental figure 3.  Scores plot of first two components from PLS-DA model built using time point as 
response variable. Data points are labeled according to fibroblast culture incubation duration of 24 hours 
() and five days (), respectively.  











For validation of the OSC filtering step, 59 datasets were generated using OSC filtering of the 
original data leaving out one of the 59 observations, such that each sample was omitted once 
(leave-one-out cross validation). For each dataset an independent PLS-DA two-class models 
was build using the 58 observations that were included in the filtering step followed by 
prediction of the response variable for the excluded observation using the respective model. 
The predicted values were then used for classification of the samples as summarized in 
Supplemental table 2. The overall correct classification of all samples was 62.7% with a 95% 
confidence interval for the proportion correctly identified of [0.5036, 0.7504] excluding the null 
hypothesis. 
 
Supplemental table 2.  Misclassification table for OSC leave-one-out cross validation 
 
  predicted 
 Members Correct offspring partner 
offspring 28 60.7% 17 11 
partner 31 64.5% 11 20 






























General discussion  
 
This thesis aimed to investigate the cellular processes responsible for differences in human 
longevity. We studied in vitro stress responses of dermal fibroblast strains derived from 
offspring of nonagenarian siblings with the propensity for longevity and compared them with 
the responses of fibroblast strains derived from the partners of the offspring, representing the 
general population. As a proof-of-principle we also compared fibroblast strains from 
chronologically young and old subjects, hypothesizing that differences between offspring and 
partners should be similar, at least in terms of direction, to differences between fibroblast 




In chapter 2  we describe the optimization of a flow cytometric method described earlier (1) to 
better differentiate between populations of fibroblasts in degrees of SA-β-gal activity. SA-β-
gal activity is a widely used marker for cellular senenescence and is routinely detected 
cytochemically, manually discriminating negative from positive cells (2;3). This method is 
time-consuming, subjective and therefore prone to operator-error. Skin fibroblasts were 
isolated from young and very old participants of the Leiden 85-plus Study (4;5). To induce 
stress-induced senescence, fibroblasts were exposed to rotenone and senescence was 
assessed measuring SA-β-gal activity by cytochemistry and by flow cytometry. Under non-
stressed conditions, fibroblasts from old subjects showed higher SA-β-gal activity than 
fibroblasts from young subjects and this difference was found for both the flow cytometric and 
cytochemical methods. However, under stress-induced conditions the flow cytometric method 
but not the cytochemical method revealed significantly higher SA-β-gal activity in fibroblasts 
from very old compared with young subjects. We concluded that the modified flow cytometric 
method for measuring SA-β-gal activity is superior in discriminating between degrees of 





Chapter 3  describes the cellular responses to stress in skin fibroblasts that were isolated 
from young and old participants of the Leiden 85-plus Study (4;5). These responses were 
compared with the responses of isolated fibroblast strains from participants of the Leiden 
Longevity Study, offspring of nonagenarian siblings, and their partners, representatives of the 
general population (6). Under non-stressed conditions SA-β-gal activity was lower and levels 
of apoptosis/cell death were higher in fibroblasts from young subjects when compared with 
fibroblasts from old subjects, as were stress-induced increases. Numbers and total size of 
colonies under non-stressed conditions were higher for fibroblasts from young subjects. 
Under non-stressed conditions there were no differences in levels of SA-β-gal activity and 
apoptosis/cell death between fibroblasts from offspring and partners. Stress-induced 
increases of SA-β-gal activity were smaller and levels of apoptosis/cell death higher in 
fibroblast strains of offspring when compared with strains of partners. Numbers and total size 
of colonies under non-stressed conditions were higher for fibroblasts from offspring whereas 
rotenone-induced decreases were lower. These results suggest that under stressed 
conditions, fibroblast strains from offspring resemble fibroblast strains from chronologically 
young subjects and provide support for the hypothesis that in vitro cellular responses to 
stress reflect the propensity for human longevity. 
 
Cellular senescence, an important factor in aging phenotypes, can be induced by replicative 
exhaustion or by stress. Chapter 4  reports on the relation between maximum replicative 
capacity, telomere length, stress-induced cellular senescence and apoptosis/cell death in 
human primary fibroblast strains obtained from nonagenarians of the Leiden 85-plus Study. 
Fibroblast strains cultured until replicative senescence (5) were stressed with rotenone at low 
passage. Fibroblast strains with a higher replicative capacity had longer telomeres. In non-
stressed conditions replicative capacity was not associated with SA-β-gal activity and 
negatively associated with cell death. In rotenone-stressed conditions replicative capacity 
was negatively associated with senescence and positively associated with cell death. These 
data indicate that fibroblast strains with a higher maximum replicative capacity have longer 
telomeres, are less prone to go into stress-induced cellular senescence and more prone to 





The free radical theory of aging states that function of the respiratory chain becomes less 
efficient with age (7). The concomitant increased levels of ROS damage proteins and DNA. 
To model this process in vitro, we chronically exposed fibroblasts to a low dose of the 
mitochondrial complex I inhibitor rotenone. In chapter 5 we describe the different responses 
between fibroblast strains from young and old subjects, and between offspring of 
nonagenarian siblings and their partners. Under non-stressed conditions, fibroblast strains 
from young subjects showed lower ROS levels and a higher growth speed when compared 
with old subjects, but telomere length and shortening rate were not different. Significantly 
increased ROS levels were observed after chronic exposure of fibroblasts to rotenone, 
whereas growth speed was inhibited and telomeres had shortened. Under stressed 
conditions, lower ROS levels and a larger decrease in growth speed were found for fibroblast 
strains from young subjects when compared with strains from old subjects. However, no 
differences in telomere shortening rate were observed. The stress-induced decrease in 
growth speed was larger in strains from offspring of nonagenarian siblings when compared 
with their age matched partners from the general population. Summarizing, fibroblast strains 
from young and old people are differentially affected by chronic inhibition of the respiratory 
chain and responses in fibroblast from offspring of nonagenarian siblings resemble the 
responses of strains from young subjects.  
 
Not much is known about the complex interplay between upstream and downstream 
pathways leading to senescence. In chapter  6 we investigated the signaling pathways 
responsible for the different in vitro phenotypes between fibroblast strains from young and old 
subjects. We determined whole genome gene expression of non-stressed and rotenone-
stressed human fibroblast strains from young and old subjects and identified gene sets 
involved in cell cycle, mitochondria and transcription. The gene whose expression differed 
most between fibroblast strains from young and old subjects was the cell cycle inhibitor p16, 
being higher in expression in fibroblast strains from old subjects. p16 is regarded as a robust 
marker for cellular aging (8) and increasing numbers of p16-positive cells can be found in 
mitotic aging of aging primates (9;10). Furthermore, p16 plays an important role in 
senescence (11). Unexpectedly p16 mRNA decreased after rotenone. To verify these results, 




the protein level. Rotenone again resulted in decreased p16 mRNA expression, but this time 
p16 mRNA expression was lower in fibroblast strains from old subjects. This discrepancy 
might be explained by differences in seeding density and/or differences in incident diseases 
in the two different samples used for the microarray and replication experiments. No 
rotenone-induced changes or young-old differences in protein expression could be measured 
by Western blotting, whereas by immunocytochemistry fibroblast strains from old subjects 
showed higher percentages of p16-positive cells in both non-stressed and rotenone-stressed 
conditions.  
 
When compared with the general population, nonagenarian siblings and their offspring 
showed a lower risk of diabetes mellitus (12), better insulin sensitivity and glucose handling 
(13;14) and a different lipid metabolism (15), indicating differences in metabolism in general. 
In chapter 7  we investigated if fibroblast strains from offspring and partners also show 
differences in cellular metabolism in vitro. Ala-gln and glucose consumption were higher for 
fibroblast strains derived from offspring, when compared with fibroblast strains from their 
partners. Production of glutamine, alanine, lactate and pyroglutamic acid was found to be 
higher for fibroblast strains derived from offspring, when compared with fibroblast strains from 
their partners. In conclusion, the metabolic profiles of human fibroblasts in vitro reflect 
differences between offspring from families with the propensity for longevity when compared 
with fibroblasts from their partners.  
 
Methodological issues 
All the results described in this thesis were derived from in vitro experiments. As already 
alluded to in the introduction, translation of in vitro results to the in vivo situation requires 
much cautiousness (16). An important strength of our study is the fact that we can directly 
link the in vitro data to the in vivo data of the subjects the fibroblast strains were derived from. 
However, cells in vitro have been taken out of their natural context and are thus likely to 
display a very different cellular phenotype, making it difficult to interpret the relevance of in 
vitro results for the in vivo situation. Depending on the proliferative state of cells, they will be 
more or less responsive to stimuli and especially dermal fibroblasts are not as proliferative in 




Results can also be different depending on culture conditions. All cell types in the body 
experience oxygen tensions much lower than the oxygen tension of ambient air (17) under 
which cells are usually cultured. It is likely that ambient oxygen tension actually stresses cells 
and this background stress might make it difficult to measure stress responses induced by an 
experimental stressor (rotenone in our case). Cells can be handled and cultured under low 
oxygen tension conditions but the equipment necessary to do this is very costly and this is 
not feasible for many laboratories. Other culture conditions that will affect the results are the 
presence or absence of factors in the medium (e.g. growth factors, cytokines etc.), mostly 
derived from the foetal calf serum added to the medium but also often added separately. 
Different batches of foetal calf serum can yield different results so it is of paramount 
importance that when experiments are replicated, the same batch of serum is used and one 
batch of foetal calf serum will only allow for a limited number of experiments. We used the 
same batches of serum for our experiments, but the serum that was used for the Leiden 85-
plus Study fibroblast strains was different than the batch used for the Leiden Longevity Study 
fibroblast strains, making one-on-one comparisons impossible. When comparing the results 
of the fibroblast strains of these studies, we could only look at the direction of differences. 
Furthermore, the sizes of the biopsies the fibroblasts were isolated from were different for the 
Leiden 85-plus Study (3 mm) and the Leiden Longevity Study (4 mm). 
Another factor which should be taken into account when interpreting in vitro data is the cell 
type. The dermal fibroblast has been a popular in vitro model since this cell type is easily 
accessible and grows readily in vitro, providing ample (yet finite) experimental material. 
However, results generated with this model are not necessarily valid for other cell types. In 
the experiments described in this thesis we aimed to oxidatively stress the fibroblasts. One of 
the most commonly used oxidative stressors is hydrogen peroxide, but due to its reactive 
properties it is very unstable and it will readily react with other components in the culture 
medium, making it difficult to determine what final concentration is applied. Since one of the 
theories of aging states that a decreasing efficiency in oxidative phosphorylation results in 
mitochondria-derived increased ROS levels, we decided to use rotenone which inhibits 
complex I in the oxidative phosphorylation chain in the mitochondria. Although rotenone is 
extensively used in mitochondrial research, it is not used much in the field of aging, 




Implications and future research 
We have now shown that fibroblasts in vitro do reflect the population of subjects from which 
they were derived. More specifically, we have shown differences in in vitro stress responses 
dependent on chronological and biological age in vivo. Fibroblast strains of offspring with the 
propensity for longevity showed stress-induced responses that tended to be more like the 
responses from chronologically young subjects. Fibroblast strains from offspring of 
nonagenarian siblings showed less senescence and more apoptosis/cell death. The latter 
could be interpreted as being a tumor suppressive mechanism, removing damaged cells from 
the proliferative pool of cells before they become tumorigenic. Removed cells should then be 
replaced with healthy cells from a pool of replenishing stem cells. This could be a topic for 
further research. 
 
Although there was much interindividual variation, in vitro stress responses might be 
regarded as a marker for biological age. Having found these in vitro differences, we 
performed initial experiments using a transcriptomics approach on the comparison of 
fibroblast strains of chronological young versus old subjects, to gain more insight in the 
pathway driving these differences. This approach should now be extended to the comparison 
of fibroblast strains of biologically young (offspring) with old (partners) subjects to determine if 
the pathways driving the differences in chronological age are similar to those driving 
biological age and to identify (combinations) of candidate genes as possible markers for 
biological age. Once pathways and key regulators in these pathways are defined, genetic 
variation in the responsible genes should be studied to see to what extent this variation can 
explain differences in responses to stress that ultimately lead to increased longevity. Ideally 
this approach should also be applied to cell types and stressors other than those described in 
this thesis. Once common pathways and genes responsible for the differences in 
chronological and biological age are identified, these pathways might be modulated by 
compounds resulting in biologically old cells becoming biologically younger, i.e. resemble 
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Uit de Leiden Lang Leven Studie is gebleken dat negentigjarige broers en zussen uit families 
met een aanleg voor langlevendheid 41% minder kans hebben om te overlijden vergeleken 
met negentigjarigen die zonder broer of zus die leeftijd hebben weten te behalen (de 
zogenaamde sporadisch negentigjarigen). Ook de kinderen (± 60 jaar oud) van de 
negentigjarige broers en zussen uit de langlevende families vertonen een significant lagere 
prevalentie van hartinfarcten, hoge bloeddruk en suikerziekte vergeleken met de partners 
van de kinderen. Met andere woorden, de leden van de langlevende families lijken biologisch 
jonger te zijn dan leeftijdgenoten uit andere families. Het doel van dit proefschrift is het 
bestuderen van de cellulaire processen die ten grondslag liggen aan deze familiair 
aangelegde langlevendheid, gebruik makend van huidcellen, de zogenaamde fibroblasten. 
Het doel was om eerst aan te tonen dat de fibroblasten van de kinderen uit de langlevende 
families in vitro (kunstmatig gekweekt in het laboratorium) anders reageren, waarbij we 
fibroblasten van de kinderen vergeleken met de fibroblasten van hun partners. Zij delen 
immers dezelfde leefomgeving en (eet-) gewoontes en vertegenwoordigen de algemene 
bevolking. Om de kans te vergroten verschillen tussen deze twee groepen te zien, 
bestudeerden we de fibroblasten onder niet-gestimuleerde omstandigheden en na het 
toedienen van oxidatieve stress. Om deze processen ook te kunnen vergelijken voor 
kalenderleeftijd, vergeleken we verder fibroblasten afkomstig van jonge mensen (± 23 jaar 
oud) met fibroblasten van heel oude mensen (> 90 jaar oud) uit de Leiden 85-plus Studie. We 
hebben ons vooral gericht op de cellulaire processen apoptose (gereguleerde celdood) en 
cellulaire senescence (een staat waarin cellen stoppen met delen en heel andere 
eigenschappen krijgen), omdat deze processen een grote rol spelen in de reactie van cellen 
op stress en in ouderdomsgerelateerde ziekten. Verder waren we geïnteresseerd in de vraag 
welke signaaltransductieroutes verantwoordelijk zijn voor de verschillen tussen de 
fibroblasten afkomstig van de verschillende groepen mensen. Met signaaltransductieroutes 
bedoelen we de communicatie tussen de verschillende processen op celniveau. 
 
In hoofdstuk 2  wordt de optimalisatie beschreven van een flow-cytometriemethode waarmee 




mate van Senescence Associated-β-galactosidase (SA-β-gal) activiteit vertonen. SA-β-gal 
activiteit is een veelgebruikte marker voor cellulaire senescence die oorspronkelijk op een 
cytochemische (het kleuren van cellen) manier gebruikt wordt, waarbij cellen handmatig 
geteld worden. Deze methode is tijdrovend, subjectief en daarom gevoelig voor fouten. Uit de 
resultaten trokken wij de conclusie dat de flow-cytometriemethode om SA-β-gal activiteit te 
meten superieur is in het onderscheiden van de mate van senescence van verschillende 
populaties van fibroblasten. 
 
Hoofdstuk 3 beschrijft de cellulaire reacties op stress in fibroblasten geïsoleerd uit jonge en 
oude mensen die deelnamen aan de Leiden 85-plus Studie. Deze reacties werden 
vergeleken met de reacties van fibroblasten geïsoleerd uit kinderen uit de langlevende 
families en uit hun partners, als deel van de Leiden Lang Leven Studie. Wanneer 
senescence, apoptose/celdood en het vermogen van fibroblasten om te delen gemeten 
werden, leken de reacties van de fibroblasten uit de mensen uit de langlevende families meer 
op de reacties van de fibroblasten uit de jonge mensen, met andere woorden, deze 
fibroblasten leken biologisch jonger te zijn. Hieruit concludeerden wij dat de uitzonderlijke 
langlevendheid van de mensen uit de langlevende families ook tot uiting komt in de cellulaire 
reacties van hun fibroblasten in vitro.  
 
Cellulaire senescence wordt beschouwd als een belangrijke factor in het verouderingsproces 
en kan opgewekt worden door cellen net zo lang in vitro te laten groeien totdat zij stoppen 
met delen. Echter, senescence kan ook optreden in cellen als zij worden blootgesteld aan 
stress. In beide processen spelen telomeren een belangrijke rol. Telomeren zijn de uiteinden 
van de chromosomen en dienen als beschermende buffers tijdens het kopiëren van het DNA 
(vergelijkbaar met de uiteinden van veters om te voorkomen dat deze gaan rafelen). In 
hoofdstuk 4  hebben we gekeken of er een relatie is tussen de verschillende oorzaken van 
senescence. We vonden dat fibroblasten waarvan bekend is dat zij een grotere 
replicatiecapaciteit hebben (ofwel langer door kunnen groeien in vitro) ook langere telomeren 
hadden, minder gevoelig waren voor stress-geïnduceerde senescence en juist sneller 





Eén van de bekendste theorieën van veroudering is gebaseerd op de veronderstelling dat het 
omzetten van brandstof en zuurstof in cellen minder efficiënt wordt met toenemende leeftijd. 
Dit leidt tot het vrijkomen van meer reactieve zuurstofradicalen die eiwitten en DNA kunnen 
beschadigen. In hoofdstuk 5  beschrijven we experimenten waarmee we dit proces hebben 
willen simuleren. Rotenon is een chemische stof die het verbrandingsproces in de 
mitochondriën (de energiecentrales van de cel) verstoort en zo leidt tot toegenomen 
hoeveelheden zuurstofradicalen. Zowel in niet-gestresste en rotenon-behandelde toestand 
vonden we dat fibroblasten van mensen uit langlevende families leken op fibroblasten van 
jonge mensen. We vonden echter geen verschillen in telomeerlengte of mate van 
telomeerverkorting. 
 
Er is nog niet veel bekend over de complexe samenwerking tussen de signaaltransductie-
routes die leiden tot senescence en de routes die als gevolg van senescence actief worden. 
Hoofdstuk 6  beschrijft de experimenten waarmee we deze signaaltransductieroutes hebben 
willen identificeren, gebruik makend van een techniek waarmee de expressie van vele 
duizenden genen tegelijk kan worden bestudeerd. We vergeleken fibroblasten van jonge en 
oude mensen en vonden verschillen in de signaaltransductieroutes die betrokken zijn bij de 
celcyclus, mitochondriale processen en transcriptie. In het bijzonder het eiwit p16, een 
celcyclusremmer, kwam in verschillend mate tot expressie in fibroblasten van jonge mensen 
vergeleken met de expressie in oude mensen. Het is bekend dat p16 een belangrijke rol 
speelt in senescence.  
 
Vergeleken met de algemene bevolking hebben de mensen uit langlevende families minder 
kans op suikerziekte, betere insulinegevoeligheid, betere glucoseverwerking en een 
verschillend lipidemetabolisme. Deze verschillen duiden op verschillen in metabolisme 
tussen de normale bevolking en de langlevende families. In hoofdstuk 7  hebben we 
gekeken of de fibroblasten van deze groepen mensen in vitro ook verschillen in metabolisme 
vertonen door met NMR-spectroscopie metabolieten in het celkweekmedium te meten. We 
vonden een hogere opname van glucose door fibroblasten uit mensen uit langlevende 




of in het medium uitgescheiden, wanneer fibroblasten uit mensen uit langlevende families 
vergeleken werden met fibroblasten uit hun partners. 
 
Conclusie 
We hebben laten zien dat de fibroblasten van verschillende populaties van mensen zich in 
vitro ook verschillend gedragen. In het bijzonder hebben we aangetoond dat de in vitro 
reacties op stress afhankelijk zijn van de kalenderleeftijd en de biologische leeftijd van de 
mensen waaruit de fibroblasten geïsoleerd zijn. Zo neigen de reacties van fibroblasten uit de 
mensen uit langlevende families meer naar reacties van de fibroblasten uit jonge mensen: de 
fibroblasten van jonge mensen en van de mensen uit de langlevende families vertonen 
minder senescence en gaan sneller dood als reactie op stress. Dit laatse lijkt een negatief 
effect, maar als cellen beschadigd raken lopen ze het risico de controle over de celcyclus te 
verliezen en ongecontroleerd te gaan delen. Dit verschijnsel is beter bekend onder de term 
kanker. Het verwijderen van deze cellen door ze gecontroleerd te verwijderen (apoptose) kan 
dus als beschermingsmechanisme tegen kanker gezien worden. De voorwaarde is dan wel 
dat de verwijderde cel vervangen kan worden door een gezonde cel. Vervolgonderzoek zal 
duidelijk moeten maken of dit inderdaad het geval is, welke genen en signaaltransductie-
routes deze verschillen kunnen verklaren en hoe deze routes zodanig gemanipuleerd kunnen 
worden dat biologisch oudere fibroblasten (van de partners van mensen uit langlevende 
families) meer op biologisch jongere fibroblasten (van de mensen uit langlevende  families) 
gaan lijken. Vervolgens zou dit principe voor andere celtypen in vitro aangetoond moeten en 
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